var title_f21_17_21776="Nailfold infarction in RV 2";
var content_f21_17_21776=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F74000&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F74000&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Isolated nailfold infarction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 329px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFJAfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDzaBQpBzVoYZuO9VwuAFFSRna3HavJPsSUKcn0pdvNKjkg49alY7l4FACfKF96TcoGSaaw6Co2BP4UmNIlDgnHapkIPQVVhUsavRgYoBi00rnk04gZoB9cUgEJwMClUkjnmgkdxQPagB4NO4qIA9afnjHekANz+NRsxUc0/cB1qN+aASGh6Yzc0YIOaaw5oKH7hjNNyCaQqecUKuDzTGO25o2n8KevSgc8UhDAvSnBeaeBTh70mwI2HHNVnFW3IwcVWkHNIaK7jPtULirTL71WkGAakZAaTtSsKaeKYzZ8Pw75xxXo9liOEYrh/DCDIJrslb5K1p6K54mMfNOxM0m+XrxWjZ5yMdK5wzN520VvaeSFGc1pB6nNKNomuzkIMVUdyxOaez465xUE0i9Aea1kYJFi1Qb89a1YlG0dqy7F1J961oj6dKSSJmxS5QdeKerA81FLznikiJxzT2ZFh9wMpXF+KG2W8mfSuzkOVNcF44kKW7/SlJl0leVjxLWI/Ovm781WNlx0rQnG66OacRgVjzM+hp0lymNJZegqGOJ45gQTxW4QKgeNd27FNTZFWhG1zQsZn8vbnrXWeH1+eJufvCuOsfmOPeu40KPDQ59RUVGePJ3uem2unz6jFOkVvNLIVXhHwAO+adqlpaweH0aKKWOfLBg75P0xVjTdWj0W4uWCyGR4wRjO3HbNVNUvG1C0aZ0ZEKlAQDtz/jXpPc8pDBJeWOjaPd2coaQh40jJGUYnhh9K6S0vvEdvafZ5pILwlF8udVLZbPsMfnis600iO78M2kn/AC2jJCknjrmug07UTbaWqzSCAQrv3RlQGXB9e9El1EtilaI11d6hBHbzQvacyzysJI5HIzuxn9e1MttPntZYJLOzguFcriRzsUj/AJ7LjnirYhi1ezl1hy4jKeXGJWwuz+IMneql1bf8I+kepLII7ZYhGAjEb0JyAFPTFSm9gsGpy6/OIVhmdWLFgiw4BYHjluD61zvidTJ4l0jzNv2hJkB2+vfmuyfUQ+lIpcuJyCgdgcoRkdK4fxBdRyeJtIsosO6SqzsPbtVRQM63SZZJrzULZ4lWAKW3N/Ee9Z/2O60me2gkdTavKHRQOn0q9Pp99cx301jcJEWzH5YPzP8A4VRa3vhBZvco+0NGMuVJz+FF+gjP8Rc7/wDeNeD+OVFtqjSLxk81754hjKvIPc14V8Sk/fk1xRdmdtIr6PLu2HNddZKCoPrXB+Hpc7BXe6cfkFRUO1bF+NcEUVYjAIBNFZDucETzg07bkcDBqVVUZOcnpmnpwmT0HerPd3EjXaMVPhVX61FFyee9SFC2ATwKAYIgJ5FKYxux0p4HTHSn7McmgL2I1TB4FSAYBzThnPHSjGc0CvcQDIpADmng7RinDmkMhx8wp/4U0j5+tS+/rSGIq+1I6jpTwSOoqGVsc0gGFeaUqcU5Dk1JtOKYyuR7U0IS1W4481IIwDQFymylRzSYGOKuTKAuRVMg5wBQCdw28e9PWP1p6Agc0uc9KTAaB6UuM8AUvpxSqM5FSIhcGoWANXJBxUBFA0ym44qu4q3NxmqrGkWiBxg1Eeo+tTtzUePmH1oHfQ6nw4h4wOPWupyEiyTXP+HYztUAVv3Me2LJPat4aI8Ku71CpbvvuRXV6eg2Dt9a5rS1HmZC55rqYXwoypFXTZjXfRDrjjoKp4y3Q1eZkJ+9UkccOeXArSWpgnYitdqYJBrThnXGFqKHyOhYHFWE8sHgikvIiTTHbgetKvTikYI2cGkXjvVEDnGAa878fnELAd69Bnfah+leb+O5A6MAamb0NqCvNHlcq/v2NI1SuP3zU1hXPc+lgvdIDUTnqKnYYzVZs5pozrfAy/pEe+UCvQNIiKGLIzXEaCuGyTgV11rqKQhcDcVOamo9TwnFvY9V8Ox3Wo3V1pa3SW9vcQguWTLNjsp7GtnxVpltaeForeIAyo2OG5PHU1xkXjnSbUmW0gkE08QSQn/lkR3Wr7eOtJlsJbSbzX2ITFIE5ZiO9dnt6fc890Kn8o6bW49L8FeUN8l62DEiDJPufpXJz659sUy3ygmT76spXcfp3q3o3jW/0x9iRW9zHyQkke7H0Nat3461e+thGNHsWA5BNvu/Q1LxlIr6tOJ0PhvVzfWFvaLJboiqqgbQCwB7/wCTUniXUo4DNGlxFMm0gI6htnXIB9Mc1wsOreIJbxdmkW8hkYHH2VRj2HpW9HPr6FnGmrD8xJ2xp/hR9ahukyHRkt7GJLrps0RLKLLEYQRrkge3pU/hXT7vUNdXUpba4ijjwR5qYGc+pq19r1O3UgQTxck5RR1qhfatfyhFu5ruRUOVV84H4VDx9NdGUsPKXU7pI7gXdzdPPHEI1JRe7DqeP60g0yX7Kk0TyKkrpKIgDsA46Zrj9U8bXs91FKoEMSBQYVX5XwMc/Ws2TxzqUckj212Y85CpjKoD2ANNY6m9rj+qTOx8RDJm7/Ma8L+JceBurtLDxwBm31ht2TxN6/WuR+JFzbXNrutZVkXGeDURnzO5tCnKErM47QJMOor0bSGzEOc8V5boz4mXmvStCkzEBTqI6zoAcJxRQnIAornYrnFxK2TnipmxtIxxkU3OME46YqXbl8etaHvXGKASDnFPifnFRsuMnOWHSkiLAZ70hln7vU1LnOBiq0RZz6mpgzBh3x1NAiaIEE570MNoPek3gyAYqQKCc4yaBFcEhvmqdVJTilMYbnvTlGAaLA2QBSHGalK+lO49OaaCQc4pASFBt6ZqtJHmrQzt4poU5oBaEcEFTSR7VpVOKcW3DmgTbIEA70/HFMIxThSKB8Yqrt+fire3OfSkMfFAJ2IcDHtTRT5F9KYoPepKHcY4pwxUf0pQaBCyEVWY5pznnGaa2NtBSRWlyTVdxU8h5qux5xSZoiMj86bGMyqKkFPtlBuk4oJk7I7zw/BiFTjmtS8TcmD0qnpLiO3XtxUt1OTwK3Wx89JtzuXNKjRcVvRFABkVhaWGABIrdhK7Rkc1cNjGruThYmHK/pTlt4WboM0KEYe9WoYRjIq9zFuwkVvGp5XFTmONhkYow+eSCKTA78VRG5C8IGSKZgipiSKjfpk0ikVb1wsZya8y8YTZdua73V7jahGccV5V4ruwZHGaym7nZhoXkjmM5lY0jDjmkg5Uk1IRnNYtn0CWhXdeDVUD56vOKozNsJpoioro0LSTYMDvW7ZNEyjeTWFotsbuUV3Gn6RGCocUnC+rPIqSUXZC2senkYfcTWtbzaXbqAYGY+61oWGkWy4PlitH+z4n4EYAHtUqh1OaU7mOuu2Vs+YbMH321NJ4snaL/R440PbIrUTRYSAZFB9scUp0q3yFVBWqpSWzMnyPcyLTxRfpcRPNMqKrA5Qc9a6qXxlp25mWeV8nOWXljWK+iQScbBj1qe10C3iAxGCPemoVFsyXGmy9/wAJvpCviVJ2z6LUT+MdImkKraTv9UpG0CFm3bBjsMVNFpUMRIES/Wk4z6v8CeWn0Kd3q2iX8LRyWMoyP7uKwLoaXHCVitXyfUV2K6bCedgBqvd6bEQflFJUE9WNSS2PG/Eq2xztiKVwWoTOpZFclTXtfjLSYmspGVQCBXhl6CtxJH/dbFbRp8mx1UWpkmmHE65r0fRJMRrivNLM7Z1rvdDl/dj1pzV0VJe8ddFISBzRTLD95gYorlauIwYkXaxAGB0x3qYpyMcc8ilVQiAgYKjBpGLHgH5d3X1rQ9u+pEE5O0YHqaaU+UkDrVmMAx5LZ6cGo9owepIpFJkSkpIAOmKtAZTGce4qFR8+QCSeKniXJIB4ApMGxiZ6k1MpOQBmolXMnoB+tT5AbAPJpIGTOPlGKYoxk5oDHbzSZPX1pkpAvTpzSkEgUKMg5PSnHOAMcUhip2FScAVEBz1pwyOaZLQHv6VGzMW+WnyMoFCDgHFJlCDHpzSbeOOKftzTdrZoAliAPBpzIMGq8bYYg1MDkGnfQlogkHJphGB71K+M01uRUForEcmlHTFOYVFuwxA6UFCMtRspA7092prPlelBSKzL1zVeRcVakPWq7EZpFIgORUlhk3aj6Ujkdql0xc3YxQTU+FneWPESirSRgv61Tsh8q56AVq2yFnB6Vutj5+WjNGzQCMVpwr04qpbqoGM1ehGetaI55E6RDr3qxGuB3qFMAVNGvvVpGTJFznvilYZHNKgFPIyBTSJuQcd6qXThQfSrU3yg4rLv3AiPrSlsVHc5jxHeiONjuxXkOt3ZnumUHOTXW+PNUELeWG5NcFbgyyGRu9YSPZwlLqXYuFFP7c0gFFYnq2GtVO4j3H8att1phILqDVImSujoPCdvtO7HFdrZfNMK5/w7Eq2+4Vt2rbJuKps8OovfZ0sUqxqB1PtVuCSRlysZ/GsqykUtljz71s29xkYFaw1OeasQ3F7PCvMRxWUdZCH58hs9MVtyo7ghulYt9FBkkqAa0cX0YQ5Xo0WYtaV/uqST6CrKahcEDETY9axoJEjbCita2kLgc8elQ79xSil0L8FzO55yKuxb+N3eq9moyMgVf8lSPShJ7mMmhsrqoqnLLlTjmi6DI+05INIseENPVsk53X4/NtpAe4r5+1u32atcADvX0dq0ObdzjtXgfiWLGrz/AFpydjtwcVKRzi/LMK7LQHyqjtXITDEgrqvDZBZVpP4TWorSPRdLjxGh9aKsaeu2FAPSioijlk9TlyoIU9SRxinSENgBeMnp604cgdcgDJ/pTVAb+IjGT9ag+gEQHjKYPQZpqoe5zgc/nUkY3NjdkZ4xRjC/M3zY4NIoJ0A6fKPWpLcfutznngfWmvkcMPlY0+Ncqd3ADDg0hPYcFwcj1qRQMZA5PFN4AJYfMScCgEgkAcGhaCHop3cnNJJHlMjOaRScegNOclQpyMHigWtyOKMgHNOBIJB6U0OVOc8GhTuY8VJXqKGOcd6kUnb1zTlTA55NLGhG6nYTaITGSMnvSElhzxU49CaaycdKPQYRntUiYLc9KYi7TkdDUnf600SxAihyaOMkCpHj44601FIPNAXIjHzk9KaV496sHB471C6YzSaBMrsOTVZl5qxJweO9MC1JoiApxzTGXHXNWmApjikUmVZF4qlKMVcnODVOVt1BaZCeRVvRwWvQPeqwHvWp4fiP2jdQRXdoM7Wyj/d5x2rTs13NyMVRtD8oFXoZRuwgroR8/K7Na3VVx61oJ2yQKyIGOAGznvWhA5B6cVotDCSLykE4wKnC7QDg4qBOACT9KsD26VaRiyQdO1OPTmkTpwacMYOaollWfvXP67KIbSV2ONozXQXRx0rzz4m35tNHkCtgtwKmeiNqK5pJHkniC6bUtVc5+RTSwRBEAHWorGEn526nk1bIxXHJn01GnyoQCgigdaO1QbEbrVduHX61ZbvUMo6H0qkyZbHbeGG3WwB7VspGTJla5zwxL+725rr7HBbmtFZnh1rxm2RGV4WBYcVvaTOZCOMe5rL1CMYB461qacqlFI44qkrSMm1KJuSIDFkMCTXNasBG4BOfauiWNSg2nt1rF1ODGTtyTW7vYypNKRh7jvGytnThJgEnBrPKBZAQpNathG8gBYlR6Csnua1GjWtY2zzJWjGr4+8DWfawKzDFaiQqg+UZ+lUkcc2Vb1AVBJ+YU0cqD3qe6VXj5PI9agQfIKpElDUtpt3BHavn/wAWrjWpgPWvoDUxiFj7V4J4yXGuS+9TUO/AfGctdLg5rd8LyDzlHvWPdL8pq14dl23SgnvU9DqxEbM9m00hoU+lFVdKlzboR6UU00ec1qc8khLsxORxTmyVDBcHnFRYDZDcjgcVZUgJ82dpztPv71ifRPQjwyg8jk5457UzcWUhj90Y6e9XIS3ZQcNjpjIxT5IlQEhSQQDjFAuaxXKsw5PIP4VZjUY2kkgkAnHfFRyFgMKMZJ60jSNGyg9mBpBuTOFcjaCSO1NVRuRASM560wSjGWPJJAqRd3+zx2pBsKyAEhui44pjRkEKe3rVgABiTySBSMcZzg80xXIBCwPPTNSxxbWyBTlKnPHc9akCnbntQkDbG5wTjvTtvI9KccPHuPWljfgjjNBJCF5IAqQJ8nrTgAw3d6jZiKB3uNIK8dqlAyBzTHfd7YoyMAflQDRLTSciliBxg9KXGOvNAiEoQdxob7tSSOegHFRM4xjFSNJsryAZ5ppFPk4Ge9Rhwcg0jQiPBqORhUshweOtVpTzQikRSAEe1UpeCcc1cbnOTVeQcH0pGiIAecdq3fDwAXeelc+zYJrb0mTbbAj0oXcxxKvCx0pujjap2jvir9ix4JBwaw7JS7DjrXRWSEgIo+pNdFPU8ypBRVjTikLBdo+X0rTt8nb0rPtIiSMq5xwARWzbRKB6GtbanBOyJEO0AGpPN5yM0hT5cdBTo4CPxqrGOnUljYsP8KkLU1ISOefzps2FqiXYbcvhMnFeK/FS9+0XsNqpOAcmvXL+bbG3sK8M8UsbnXnZucVlVeh34CnzVLmbAgVAKcy1IBjihxXGfRorleaMcVJtOeKRhQBCwqGUfLVgjk0xxlSMUITRs+GGPmAV6FYR8A1554Yz5/Fel6WMoK2p6nh43SRBqwAjGM5qXR7higGwkVNqkeY81RsJykhUKeKclaRzx1gdNFcbV+ZCKp3s2/IAOPpTEujgZXJpFllkYfuSRWqnoZclncrRQyyScJ8tbNrbuqAHAFJAlww+WMJ71ahtbhhlpD+AoJnK5YtoQnUnFXQygfeqqtq2MPM1OFmi/wDLVvzqrvsYOz6kzbGB3YqvIFXoaHtMDCytimtaZT75Jpe92DTuZWrSAwsF64rwjxlzqzGvbdaH2aJ93ccV4h4qbzNRZvU1M9j0MAvfMCcZQ1WspPKulPvVtxkYrPnBSQEdqmJ6GIjdXPVNBvg1ugz2ormfDt5iJBmipeh57gdEmQrDjJPQfpTQcHy+eOf1pAzEkDOQQRiiNNw6kYyak9uxd3KACCcg8kc0wOSGYEjIBIp2QTtX7tNYZAKEncR17UiUI8m8ccck/wCFSBQjZION3AH0qsoGW3kkYPHpViMYJ259yeKTG0KxDMNq/h2pTGwUgkE5PelZSnODjAOe1IH2MWz1zjimCHgnbj1xz6VLtXIIHPvUClXAK88jj2qZSuMDPyg+1BLQ6UKDkEkA9qlwWjC4AAHQ1GSxPC9uRUqKDCrO3507kvQYo+XbjtTSrIxAHepep4xkChGPzEjPGM0hiKpxgnBzTXQkc1KoBGUII9KXIB+frjpQK9iqqjeQw+lSbcgjHSnvgnPSkXBHB5pIdxVOEpzHKjI5qND8+D0BpZGPpxR0FbUiLHJGKicEUrbi2RSM2cZqWaJWAYIxVeRSG4qQvg8UhO5smkNKxCykDnvVaVeSR0q65A4xVeUgjnigpFKRscVE3IqSRRu6VG3K470GqRUlGMn8q2dIQm3THOe1ZEinGK6jQof3Ma4powxDsjV0yL51U9a6izt+QeQPasixTypwccGultPLCjqK6aWiPHxE3fQsWUOzp0NacUZ2kgfL61VjKlfvYHTNX4whjUHexA+6K3ijz5sizz1/Kp0GV7U8I5A3DaM8UzHJAOaZN7jlYjIzUM+AtS4x0qvOcjmkCMPV3KQN6EV4vfsJtUuH7A4r1rxRceVZzk8BVzXkFt+83v3Yk1z1ux7OWx1chhBzTsHHNWNlNZMdK5j2LkO2opBxU5pjCkNFbGTSOvympiMdRSMOOaaBlrw3KEuwDXpNhLhRg815Pp8nk3y/WvT9HPmRI3tWsH0PGx0bSuaszho+TzVCORY3ZuBV+SPcOOKqi3HmnIyfetGn0OGDSIrW5aW5wiMx+nFb9rO6DmE1FZW6QrkLyatKzu2EGM1VODitWRUmpbImW5uJOI4woPUk1YhW4fgyAeuBUMUEmRuY1ajhXnLHFaWZi2uhYjgwBvkLfjUv2dCOCR+NQqEHQE1MoUgYBpWRDuJ5AH8RprRFe9ShQM9RQzDb1ppIm7OQ8VL+7JJPSvDvEbZ1Jl9K938UrmF8eleBa1ltXmHoaymerl6vIoMKp3UfGavsKgkXchFQnY9WceZWHaFcFJdhNFUImMNwD70VTR5zVnY9QVAJM8kZ6VOIgyFccs3WlRH55XJOSasrDIXPKkADBzWdj0XIjgUqPlOQMgj1qHy9jFj1Y4HPFXFiYgYAyc5OagMMi5xjIweTwDTsxKWpXXLAAjPb8amUEpyBjPHNMjiJcZHBG7ir6WkjDOBkknJIzipsypSSKrqyxJtAPOM+tRmJmkCqhJO7jritMW53KryLvzyqjdV2NYbJGcqWY5wuck01EzdS2xhCJkdeMHIyKsRpv5xgdMD61bumafBWPZjBHufrTEUZGVy4HJotYfPdajdnlsSc7h1z1pWIV1JHXFSOA+4jkjqaQHkq6ggYosSmRbC4yflJFQBHDZ3ZUHkVcCgLtPQDrmkIXgAnkE0mikyKJcyc5A6jmnFgsg7g96euw4zxntTk2ELvXj69KEDZFKAVAH1NRRjHT86lLBTjGAQefWiMAMAelIrZBGQNwYU2YbSuDxTmHBGKZK+AMjnHegS30I+QeRUMw4OB+NTkgqaiBXJB6etItFYhgc0vJ5Gas8FT7VFE3zsABSKuQOGCk5zVdxuBx09KvSRlgcVWdNhx60DTKbLk8GoHBBNW5V2Hmqkr80jREJyzDjqRXc6PbAQx1xlmokvIk65avRbGMLGiqOlXBHFjZ2si7FHtbJHTjIrRhPC5NVCQExjmlhkYsARwe1dC0PMknJHQ2u1FzsJNXoZuR754rJtpVdQGzgVqWIR2B2/L3962jrscU1bcuuu9AwByKgClWz2q9MMICOcjgiqPRuTVyRlFivnaSaqz81ZfpVOdsZA61JaOQ8aD/iU3Z7lTXltom2JfpXqXi850u5UDqprzWNPlXFctbc93LV7jEI560jYxUsicZqu2c1znpIjfvioyKl25FIRg8ikWQupqFqtMKhdaAKUnyXCMK9L8My77OI+1eaXgI2t6Guz8H3ZNqqk1rB6nn46F43R3e87faoCcyZ7UsRO0Z6U8gfSuhnipWZchk/dgdeKlimwRgfjVWNxgDjFWAg25H5VSuS0iyt0+eO/tU0UhMwBYkCqaJgD196vQqAAVGc0zNo0Io892qaMBOxxUMDsgAycVMpJPJqtDF3JQwNRSoD2py5zmiT7vvRuLY5nxAm6JgK8D12PbrNyPRq+gtYXKkEeteD+Jk265dj/arCoetl3xNGKy+tRlc1YYVEwNZHsGZeR4bcKKt3Me5DxRWiehyVaV5XR6ckY3fez60kx2sMfKOn1p3IbA45p06jIyazN1uRLIdoIbGM/jVjYBES5DZO4EdRVVHQbTtzntVhEXhAcA0IbGNGdoXIyRirUNsGy874jzgE9fwFViCjYUbhge9TeZgEHr7npQrCd3sXDOEOy3wiAgFj1NVt5EjFT8wyckU2JueSQppUj+YnGOv407kqNi9HLvQ/wn09agblSANvygciovNWNSJBg5wMVIjBl28nI5FG4lGxHuIJHIGenpT4g3mepwBn3oKsrHf8y5xkGlV0B2nnkUh+gOp3MpJ9efrSmMlsqRkjGcYqVRtAIbnGBn60o2liFUn6UNCuRpnawc5YelM3YUAipk2orMe/aqdwXHllzkAdPxpMa1ZPtHyk4I54zmmb2MpyuAOlMtX8xsHgMD07e9SYUNtDEnPWgrbRjyoZCw68HmqhPznIBxxmrBYb9vfGKhfIGCODzSeoR0G5yMYqLAI209j8xwOajDZPuBzUloCNqY7mmInzcHilfpnqBUqjK+nekPYhbO3ANQPJnHtVosNxBFU3BY8Ec0McSnOxLGq6xls1YkDEkEc1ABx1xQjaw/SE26tDnsc16NZc49K4HSV3anESOxrvrQEKgHNaUzzcb8SLu3OPSniQK/y9fWpiPLhyc81FFE8p4Tr3roehwJprUu2gduFxz1NbmmA7guRjvWbZWThB0DVdigubdwVw2D0rSLsctRqWiNi5WQRqG59MVnElnHXirMt60oTemwpwOKgkkXd8o/GtG0zCKaFbp7VWn7YqbdlSTUbjcDipZS0OT8UxhrCUKMkg15tGp2DivUPEmFtZiR/DgV5pFjywa5a+57eXP3GQPnP41CRzVsjI471WdcGudnpoZ3pj05uKifnpmkWhrdzmoXOalIPeomHP1oKK9woaMitbwhNiQoT0rLlyMipPDk3l6jt6ZNUjnxMbxPVraXcg64q2AGwe9Zlk48oE1fhOU3Hj0rpWp8/JWZPEvz5Ga0Ihj3qrEwIGAfercfzYwKtGcixHErjgHHrmpo1C5yPypqfc5zUsec8gY9RV2MWWIyu3HQ1Mh71GMFcDHFSRjCimZsnX2NKVGTTV5xinsDVIgwtVT5j3rwnxlHs8QXIx1wa971QAHnvXh3j2PZ4hkP95RXNV2PUy5/vPkctigrTyOaa1YnuETqCtFO780UxWPRdylT+VKxUKAwyfWq4BIIHSpEzkZ6igixH5QXDEY44xUpIZoyM5AIxSH1OcAU5FyPwoGOTpg44wKXqd3bmmom/dtPPH4UEMgP90UmBKvDjgc84podnToecjn0zTUZlf15yKRiwPpkUBYUbsk4ycjHoKnjjIw3XjPXp601VPyYYc8/Spdw2nnHTmmhNkvmcthcY6ZpF8uRyW4YHg9M0hJwf4eeT60/afkLYzQZkaAKuZCQo6k/WpAck7eeDTZJMqsbAMOD9OaSVBuJVskA855oH6jvMJQg4Hygk1TnfzQcHHHSpmVnXBXJbByKYkagjzMg45x65qdy0kgtyQ6rjJwQDipgcXG3qp5P5UkcWGzxzkg560+NCZcDPXkChCZAyHcCAAQaldSSuaUbduADn1pCuVGOcE59aEFypOuGYr1z1qJh82cDBAqxKPlB7K3A+oqvEDkB84pWLWw4MGAVRTlbkA8YpjJkhlb1x70BccNyCe3agY47Wzjqaq3KYUYPPrU5JCtkcAdfWq1ySyDA4pDjuUmZlJxUTAHrwKmdcAYPX9agfO3JPFI2Rd0FQNTQE87TivR9NjBKZFec6FgarCBzlTXpmnngDuK2pHk5hpI1CkZKo2CT+gq1DagNnJCkdMUW0SIBkbpWGT7VajT5iT1rsUU9zxnJjoVVWCjPTvVodOOTUCL85ParSgADBOTVoyZEFyCCM1EY1GcVdC1FKnHTkD86GhKRnyHqM4phYgEnoOKLh8kNmoDKMc1Juloc/wCLpNtuwJx8pJrzqJMxLXbeMpv9CmYntgVx8SERAe1clfc9rAK1MYkWc5qGePDGriDaeTUM4ya5zvT1MyTimY4qaeM5NRdOooN0Rt0pgWnt940ZwKkZWlXioNPHl6oh6ZNWZTzVZQVvYmHc1SIqK8T0zTmMkYHUVtwx7lUZyB2rD0nIjSumtUyoYDiumGx87V0ZZtVULtx/9arCDaRzgH0qFPlcHHFWAwbIxWqZzMljC7ueatIox7VWiGAOlXIiBiqRlIEUcYFWIwQMUxCAeTUgPXFMhkinkcU5uRUakVKeFqkQzJ1QAoT3rxj4jR7dWifsyYr2zUVAhbHWvIvibEB9lkA6kisKy0O/L5Wqo8+kHpUBOKsvg5qrL1rmR9EOHNFMQ8UVQrHpClQ2RTWlUtjoT6U0AimiIM3PpQRYkVQQV68Zp4AHA6GmxDB689KcW7d6ACKPDNjinO25Dj71CN8+TSttJ4HFHQQyFCWxzmntEzcA81MsqMAAMDpTQCWUA4wKBXZAFIlwR92pEJBck9QAB6VMoVWy+BnNPBVucZIxQgbGrIVQ7gRk8Gnu6kh2PzbuD7UxsEkZyV5waYxyCPlOW6H6UCtcfIDsBHPGcVEqN5gIB6enepY2BAx0A/OrIA2hugI4xRYL2IcBgpYBDxyB1pBHtJbHy+xpJtzSDpjjA9KRS8Tdt2PXikFhBnzCf4huxmlVnwDuB59Ka5XK4PLZ4/8Ar0xXCSCJlJBIyO1BVrkxjG8nkDGcE/570qDbwGwee1J8rKcsRnH86hkcq7fKPvcDPSlsJK4+ULJhsAEHJFVCQI1BO8MOOKlL5YKM/Mc896aQwlCgFgRke1G5SViNB0zn8amUHBA454pkwkAVGzzySKnGwKAR04470A2VsZkZTwOO1QzICRk8ZxVuQhAMngjpVecBfnGTmkykyjO2HCgZA9aq7A5I6e9aEib0ZmIznBAqq8ACLjoelSzaLGWsn2fUbVuxfaT9a9S8PqblgOMAZJJryzHzxMSBtccZ969M0WUpb/KDuYdq2o76nmZitNDprLc4Lt941dAwv1qta4WFfpVncMCu1bHgvcliUn86l5BHpS24/dA4608jLEAdBVEMcnHFEnALelIhpJm/dNTFYwLpv3hA5B5zVeY4QgdafM43ZPXOAKragTHat6kcms7nZFbI4rxbcBrfYvRnArHycDNWfEUolvreIdiXNVXHPFcdV6nu4aPLATPIpHA6mnA4NMJJY5rE3IZAG5xxVObAOBV+TABqlOARig0iyo3Jpj9MipXAA5qInIPNI1RXc81HKdrxt71I3WobofuwfQ5poU17p6VoB3woT6V1dt8sQrkvCY32cTHuK66324AJ+ldMNEfN4j42TNIAORzTYpDv4GBSOCRmlClQPWruYWLcbnPX8KtRk9qoRAg81diyy56e+auJlIsISOpGOlWFAI4NVo0GRyTUyHBNUjNlhBwKlzxUCE+tS545pohlO/GYyDnBryv4qoBaWzKMYevWLoZHFeWfFRc2MWDx5grOovdZ1YJ/vYnlzZxVWU89auOMLxVWReuRXIj6cjDUUgSiqA9FRjxVkDPzdOKhiXBGelTOCo4oSMXuN2ASEio2ODk1NIMJweagKksCegoY0SrhmzTiefamJ1p/3aAIwnzLjjHNKGYMBjr3qVV3OMdakWMMSB1FFgv3Ef5iqkg98mnIAUIHOKYylVIxk06PG1snBNBPQcMDK7cHPX1prfLhmAxnpTm6fTkZNEoPysRjJosJEsSqFBUHjnBqRsbgCOlR27ASdcccj1qQKHDHBHHB96ZL3IypViVHHGaZHH8rEgkY4PerJyOoyDjJpoYN1BCjtSGmUzHgjK/KQcds0+AqfvA7cDA9qfPhwew561AsuwAHocYx/Ok9yldoszxgxgxtnnp+tQSr+9JAO7cSc0oIIySQCM8dam4TLMN3PGR1p7i2KoTO0qM7ec9z7UMWBynHy/1q2kQDAjaFJHSklRCMxlTgEE9KLBzELrn72OQc01QVGGyM9KVW5xgjr1prAblBOMkdaVikQzoxQjlm2/1qCRhnjkjgj0q+rFBkjBwePWq0i7i/AyQSeaVikyGVQoIY4yeOKy5exySvQCtF0eQYbOQR1qnKgVtuQWHGKhm0CpMC0DHksBxxXpnhKeOdbRnPDjn8q86lj2YxyeTgVu+FrxY7VomY7oGI47dxWlN2dzlx1L2kND1ba8ZI6r2pxk+bBHauc8NeLYdSl+zSjLLwXx+prqWa2Klt649jXdFqSuj52pTlSlyzRdtWIjTgYPQVLIxaZ9owAO1UfttojKhkJI9BUi3kIViCST2xV3MXF72JdxOMDrSy7YoXkmYLgHaCepqnPqMir+4jUY/vVnTTy3DA3B3Afw9hQ2VGDe5WgjaQh369RUOpuDGwPQDvVxnCKfXFc14q1NbPT5pupAwo9T2FZt2R1wTnJHHXJ+0axdPniMhB/WnEAL1qrpoZLYNLy7ksx9zUuSa4pas9+EbJIXOeetJjv0pygKCT0pcZHFQUVXyeg5qtKpyKusMjJqlOcnjtSNIlScc4FVm46VZlyelRkDqKRqiuainGYW+lTOCBmoWyUIpobV0egeBpN+lQt2xiuugYEZz/APWrgvh7NnTdndGINdnAxCkGt4s+crx99mvblTxyTU5ibBYACqNu/QCr3m7VPp3raOpySTTK9xIyMAcU62kY4ABqKeUO+49BU9sVJGKLag9EacSsQOakLMv3hxUMLDucCpJOSNxzWhiTxvnAqxkbetUowWbA6VaxxQRJENwcKRXlPxTkzDCozzIOPwr1SbkYPevHfinKf7Qt4OwJb9Kip8J1YGN60Th3HNRGPGanNMY5GBXKfSFVhycUU51xRRYZ6IqEH8KlAyhz1FNhlGfmoDZYkdKo5tRAoOaNo2460jNjPrTo+lIobGgpCPmANSggDio29RQxpjkyJR6YqQHBJ7VGgLYxUyDIOaEJg/C03bhWPPHan7c85qUDHAxk9aYr2KRbLfNTySyDHap3jGcgCmCLHT60kVdCR7Q4OecVZBUrgZ55JqCNBuGatom0gYHI60yJMUp+7ByMCnbRsAxjFOCDA9qjlb5cDO7tQZ7leaAI/B3HniqjREMvyHOeCe1agD55I+b9KSRhgKPr0pNXNIzaKcSmIAkcFanMgZeewP41JIitGOuMdB3qOZdsQ+Xkk9PSnsK/MV2nxu2kKBycHpTFlU4X5ckZLYoaIk4BG04JzTIzyE+XB7+lSaWVieVJAWZeSDwRUWWKjeAcjORUiNIZiAcDvTCV3j2OOBxTYIizkDHvnipD8w2sMdcEVIY1LAooDkke1KqZkPPXrnpSsHMio67QS33sjiqc4Xluc4yM9/xrRkjIlITjnOcZqnLFuTaBwpzjoOTUyRpBmdIyqpwGJOTzzio4Lk6fepcNxC+I5c9vRquGIBzkYUE8A9KjnijfKOpYEcA8ipTNWlJWOt0CytrO6kubYEPKPmGeD+FdOtzuU8geleT6Xq1xojiK5Z5rMY2uAS0XsfUe9dnZavBdRK8EqOp6FTmumnNJWPJxGHk5XkdXC6ZBJGe1XFuVQ84zXLRXuMHdnFS/bstlj+tbKZxyw7Z0UlzvPBAqtNcAZyRmsuS7BXIbisu71AKD+8B/Gh1Ahh2zXur8RRkkgntivPdZun1nVRChzb253OR0Len4U3VdWnvpPsmnMWZuGkXooq3p1j9it1jUcnlj3JrKcrnfQoKDuRldqgD8qNvB459ankjOWFIAVU5rDqdtyDy2wBTghUDIqRDkDmnuFPQ9qLCuU5f4u1UZ4+M1dnB38DiqkjZzmpNYFQjio2XnjrUznaeKiYlRnHWkaohlGcComwI8YqViWNNZSQMCgo0/AlwY7i6gzyH3fnXoCydPSvLvD8n2fxGB0EiEfiK9MsgZEFax7Hi4qNp3NOyO5wGbA9fQVPcz8fKTgdKp+W0aNg84pBg4BySK3jorHE4pu48u0gwePpWhpykYB5rP+8fl49q0LQMMDvVR3IqbGqpQDaaa7EcAZ+tRxAAg9akyS1WznsWrdicFuDVodPaq8HC89asKdwpoykQXQAWvHPiggOtW/uhr2SZcrivKfibCP7StJMdVYfyrOr8J2YB/vkeespzUZGOuatzL83SoJBxXIfREDAHtRSPwaKBncg881YjZdtVieKWOquZNXJCQWqQnnioN4FKWOKLhYercnmpFJAHFQw4Y5NW0XjPagUtAAABIpFck07kHHanIBnng0yR6LkY/Gn7SBx1pyAA4zTyABQQ2RhcjnvTWIjxUzHHSq8oLHI7UmC1HRt1z1PapfMwwB64qOBTg7+MU6bAIx1PegHZsd5gRiM8UseW5P3ahb+7jOe9S265j2ngUwash78A4AxTVAYeue1TGMFBnpUbBUAK9fSgQjKCq84AqKRNyn5gCOc+tPwHXBx9aaBtkOOR/OgaKhZjuHGAOlRmQEYA4xyPWrDKN+BwDxkioY8CQgDABIBPepNUEMvznPAB4z3pCpHz9e/FSwnGW4OTRneNoGMmkwvqNi5AwcMc9T0qXA4znJ6Faase3GU45HPelYMTgfw/4VSEwA6Eng4wahMYPGODyfXrUylSBnAxikZU4YAE5wR0z70gWhQlGJSu3ljwODn0zUEkX3WdcMQM57VqS225t6klfbrVdrbzOMYI71DTNYzRlvAVcEH5eM5PJ5rNl00RXTvZyyWj5yTH0b6jpXRSQkDkcfTnrUbwqHyCQecKR39KWqNVJSVmZKahrVnwyQXSY6q2xsfTpUx8SXiAedpN2M8ZABq9Ci+YR8u0AZ4qeNC0GzscHj61akZSpxMn+3NVvMR2umSjPeQ4FKNK1S+cf2hcLDH3jj/rXQxBSSoGAO/c1aQ7ioYDjjirRjKy2M+zsYbKIpAgXHfuanZvlXrmrcpVsgcn+VVSmfuKd3c0bkp3IJEySRTGPYjHGKk3EOQG9abzk/wB3salmqKxUBweMdMDvSncCMd6kIxnjmoXGWA6H27UhlaUknHcdRUMsZHJPWrTLsLE9ahkYcZ6ipNEyhIn8R60xlJwDjFWWXcQBjPeo5Y1x3yKRqmVnjweKYM1O2TnjAFMBVRz1pjuU1zFq1lN/002n8eK9MsJP3SkV5nqIxCki/wADq3616Po37y1U/wAquO552NjbU3oZ1dArMM/So3Vui96iMJUhhWlaqHC7jiuhO+55jtHVFRAoOB1FX7aTPA60rWaZLVZ0+NY26ZNWkYzmmizbwyEZIAp5XYcHmtSKPzI+BioLmIKK0aOZTuyGNuKsR+3SqiAipo2O7pxSQSRLLgKc15h8T0bbaydg7D9K9QkGVzXEfEC1+0aVIQPmjO8fhU1FdGuEkoVYtnkkjAVVlbg9KmmUhiRVWf7tcZ9OV5H3HjrRUZ6migZ30g59KVAV60ucmn4zjvQZ3I24zRGdwFOdc0iDaKB30HAbDVhWOOvNQE7jTwCBRcl6k6vntT4zkkmoouhyKkTP51SJZLuy3WpY2zUCIc8mrMY596DNkgGVPrTW2gZ70vIqOU9hyaCUNMm7pxQSCOah2HPFSxIcHdSNGkhCmWHOKkUEdOtNwQeKUFjJgUCZPESFbJ5qTZuA9ajAKnA60okIY57UzN+RE/39vamSIPM+XJxUpYHjFNY7m6c9KRaIcZK44qMxfvTjljzirAQltozxSRphznOTxnFBVxiojLxkHPNKUB6ZBFPIxuC9fWiNWMZDHBzQK42RegByoHJzUYz5gYHaKmcBWUDp7Um3ao7e2aB3ICASxXG4AdqVCFBXOeecjNBTamCPnx2pseFBx97JzRYqw9Swf5cE5wTUjIWI3D8T2pY1AGAMqSMnPWpGZTjfkJmixDepVMZYfL8zYwwz1GaT7OGlPUtyOnGcVcIHmZHI7U9Qe+Wyen4Ucoc7Rlx2xR8lOvBqaO3QBgMkYzyKumMFfvYBHBPbFNkQbCucZ6AdKFEbqNjViVFARcken0pdgQkHk57etB4PpgcjvSSIxfdw2e5PQUyLkanBQsMkDsaZNJhTtB+hPWnyAIpTIOQcY7VVlYeWeN2MjpSuWtRAAzc4AzilYBHw3BpA6vFkkYzkDPXijyuQXY89c9hQVfuJIny9RkdxVKVOSwbHPX1q4Ohx0GetRldzkg8deR1FSyouxSKl8/Md3YHvUDxnPzEbiKuNzLg+nemmH5c4+bHWpNVKxmMDEcZ2n19aieXe23jAq9coGIBHHas9hhzjtSNY6jnIA6//AF6jK7+fzpkmQ5J6D0pVmABB4Yigq1itfRs1lKvotd14QnMul27Hncin9K4uf97kKDtIOa6XwBJnS0TP3GK/kauJw42PuXO7jTcB71Ps2YxVaB+Rg1clwYuOuK6UtDxHe9gWZunWrFpM28ZHHrWbGTnk1ftSMZxVLUU4pI6rTpFIAo1GPoQMCq+lEcMa0L3aUGOtdKV0cD0kYZUgkk8URv8AMBT7kMH9KhjySMVl1N90XQcqc9Kw9chV7WVXGVZSK2QflxVDUV3wPn0oZEdGeBXKlJ5Iz1Ulao3Ax0rW1mMx6ndIR0cmsmRCevSuKWh9XB3SZSIwT60U+RcEntRSNTtskHpTvNIx6U8pmmyRinYyTTJBIGFPABHFVwvSrEYoQnoOVefapUXPakWlLYPFMhsmCDFO28AjrUSnNTxnPBoRDFTr0qdflwaRQFHSlHNMhu4rHNIV70venhhtpC2I0AzzUhIUHAFQg5bg05j096ChOvanKADjvTVPzVKoGcmkDIxJmTAPFIZOTkU/ywDkDNMZODTBWImPzZU8VMMlQRzUbpgZBp8LY+vpSKew1XdG+tK0hAOeRUxTcDkVAU+Y45FBN0x3O3cByaaobzNh6dacwOQBwKeiMACetMLiSKxfB9e1KyMGG4BjjpUiBg+agYsXJOdxPFAk2xjJ8xXJGBUciKV7gZ6jvUiyZYjHOKZc5UAjkDsaRotwiGejYC4I9zVgrvCFjk56dutQROhIZgAfSpd58sjAznAzTFK9wZCshKnls4FSxqCOSM8daifO9MH3JqxF83GAcYpkN6DGIJK7eehPqKjD7nBYAjaeKklUOx2nHaopYsyIY/l9j2oBWHCKOXcScBQMkjmqs7mNQo+bnOccVc2kwg5OehFVpSYl3L0xhj6/hQyo7kMfIIOSqkg4/OoXIZt65BGccVcBUhtoIHcgfzFRCB95LcqSDgd/8mpLTKwkBJyi4ADEA/rUIlzvwcDqAe1PaMhj7jmpdgQYPcdaC9EKjAKQ3PXkU2WRXXIHpzipRkyZGMZAOaadikbwwz0HSpsSV2izj+93IqBmIOOSTkdOlXHZ1YY475qCRiV6EcndSZaZUmXk54yD+FVGBaNlYcD09auFd0XyNx35/SqY3A/MDjGcd6g1iVSCcAkZFRmNW5JqWTBBK54P400smRgfKOPc0zVECSOGO0YxW14Dl8s3MR/hlP681kyIchkxg4q54UYrqV2rYBO1gP0/pVROfFLmpnpsA+UEdcVYD5Ue9UbBmaEY54q2qnjrmuxbHgtakZB3461oQZWNQKgtLWR5csM1sQWQA5oimRVqJaFnT5xGgU9a14rhHADLWdDbqhzjJq0uMccVvFs4ZtN6Db2NJCzLkcVl/cJxWpKcrjtVKaHutJ73Kg+g2Nt2aiuRujYdqliAXrTJCCG55pbldTxzxlbCHVN443gg/UVytwQAQK7/AMfw5CuByr/zrgplz1FctRWZ9Hg581JFRgdvIoqRvfiisjqudu7AfSmE5FRlsnmndsVRklYTdT0fPao9uTipY16ZpDZYj6UpAI96F4GKOcUzMUcVKjiq7MQfalTmlcbRoBwQOacSADVRDjpUhbjrTM3EnzxSMcDrUSMeBUjDK0CsQs5ByKdFL60woaTbt7daRpZFtWXGaGfLYFQ7crxTkBBoIsiwhyKcyZNLHgr70DluaZFxpTjmmIdpwAM1MzdqqSHaSR1oGtS0SW9Kd8iDLDmqCStmlkmZ3AoD2bLeFZ8k4FSoyjOCTVZOMbqk4z8o5piaHIfnxmiQgfd5NNUZfmldSBxQhdSttIbJ70+SIMNw5HpSE5/1lOAJIx0FIu5RdCkh6nFOaRtigZHOKtTKCOnWozGFUDNMvmvuRjduweVPvVhGIOV6Y79qh2kNzzT9zmHAz+XUUEvUnP3wrAdeMUsrDOOM5zmq+dko9/WpA4ZeTg55zQTYG3KoC+nfmq8qHnONoHJI5qWQhgACBj8qYxBOWIxzmlYpDkGA3OA2OfWo3Zw24njg4onL7ScYUgYFRzKdgA5eh6DSB1MgwMjrk0rRAAgnOBwO9SBQRjuuc1HIhZVAyOOvekC7BtCKNxzkjHfNMm+YZBJ4wPanQqFGWw2B0/wqOZzvZVGAw6E0mNbkci7SGVuOR+NQXBJfnOc5we/4VKNpTHORxmkJQhQoOARg1JotCk6gRb8HbnFUDkkNghsHA61pXKZY8gsBnGOMZqhMjrNhOScgj0FSzaDIH+Q46HNVpFYsrcBe1XMDeAc8deahdVaMsCSPT0pGqdivuOBjJPQVJpT/AGfXIugWVCp+oOarsXQjPXpxwBSoCl1aNknEmDntniqi9SasbwZ6ro8u5AufxrbQLlS3JrA0f5YlPY1uWxLSMzfdHAruitD5itpJ2NO3OMcVdRyMVUtlyMmrar07VrE45E6sWGaRSS1KgG2lUDNUZilT602RPlPFPJIqQ421W4bGYykcdKqSOQxXvWjdpgjHesy4UiU1lbU2g7nF+NoybKXjuDXnsyk8AV6p4zgzpczAZ4zXlzjK5J6VzVlqe7l8r02UXiyfWipyrL8xGBRWR33N3eS3HSpFyRTFQ55qwgAFOxLYirxU0Z55pwAFIB81BDdyQ+oppOOKUCmlTmgSEdhjmljf0qN1JpIgR1pF9C6p4yetP3VXyaaWPancjlLW7nipVOVqrGS3OKmGRQS0O3FWOKaXycd6jbOajywbvSKSLsXpnNO5DVFbtk81ORTM3oyRGwaeWNVQW3VKx4HFBLQFiTjNRuB070BDuzzUnl7jk9KB7FcAq31qXy+d2KkWME1My/LxQDkVRknFTAEGnBcnAFMdXByBRYV7itkNx+NOZsYpFycZpZuMZHFAhGXPIFR8rzUsbDeADxTJgC/BpjXYjRixYE8e9AViTyNtC4GcU5TuPtSGxGOG7Yoj3dWIzjpUuNzDHWnEAcnGaYrkaANu3jnGaY4HCAjBI5FSu4C+gxUDsDFhBzQCGbfnZEJJHemE4Yh/XtToFfnGetLI2WwRkk9aC+tiKQlAPLJzikyzbtxJIHX0peQo2j5sYNIqlBzk7u9A9CxFn5tnIyCT7UFlLEleM8e9EDBYmUdCR+FQDcspxzzgZpE2HSKpTg/w8Y7VXCKSfmbrzg9KsDKrg8E5HIqAnAIxjOM0ikNXIX7oUZxnNQyLlVIbPHXt1qwxUlmVQOnNV23R7uOCTgenekWhrLn5iAwxk84qncR5bkHO719aukZDbBgkflUDKSgUdueallp2Ml8qu1Dx39c1C4YnJUDjHFXTCOVIwwyAKgkjOxWz0yMg96mx0JoqYG4AkMxz7YqK8/cRqUZW2urbh65qWQZOAOSec9aa0LtC3ygkKVAPTPvQhy2PTvD5WS1U9yBXRhTDFEmB8xyTXFeD7oS6ZAcjJQfnXXCbzDAp42givQg/dPlsRFqozWtziranJqlbkYBq7HjAq0ccidTxSL1IpY8ZNL0YVRA4j608dKQnim9FpoQy5XfCcdaw7uQiTHc1v5ypFc5qClJmbPGalm1HexQ8RL5mmSA91ryZ0UNyc89K9e1AeZYup9K8luQUuJM44YjBrnq9D18u2kipNkAgDgiillXnB70VhY9Q6PaM0mQMUhY4pOtUZpEm7tS7uaiXrjNSnGPekOxJGwzU2QR71VWpVzQS0P2A0jIBTgcComfNAkLnPenqgaoR1qaNuaRTJFG31pxYHAzSt04qMcGmRuOXk81MiLUYU04ZzRYGShcHinlT1zSxLnrS7cHmixFyMginx4PWnN05qJQc0BuTZGOKjB+frTwDTDGd2RTErD0O1uakDc81BzkjFSR+h5oE0S5A5qPcS2BQ4I6VGoJOaASLAFNk45NNRzu+btUrMCvvQLZkCJubI4pfL+fk1NGMnjpRKBt4FOwX1K+wZJzxRFhjkUrAhdopFXHtSKJ1O05yDTZWG4c1EOp70oQ96BW1B13L1qI4Ck9xUxGE56CoTwMHkGgpEisp45U1DNkNgg8d6c2Qdy9fSlWUtu3AEkd6AWmpDCRjoW680pJHygcVLDBz81EihRkg/nQF1ch2nBPXGDioQ2CWcfNnpVtVPlknGCKhCAocYLZoKTELeZtJVhk9aiZWZsnirBw0hUnGOfaoncMuwjAB6+tJoafYhAAXGRtxxSsSSWb8KcylV3EYzSOWAxtHUHFK1hkRZQxBBGRk1WdsHC/MgXI4q0VCkHGMHBNV5VByx6AYOBSZaIJo8OWbODnGDWbJKVJRVHzdK0pvvZJJJIxWbcod7Nwe5I/nUtG9PzK7PuXoAw7j+dIcr1YlQfzNKCFYuqnrg57UkjZUKRxk8nqfxqTWxt+DbtIkeHGBHIRj0B5H867qzmWRww6968l0uc2eqDn5Jxg85+Yf/W/lXpnh6VWlUMeGFdNOXQ8XHUeVuR1dvINorQjb5eOlZiQsvK8ip1kZUORgiupHjNXNVHGcU4t8wrMhuDkVYE/ziqIcDSVflz3qB3wSDTROSOOlRs6Ll5GAFFyUh+48471iasu2VFJ5bnFXptUQHEK5PrWbMWnl82U/N2HpUSd9janFp3ZWveLdgfSvJ74D7ZOep3kAGvUdUkxBIx6AGvKLhvMnldedznvWVU9XL1qxNu0fN146c0Uij5cMwBxRWNj0r2NkNTwRzUDHnimhyKQ7FrI4o3nNQhsinLzQFidDmpVPHNRoualxgUEsGbAqInJpznioe9JjSHo2DzVhPXNVTnFPjk5oBoug0Y/CokbNTKOaqxnsTx/d5pSQDTVOAajlOaCEtSwkozU5YEVmI2Gq7E24UwlGwpFOTrS4FMzhsUEosLinDHPSo1GaVuBSJBtueKVQKg5zz2p6vj1oHYe3OQKj/ixTg4JoI5zRYBCCAeKfCoxzTGbsakjIxzTQMfnb0puetObB+tRkd6BIXj0pr8LmmruJp5XPXigZXjX5qmG7JppQg8fjT1BwRQNsa361CzEMNwyKnAI6mkGBkkc0gTI2kVOcU1SvU9aSUB844pinaMYzTKtoXUClTk1FIA/yk9KdCflGDRMvz5PU0WIWjKspZBgHIPao0BDnGeasSAAcdajU9uB60GiegwkjIAz70jDJBIzznpTpOB6LS7QI93JFIBksiSDawGexqMcqxJ+YdMdqSUZYEDGKYo+8eelIpLTQGG9SN3A6j1qJiBnPHPT1qZSEXnoahYb138jHTFBSILhVKDGTjHAPSqssSlD16dfWrLpIQQOOcY61HtLAqemMVNjWLsZTAMSucqD1qIMRgSDKirk64cr0GeSO9V2XbHuTlunrioZunczb9S8e5OHTDLj+8K6vQNS820SSN+cZ69K50hgSwbLYx06VFpdz/Zl/hxi1mbj0VvSqgzHEQUkesaVr0qKBN849a6G21W2nTDYBPrXndtcoygqeK1IJvlGCK6Y1GjxquFi9VoduJbYt8rj86JLu1jIwwJrkY7kDjnNSJNlsVopXOb6rbdnSzaqp4h/OqEt0ZDlmLH0rN89EHJ5qvNdYXKmncqFBLY1TNg9qcZ+BWH9sz1NJNfKkZyegpXLdEZ4t1FbXSpmDfMw2qPUmuAU7UU5+YDmn6vqT6zqixxN/o8GSf9o0cKTlfmz2rKbuejhKfJFtjWx3IzzRSSfOoA/P1oqDqNWkCkmlHSnp0pASRJkU/Zili6fjT6diL6ixdKkb2pkXQ1J60hX1K7gimr2qSSohSaNFsS9RQic0DrUo60CZNEnFSAYNEPSpD94VVjFvUAPypsimpFpX6fhQTcrFakhbDYpG6CiH7340F7oupyKQpzSxfdpwpmIKcVICCOetRv8AdpI/vUWAcVHam4xmn9qY38X0pAgQDPSnkZPHShKlTqPpTQmQtHg0gGCMGpn6Gox0FAx3fvSE0N0pG7U0gHpg04ggZFMip/8ABSJZGeDTlxgmkboaU/coGNYigqCMmkPSk7GhAQyKAcL3pVQbTmmtUsf3BQinohkQKk04k7CT1zT6R+lNIREMntTfLBGWFSJ0pz/dpWHcgkUMAQOKaWwMY61P/CKrt1P0oKWug2QA4HvVdtucEnmrB+6PrVST7y1JcUAj38E4A9aayEqTkgYyM1Meo+lNbqPpTsO5CM45/A1CyDzB1+o71MepqN/9UPrUstGfdx7gO46+9VHZVjBXIY8GtSf7q/SsqftWbN6buRzIACATvPIOarT2yTw+VKMqfQ8g1Yl/1n4CmH7p/D+dI08inZarNpcogvCXgzhZR/I11tlqUcsYaOQMCOK43Vf+PWX6GoPDH3PxrWLurnLVgk7HogvSelSR3hz1rHg+7Uy9RVxbMHBGo9wCMk0w3QxjNUn6VWk/jq3IzUUXLnUY4Vy7AD61y+qazc6jL9msQcHgkCoPEHQfWn+Ff9bJ9KaXu8wuVOVjQsNPSyt9gG6Rj8xHWnSAgAdC3OQeR2q4e/8AviqJ+4f896yvqdaWliMkKSeq4+tFOP8Aq2ooKtc//9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This cutaneous manifestation of RA does not usually signal the presence of more severe underlying RV and does not require an intensification of therapy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of John Stone, MD, MPH.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_17_21776=[""].join("\n");
var outline_f21_17_21776=null;
var title_f21_17_21777="Temporomandibular anatomy";
var content_f21_17_21777=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F64227&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F64227&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Temporomandibular joint anatomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 333px; height: 411px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The temporomandibular joint (TMJ) is the articulation of the temporal and mandibular bones.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_17_21777=[""].join("\n");
var outline_f21_17_21777=null;
var title_f21_17_21778="Alternative port placement for cholecystectomy";
var content_f21_17_21778=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F65844&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F65844&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 502px\">",
"   <div class=\"ttl\">",
"    Alternative port placement for cholecystectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 482px; height: 586px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An alternative port placement for cholecystectomy places a 5 mm port halfway between the xiphoid and umbilical ports. The surgeon retracts the infundibulum of the gallbladder through the midline port and uses the dissector through the subxiphoid port (shown in red). The assistant retracts the fundus of the gallbladder through the right lateral port and operates the laparoscope via the periumbilical port. The gallbladder is removed through the umbilical port.",
"    <div class=\"footnotes\">",
"     * Port placement and technique may vary amongst laparoscopic surgeons.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_17_21778=[""].join("\n");
var outline_f21_17_21778=null;
var title_f21_17_21779="Bronchiolitis anatomy PI";
var content_f21_17_21779=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F52758&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F52758&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Bronchiolitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 484px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bronchiolitis is an infection that affects the small tubes that carry air in and out of the lungs. When infected, these tubes (called bronchioles) get swollen and inflamed. That makes it harder to breathe.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_17_21779=[""].join("\n");
var outline_f21_17_21779=null;
var title_f21_17_21780="Avian influenza virus vaccine (H5N1): Drug information";
var content_f21_17_21780=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Avian influenza virus vaccine (H5N1): Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F4598869\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Vaccine, Inactivated (Viral)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F4598894\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Immunization: Adults 18-64 years: I.M.: 1 mL, followed by second 1 mL dose given 28 days later (acceptable range: 21-35 days)",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15897882\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15897883\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F4598899\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, suspension [monovalent]: Hemagglutinin (H5N1strain) 90 mcg/mL (5 mL) [contains chicken, egg, and porcine protein, and thimerosal]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F4598867\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block accres drugH1Div\" id=\"F11233933\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Prescribing and Access Restrictions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Commercial distribution is not planned. The vaccine will be included as part of the U.S. Strategic National Stockpile. It will be distributed by public health officials if needed.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F4598895\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     For I.M. administration only. Inspect for particulate matter and discoloration prior to administration. Vaccinate in the deltoid muscle using a &ge;1 inch needle length. Suspension should be shaken well prior to use.",
"     <b>",
"      Note:",
"     </b>",
"     For patients at risk of hemorrhage following intramuscular injection, the ACIP recommends &ldquo;it should be administered intramuscularly if, in the opinion of the physician familiar with the patient's bleeding risk, the vaccine can be administered by this route with reasonable safety.  If the patient receives antihemophilia or other similar therapy, intramuscular vaccination can be scheduled shortly after such therapy is administered. A fine needle (23 gauge or smaller) can be used for the vaccination and firm pressure applied to the site (without rubbing) for at least 2 minutes. The patient should be instructed concerning the risk of hematoma from the injection.&rdquo; Patients on anticoagulant therapy should be considered to have the same bleeding risks and treated as those with clotting factor disorders (CDC, 2011).",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;text-align:justify;\">",
"     Simultaneous administration of vaccines helps ensure the patients will be fully vaccinated by the appropriate age. Simultaneous administration of vaccines is defined as administering &gt;1 vaccine on the same day at different anatomic sites. Separate vaccines should not be combined in the same syringe unless indicated by product specific labeling. Separate needles and syringes should be used for each injection. The ACIP prefers each dose of a specific vaccine in a series come from the same manufacturer when possible. Adolescents and adults should be vaccinated while seated or lying down. In general, preterm infants should be vaccinated at the same chronological age as full-term infants (CDC,  2011).",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;text-align:justify;\">",
"     Antipyretics have not been shown to prevent febrile seizures. Antipyretics may be used to treat fever or discomfort following vaccination (CDC, 2011). One study reported that routine prophylactic administration of acetaminophen to prevent fever prior to vaccination decreased the immune response of some vaccines; the clinical significance of this reduction in immune response has not been established (Prymula, 2009).",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F4598872\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Active immunization of adults at increased risk of exposure to the H5N1 viral subtype of influenza",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F4598861\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Influenza virus vaccine (H5N1) may be confused with the nonavian strain of influenza virus vaccine",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F4598882\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      All serious adverse reactions must be reported to the U.S. Department of Health and Human Services (DHHS) Vaccine Adverse Event Reporting System (VAERS) 1-800-822-7967 or online at",
"      <a href=\"https://vaers.hhs.gov/esub/index\" target=\"_blank\">",
"       https://vaers.hhs.gov/esub/index",
"      </a>",
"      .",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Headache (3% to 36%), malaise (22%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Local: Pain (74%), tenderness (70%), erythema/redness (20%), induration/swelling (15%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Neuromuscular &amp; skeletal: Myalgia (16%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Fever (up to 7%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Nausea (10%), diarrhea (6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Respiratory: Nasopharyngitis (2%), upper respiratory infection (2%), nasal congestion (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Additional reactions observed with other influenza vaccine formulations: Allergic reaction, anaphylaxis, angioedema, asthma, encephalopathy, facial paralysis, hives, GBS, neuropathy, optic neuritis, vasculitis",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F4598877\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Manufacturer states no contraindications",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F4598878\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Anaphylactoid/hypersensitivity reactions: Immediate treatment (including epinephrine 1:1000) for anaphylactoid and/or hypersensitivity reactions should be available during vaccine use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Syncope: Syncope has been reported with use of injectable vaccines and may be accompanied by transient visual disturbances, weakness, or tonic-clonic movements. Procedures should be in place to avoid injuries from falling and to restore cerebral perfusion if syncope occurs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Guillain-Barr&eacute; (GBS): Use with caution in patients with a history of GBS; these patients may have a greater likelihood of developing GBS. Relationship to this influenza vaccine formulation is not known; in patients with recent GBS (&le;6 weeks), decision to administer vaccine should entail careful consideration of risk:benefit.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Immunosuppressed patients: Use with caution in severely immunocompromised patients (eg, patients receiving chemo/radiation therapy or other immunosuppressive therapy [including high-dose corticosteroids]); may have a reduced response to vaccination. In general, household and close contacts of persons with altered immunocompetence may receive all age appropriate vaccines.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Chicken egg protein: Manufactured with chicken egg protein.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Thimerosal: Contains thimerosal; hypersensitivity reactions may occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Effective immunity: Vaccination may not result in effective immunity in all patients. Response depends upon multiple factors (eg, type of vaccine, age of patient) and may be improved by administering the vaccine at the recommended dose, route, and interval. Vaccines may not be effective if administered during periods of altered immune competence (CDC, 2011).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299518\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F4598884\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Belimumab: May diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fingolimod: May diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Immunosuppressants: May diminish the therapeutic effect of Vaccines (Inactivated).",
"     <b>",
"      Exceptions:",
"     </b>",
"     Cytarabine (Liposomal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F4598873\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F4598874\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reproduction studies have not been conducted. Vaccine should be given only if clearly needed. Inactivated viral vaccines have not been shown to cause increased risks to the fetus (CDC, 2011).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F4598876\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F12704133\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inactivated virus vaccines do not affect the safety of breast-feeding for the mother or the infant. Breast-feeding infants should be vaccinated according to the recommended schedules (CDC, 2011).",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F12704134\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Monitor for syncope for 15 minutes following administration. If seizure-like activity associated with syncope occurs, maintain patient in supine or Trendelenburg position to reestablish adequate cerebral perfusion.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F4598888\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     A monovalent, split virus (inactivated) preparation of the H5N1 avian strain of influenza virus (A/Vietnam/1203/2004) which promotes active immunity to avian influenza.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F4598890\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Onset of action: Fourfold increase in antibody titers occurred in up to 58% of patients 28 days after second dose.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;Recommendations of the Advisory Committee on Immunization Practices (ACIP): General Recommendations on Immunization,&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2011, 60(2):1-64.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/17/21780/abstract-text/21293327/pubmed\" id=\"21293327\" target=\"_blank\">",
"        21293327",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      <i>",
"       OSHA Guidance Update on Protecting Employees From Avian Flu (Avian Influenza) Viruses,",
"      </i>",
"      Washington, DC: US Department of Labor, Occupational Safety and Health Administration; 2006. Available at",
"      <a href=\"file://www.osha.gov/OshDoc/data_AvianFlu/avian_flu_guidance_english.pdf\" target=\"_blank\">",
"       file://www.osha.gov/OshDoc/data_AvianFlu/avian_flu_guidance_english.pdf",
"      </a>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Prymula R, Siegrist CA, Chlibek R, et al, &ldquo;Effect of Prophylactic Paracetamol Administration at Time of Vaccination on Febrile Reactions and Antibody Responses in Children: Two Open-Label, Randomised Controlled Trials,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 2009, 374(9698):1339-50.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/17/21780/abstract-text/19837254/pubmed\" id=\"19837254\" target=\"_blank\">",
"        19837254",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Steering Committee on Quality Improvement and Management, Subcommittee on Febrile Seizures American Academy of Pediatrics, &ldquo;Febrile seizures: Clinical Practice Guideline for the Long-Term Management of the Child With Simple Febrile Seizures,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2008,  121(6):1281-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/17/21780/abstract-text/18519501/pubmed\" id=\"18519501\" target=\"_blank\">",
"        18519501",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Treanor JJ, Campbell JD, Zangwill KM, et al, &ldquo;Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2006, 354(13):1343-51.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/17/21780/abstract-text/16571878/pubmed\" id=\"16571878\" target=\"_blank\">",
"        16571878",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Zangwill KM, Treanor JJ, Campbell JD, et al, \"Evaluation of the Safety and Immunogenicity of a Booster (Third) Dose of Inactivated Subvirion H5N1 Influenza Vaccine in Humans,\"",
"      <i>",
"       J Infect Dis",
"      </i>",
"      , 2008, 197(4):580-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/17/21780/abstract-text/18237269/pubmed\" id=\"18237269\" target=\"_blank\">",
"        18237269",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8922 Version 30.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-122.72.76.133-0ACB48A304-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_17_21780=[""].join("\n");
var outline_f21_17_21780=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4598869\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4598894\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15897882\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15897883\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4598899\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4598867\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11233933\">",
"      Prescribing and Access Restrictions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4598895\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4598872\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4598861\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4598882\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4598877\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4598878\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299518\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4598884\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4598873\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4598874\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4598876\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12704133\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12704134\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4598888\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4598890\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8922\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8922|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_17_21781="Darier keratotic papule";
var content_f21_17_21781=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86188&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86188&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Keratotic papules of Darier's disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_17_21781=[""].join("\n");
var outline_f21_17_21781=null;
var title_f21_17_21782="Fundic gland polyp Light";
var content_f21_17_21782=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F66607&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F66607&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Fundic gland polyp",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 446px; height: 268px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power view of a fundic gland polyp shows normal gastric corpus-type epithelium, arranged in a disorderly and microcystic configuration.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert Odze, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_17_21782=[""].join("\n");
var outline_f21_17_21782=null;
var title_f21_17_21783="Cannabis use disorders: Clinical features and diagnosis";
var content_f21_17_21783=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Cannabis use disorders: Clinical features and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/17/21783/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/17/21783/contributors\">",
"     Robert L DuPont, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/17/21783/contributors\">",
"     John A Bailey, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/17/21783/contributors\">",
"     Scott A Teitelbaum, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/17/21783/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/17/21783/contributors\">",
"     Andrew J Saxon, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/17/21783/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/17/21783/contributors\">",
"     Richard Hermann, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/17/21783/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION AND DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American Psychiatric Association's Diagnostic and Statistical Manual, Fourth Edition, Text Revision (DSM-IV-TR) lists 11 classes of substances that can cause intoxication, abuse, and dependence [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intoxication develops after ingestion of a substance and is characterized by a reversible syndrome of maladaptive behavioral or psychological changes, such as mood lability, cognitive impairment, or poor judgment.",
"     </li>",
"     <li>",
"      Abuse is a problematic pattern of substance use that results in poor role functioning, interpersonal difficulties, recurrent substance use in physically hazardous situations, or repeated legal difficulties.",
"     </li>",
"     <li>",
"      Dependence is a maladaptive pattern of substance use manifested by such symptoms as repeated substance ingestion despite physical or psychological problems caused by the substance, ingesting larger amounts of the substance over longer periods of time, unsuccessful efforts to limit substance use, tolerance to the substance's effects, and physiologic withdrawal.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Cannabis can cause each of these disorders.",
"   </p>",
"   <p>",
"    The psychoactive properties of cannabis are primarily due to delta-9-tetrahydrocannabinol (THC) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/2\">",
"     2",
"    </a>",
"    ]. The THC content of marijuana has increased significantly since the late 1960s from approximately 1 to 5 percent to as much as 10 to 15 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/1\">",
"     1",
"    </a>",
"    ]. This increased potency may contribute to increased rates of dependence.",
"   </p>",
"   <p>",
"    The clinical features and diagnosis of cannabis use disorders in adults will be reviewed here. Other issues related to cannabis use disorders and an overview of treatment for patients with substance use disorders are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/3/1079?source=see_link\">",
"     \"Cannabis use disorders: Epidemiology, comorbidity, and pathogenesis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/28/4554?source=see_link\">",
"     \"Cannabis use disorders: Treatment, prognosis, and long-term medical effects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/58/5033?source=see_link\">",
"     \"Substance use disorders: Principles for recognition and assessment in general medical care\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Intoxication",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intoxication occurs within minutes if cannabis is inhaled and within a few hours if ingested [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/1\">",
"     1",
"    </a>",
"    ]. The disorder manifests with clinically significant maladaptive behavioral or psychological changes. The intensity or magnitude of these changes varies widely, depending upon the dose of THC ingested and characteristics of the individual using cannabis, such as the rate of absorption, tolerance, sensitivity to the effects of cannabis, and metabolism. The duration of subjective intoxication is typically three to four hours, and is prolonged with oral ingestion because of continued slow absorption from the gut [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Marijuana has a remarkably low acute toxicity. There has never been a documented death attributed directly to marijuana use [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/2\">",
"     2",
"    </a>",
"    ], although THC and its metabolites are commonly found in drug overdose cases [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Mood, perception, thought content",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ingestion typically leads to feeling \"high,\" marked by a euphoric, pleasurable feeling and a decrease in anxiety, alertness, depression, and tension. However, first-time cannabis users as well as anxious, and psychologically vulnerable individuals may experience anxiety, dysphoria, and panic [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/2\">",
"     2",
"    </a>",
"    ]. Increased sociability usually occurs during intoxication. However, dysphoric reactions may be accompanied by social withdrawal.",
"   </p>",
"   <p>",
"    Perceptual changes include the sensation that colors are brighter and music is more vivid [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/2\">",
"     2",
"    </a>",
"    ]. Time perception is distorted in that perceived time is faster than clock time. Spatial perception can also be distorted, and high doses or potent cannabis products may cause hallucinations. Mystical thinking, increased self consciousness, and depersonalization may occur, as well as transient grandiosity, paranoia, and other signs of psychosis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Cognition, psychomotor performance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cannabis use decreases reaction time and impairs attention, concentration, short term memory, and risk assessment. These effects are additive when cannabis is used in conjunction with other central nervous system depressants [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/2\">",
"     2",
"    </a>",
"    ]. Acute cannabis use also impairs motor coordination and interferes with the ability to complete complex tasks that require divided attention.",
"   </p>",
"   <p>",
"    Impairment of cognition, coordination, and judgment lasts much longer than the subjective mood change of feeling \"high.\" Psychomotor impairment lasts for 12 to 24 hours due to accumulation of marijuana in adipose tissue, slow release of THC from fatty tissue stores, and enterohepatic recirculation. However, a marijuana user may think that he or she is no longer impaired several hours after the acute mood altering effects have resolved. As an example, a placebo controlled trial with licensed pilots found that smoking marijuana impaired performance on a flight simulator for up to 24 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/5\">",
"     5",
"    </a>",
"    ]. In addition, only one of the nine subjects was aware that performance was still impaired at 24 hours.",
"   </p>",
"   <p>",
"    Acute psychomotor impairments interfere with the ability to operate other heavy machinery such as automobiles, trains, and motorcycles. A meta-analysis of nine studies found an association between cannabis intoxication and an increased risk of a motor vehicle collision involving serious injury or death [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/2,6,7\">",
"     2,6,7",
"    </a>",
"    ]. Drivers using cannabis are two to seven times more likely to be responsible for accidents compared to drivers not using any drugs or alcohol [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/8\">",
"     8",
"    </a>",
"    ]. The probability of causing an accident increases with plasma levels of delta-9-tetrahydrocannabinol [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Physiologic signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physiologic signs of cannabis intoxication include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Tachycardia",
"     </li>",
"     <li>",
"      Increased blood pressure",
"     </li>",
"     <li>",
"      Increased respiratory rate",
"     </li>",
"     <li>",
"      Conjunctival injection (red eye)",
"     </li>",
"     <li>",
"      Dry mouth",
"     </li>",
"     <li>",
"      Increased appetite",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Abuse",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cannabis abuse is a repeated pattern of use and intoxication that develops over an extended period of time and leads to harmful consequences such as recurrent failure to fulfill major role responsibilities, persistent social problems, and legal issues. Abuse is distinguished from dependence by the absence of compulsive use, physiologic tolerance, or physiologic withdrawal [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Dependence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dependence is marked by behavioral and physiologic symptoms resulting from compulsive use that may continue despite ongoing physical or psychological problems caused by cannabis use [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/1\">",
"     1",
"    </a>",
"    ]. Other features include using larger amounts of cannabis over longer periods of time, unsuccessful efforts to limit use, tolerance to cannabis's effects, and physiologic withdrawal.",
"   </p>",
"   <p>",
"    A German epidemiologic study of adolescents and young adults found that among those meeting DSM-IV criteria for cannabis dependence, the most common symptoms of dependence were [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/9\">",
"     9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Withdrawal (91 percent)",
"     </li>",
"     <li>",
"      Tolerance (83 percent)",
"     </li>",
"     <li>",
"      Continued use despite a health problem (72 percent)",
"     </li>",
"     <li>",
"      Great deal of time spent obtaining cannabis or recovering from its effects (65 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Chronic heavy use may lead to a loss of pleasurable effects during cannabis use and a corresponding increase in dysphoric effects [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Withdrawal",
"    </span>",
"    &nbsp;&mdash;&nbsp;A cannabis withdrawal syndrome is not universally recognized. The DSM-IV-TR criteria for cannabis dependence include physiologic tolerance but do not include a withdrawal syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/1\">",
"     1",
"    </a>",
"    ]. The World Health Organization's International Classification of Diseases-10th Revision ICD-10 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/10\">",
"     10",
"    </a>",
"    ] does recognize the existence of cannabis withdrawal.",
"   </p>",
"   <p>",
"    Cannabis withdrawal is uncomfortable or distressing, but is not life threatening. This may contribute to questions regarding the clinical significance of the syndrome.",
"   </p>",
"   <p>",
"    There is substantial evidence to support the validity of cannabis withdrawal. A large, nationally representative US epidemiologic survey found that among all frequent cannabis users who did not abuse other substances, 44 percent reported two or more withdrawal symptoms upon cessation of cannabis, and 34 percent reported three or more symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/11\">",
"     11",
"    </a>",
"    ]. The most prevalent symptoms were:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Fatigue (31 percent)",
"     </li>",
"     <li>",
"      Yawning (27 percent)",
"     </li>",
"     <li>",
"      Hypersomnia (26 percent)",
"     </li>",
"     <li>",
"      Psychomotor retardation (25 percent)",
"     </li>",
"     <li>",
"      Anxiety (19 percent)",
"     </li>",
"     <li>",
"      Depression (16 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The most important finding was the strong, significant relationship between the presence of cannabis withdrawal symptoms, such as craving, and use of a substance to relieve such symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. This suggests that withdrawal may lead to relapse during abstinence. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/28/4554?source=see_link\">",
"     \"Cannabis use disorders: Treatment, prognosis, and long-term medical effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A review found that other common and clinically important withdrawal symptoms include anorexia, weight loss, anger, irritability, and strange dreams. Less common symptoms included chills, tremor, diaphoresis, and stomach pain [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The withdrawal syndrome begins on the first or second day of abstinence, peaks between day two to six, and resolves within 7 to 14 days. However, sleep disturbance, irritability, and physical tension may persist for weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    THC is highly lipophilic and redistributes quickly into body fat. The high lipid storage increases THC's elimination half life and may thus diminish the severity of withdrawal symptoms, but extend their duration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cannabis intoxication, abuse, and dependence are each diagnosed according to criteria set forth in DSM-IV-TR [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/1\">",
"     1",
"    </a>",
"    ]. The comparable diagnostic terms in the World Health Organization's International Classification of Diseases-10th Revision (ICD-10) are acute intoxication, harmful use, and dependence syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When considering the diagnosis of cannabis use disorders, epidemiologic findings are important to consider [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Cannabis use rarely occurs before age 13 years; the highest risk for initiating cannabis use occurs at age 18",
"     </li>",
"     <li>",
"      Abuse and dependence each develop at a mean of 2 years (range 0 to 10 years) after first use",
"     </li>",
"     <li>",
"      The risk for becoming cannabis dependent is highest between ages 17 and 18 years, and nearly ceases by age 30",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Cannabis intoxication",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intoxication from cannabis is diagnosed in patients who meet each of the four criteria in DSM-IV-TR [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/1\">",
"     1",
"    </a>",
"    ]&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef73321 \" href=\"UTD.htm?19/29/19931\">",
"     table 1",
"    </a>",
"    ). These criteria primarily involve maladaptive behavioral and psychological changes, and physical signs.",
"   </p>",
"   <p>",
"    ICD-10 criteria [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/10\">",
"     10",
"    </a>",
"    ] are nearly identical, except that the ICD-10 requires a minimum of one physical sign of intoxication, whereas DSM-IV-TR requires at least two.",
"   </p>",
"   <p>",
"    Complications of intoxication include trauma or bodily injury, delirium, psychosis, and anxiety. These should also be diagnosed if they occur.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Cannabis abuse",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cannabis abuse is diagnosed in patients who meet both of the criteria in DSM-IV-TR [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/1\">",
"     1",
"    </a>",
"    ]&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef53923 \" href=\"UTD.htm?24/5/24667\">",
"     table 2",
"    </a>",
"    ). The criteria primarily involve repeated episodes of intoxication that occur in physically hazardous situations (eg, driving) and lead to impaired occupational and social functioning, and legal problems.",
"   </p>",
"   <p>",
"    The criteria for the ICD-10 diagnosis of harmful use of cannabinoids [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/10\">",
"     10",
"    </a>",
"    ] are essentially the same as those for DSM-IV-TR.",
"   </p>",
"   <p>",
"    A multicenter, international study showed that the test retest reliability for the DSM-IV-TR diagnosis of cannabis abuse is good (kappa 0.51), and reliability for the individual criteria is good to excellent (kappa 0.56 to 0.86). The most commonly reported criterion was recurrent use of cannabis in hazardous situations (48 to 56 percent of the sample). The most reliable criterion was legal problems related to cannabis (kappa 0.86), and the least reliable was failure to fulfill major role obligations (kappa 0.56) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Cannabis dependence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cannabis dependence is diagnosed in patients who meet at least three of the six possible criteria listed in DSM-IV-TR (",
"    <a class=\"graphic graphic_table graphicRef64590 \" href=\"UTD.htm?31/34/32299\">",
"     table 3",
"    </a>",
"    ). These criteria involve cognitive, behavioral, and physiological symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The ICD-10 diagnosis of dependence syndrome due to cannabinoids also rests upon the patient meeting at least three of six possible criteria [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/10\">",
"     10",
"    </a>",
"    ]. The six criteria in DSM-IV-TR and in ICD-10 are quite similar. The primary difference between the two diagnostic systems is that DSM-IV-TR does not recognize a withdrawal syndrome in cannabis dependence, whereas ICD-10 does. Many studies nevertheless report that withdrawal does occur. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Withdrawal'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    A multicenter, international study found good test retest reliability for the DSM-IV-TR diagnosis of cannabis dependence (kappa 0.67) and its individual criteria (kappa 0.44 to 0.74). The most commonly reported criterion was continued use despite knowledge of physical or psychological harm from cannabis (82 to 85 percent of the sample). The most reliable criterion was tolerance (kappa 0.74) and the least reliable was continued use despite knowledge of physical or psychological harm from cannabis (kappa 0.44) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individuals who report cannabis use or who are otherwise suspected of cannabis (or other substance) use disorder should be screened for potential abuse and dependence.",
"   </p>",
"   <p>",
"    The Drug Abuse Screening Test consists of 20 items that screen for cannabis abuse and dependence (and other substance use disorders) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/17\">",
"     17",
"    </a>",
"    ]. The instrument takes five minutes to administer, either in a self report or interview format. The operating characteristics of the instrument are excellent, including sensitivity (0.96), specificity (0.79), positive predictive value (0.73), negative predictive value (0.97), and efficiency (0.85).",
"   </p>",
"   <p>",
"    The Severity of Dependence Scale consists of five items that screen for cannabis dependence (and dependence on other substances) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/18\">",
"     18",
"    </a>",
"    ]. The instrument is administered by an interviewer and has good psychometric properties, with a sensitivity of 64 percent and specificity of 82 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Drug testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Drug testing is useful for monitoring progress of treatment and early detection of relapse. A review found that intensive monitoring of substance use may increase recovery rates [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Urine, blood, oral fluid, and hair can all be tested for cannabinoid metabolites [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/20\">",
"     20",
"    </a>",
"    ]. Urine testing is most common, is generally less expensive, and it is more widely available. Urine drug tests are vulnerable to cheating, which can be mitigated by direct observation of collection.",
"   </p>",
"   <p>",
"    A positive urine test only establishes past use and cannot be used to diagnose intoxication, abuse, or dependence. This is because cannabinoid metabolites are highly lipophilic, persist in bodily fluids for extended periods of time, and are excreted slowly [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/1\">",
"     1",
"    </a>",
"    ]. Thus, urine tests for cannabinoids remain positive after discontinuation of cannabis for up to:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      7 to 10 days in a casual cannabis user",
"     </li>",
"     <li>",
"      Two to four weeks in a heavy user",
"     </li>",
"     <li>",
"      Months in a chronic heavy user",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Nonetheless, a positive test indicates recent marijuana ingestion and should prompt an assessment of patterns of use and sequelae.",
"   </p>",
"   <p>",
"    Patients prescribed",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/49/30485?source=see_link\">",
"     dronabinol",
"    </a>",
"    for nausea induced by chemotherapy or for the HIV wasting syndrome will test positive for delta-9-tetrahydrocannabinol (THC). It is possible to differentiate smoked marijuana from oral dronabinol on urine drug testing [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/21\">",
"     21",
"    </a>",
"    ]. This needs to be specifically requested on the drug screen.",
"   </p>",
"   <p>",
"    Sweat patch testing is another means of assessing use of marijuana. The patient wears the patch, which continuously absorbs sweat. The patch is more resistant to cheating compared to urine tests because once the patch is removed, the edges become disfigured if the patient attempts to replace it. The patch can be worn for a few hours to a few weeks, after which it falls off. The patch collects prospective evidence of cannabis use while it is worn, compared to the retrospective data collected by other types of testing. The patch is intended to be removed under direct observation, after which it is sent to a laboratory for testing [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients testing positive may deny use and claim the result is a false positive. However, clinical laboratories follow a procedure that eliminates the possibility of false-positive results, regardless of the specimen tested (urine, blood, oral fluid, hair, or sweat) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/20\">",
"     20",
"    </a>",
"    ]. Testing begins with a highly sensitive immunoassay screening test. Presumptive positive results are then confirmed with a highly specific confirmation test, such as a gas",
"    <span class=\"nowrap\">",
"     chromatography/mass",
"    </span>",
"    spectrometry test. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intoxication, abuse, and dependence due to other substances resemble comparable syndromes caused by cannabis. In addition, symptoms of psychiatric disorders not involving substances can overlap with symptoms of cannabis disorders. The diagnostic evaluation needs to ascertain which disorder is present so that treatment can be properly directed.",
"   </p>",
"   <p>",
"    Psychiatric disorders, including other substance use disorders that resemble cannabis disorders can also occur in conjunction with cannabis disorders. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/3/1079?source=see_link\">",
"     \"Cannabis use disorders: Epidemiology, comorbidity, and pathogenesis\"",
"    </a>",
"    .) Every DSM-IV-TR disorder that is present should be diagnosed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Acute cannabis intoxication",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Intoxication from other substances",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinically significant maladaptive behavioral or psychological changes that occur during cannabis intoxication can resemble intoxication due to other substances [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Alcohol, sedatives, hypnotics, or anxiolytics &mdash; Impaired judgment and motor coordination are common to intoxication due to alcohol, sedatives, hypnotics, anxiolytics, or cannabis. Alcohol, sedative, hypnotic, or anxiolytic intoxication is distinguished by the occurrence of nystagmus, ataxia, decreased appetite, and increased aggressive behavior.",
"     </li>",
"     <li>",
"      Hallucinogen &mdash; Impaired judgment and motor coordination, paranoia, anxiety, and tachycardia can occur in both hallucinogen and cannabis intoxication. Hallucinogen intoxication is distinguished by more prominent perceptual disturbances, pupillary dilation, diaphoresis, and tremors.",
"     </li>",
"     <li>",
"      Phencyclidine &mdash; Impaired judgment and tachycardia can occur in both phencyclidine and cannabis intoxication. Phencyclidine intoxication is much more likely to cause nystagmus, ataxia, mild hypertension, and aggressive behavior.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Primary mental disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute adverse reactions during cannabis intoxication can resemble symptoms of many psychiatric disorders not involving substances [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/1\">",
"     1",
"    </a>",
"    ]. These include",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Panic disorder",
"     </li>",
"     <li>",
"      Generalized anxiety disorder",
"     </li>",
"     <li>",
"      Major depressive disorder",
"     </li>",
"     <li>",
"      Bipolar I or II disorder",
"     </li>",
"     <li>",
"      Schizophrenia, paranoid type",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These disorders are distinguished by the absence of tachycardia and injected conjunctivas that occur with cannabis intoxication. A negative urine drug screen can also help make the diagnosis. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Drug testing'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Cannabis abuse and dependence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic use of cannabis may result in symptoms similar to dysthymic disorder, including depressed mood and impairment of social and occupational functioning. Cannabis abuse and dependence are distinguished from dysthymic disorder by the determination that the patient is chronically using cannabis. A urine drug screen can also help make the diagnosis. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Drug testing'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Polysubstance dependence",
"    </span>",
"    &nbsp;&mdash;&nbsp;DSM-IV-TR also includes the diagnosis of polysubstance dependence for patients who repeatedly use three or more substances (not including caffeine and nicotine) during the same 12 month period, with no one substance predominating [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21783/abstract/1\">",
"     1",
"    </a>",
"    ]. In addition, dependence criteria are met for substances as a group, but not for any one specific substance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?17/54/18274?source=see_link\">",
"       \"Patient information: Marijuana use and addiction (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cannabis intoxication is characterized by psychological changes in mood, perception, and thought content. Impaired cognition, judgment, coordination, and psychomotor functioning also occur and can persist for hours beyond the mood changes. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Intoxication'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cannabis intoxication is typically pleasant, but may induce distressing symptoms such as dysphoria, panic, depersonalization, paranoia, and unpleasant hallucinations. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Intoxication'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diagnosis of cannabis intoxication requires the presence of these behavioral or psychological signs with two or more physical signs (eg, conjunctival injection (red eye), increased appetite, dry mouth, and tachycardia) (",
"      <a class=\"graphic graphic_table graphicRef73321 \" href=\"UTD.htm?19/29/19931\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Cannabis intoxication'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis for cannabis intoxication includes intoxication from other substances as well as panic disorder, generalized anxiety disorder, major depressive disorder, bipolar I or II disorder, and schizophrenia, paranoid type. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Acute cannabis intoxication'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cannabis abuse is a problematic pattern of substance use that results in poor role functioning, interpersonal difficulties, recurrent substance use in physically hazardous situations, or repeated legal difficulties. Abuse is distinguished from dependence by the absence of compulsive use, physiologic tolerance, or physiologic withdrawal (",
"      <a class=\"graphic graphic_table graphicRef53923 \" href=\"UTD.htm?24/5/24667\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Abuse'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cannabis dependence is a maladaptive pattern of use manifested by neglecting occupational or social activities, repeated ingestion despite physical or psychological problems caused by cannabis, ingesting larger amounts over longer periods of time, unsuccessful efforts to limit use, spending a great deal of time obtaining or using cannabis or recovering from its effects, physiologic tolerance, and physiologic withdrawal (",
"      <a class=\"graphic graphic_table graphicRef64590 \" href=\"UTD.htm?31/34/32299\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Cannabis dependence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Symptoms of withdrawal from cannabis include sleep disturbance, irritability, and physical tension. This typically begins on the first or second day of abstinence, peaks between day two to six, and resolves within 7 to 14 days, but may persist for weeks. Patients may relapse because of withdrawal. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Withdrawal'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients who report cannabis use or who are otherwise suspected of cannabis (or other substance) use disorder should be screened for potential abuse and dependence. One commonly used instrument is the Drug Abuse Screening Test. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Screening'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Urine drug testing for cannabinoids is widely available and inexpensive. A positive test only establishes past use and cannot be used to diagnose intoxication, abuse, or dependence. Urine tests for cannabinoids remain positive after discontinuation of cannabis for up to 7 to 10 days in a casual cannabis user, two to four weeks in a heavy user, and months in a chronic heavy user. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Drug testing'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed, American Psychiatric Association, Washington, DC 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21783/abstract/2\">",
"      Ashton CH. Pharmacology and effects of cannabis: a brief review. Br J Psychiatry 2001; 178:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21783/abstract/3\">",
"      Hall W, Solowij N. Adverse effects of cannabis. Lancet 1998; 352:1611.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organization. Cannabis: A Health Perspective and Research Agenda, WHO, Geneva 1997.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21783/abstract/5\">",
"      Leirer VO, Yesavage JA, Morrow DG. Marijuana carry-over effects on aircraft pilot performance. Aviat Space Environ Med 1991; 62:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21783/abstract/6\">",
"      Kalant H. Adverse effects of cannabis on health: an update of the literature since 1996. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28:849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21783/abstract/7\">",
"      Asbridge M, Hayden JA, Cartwright JL. Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis. BMJ 2012; 344:e536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21783/abstract/8\">",
"      Leggett T, United Nations Office on Drugs and Crime. A review of the world cannabis situation. Bull Narc 2006; 58:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21783/abstract/9\">",
"      Nocon A, Wittchen HU, Pfister H, et al. Dependence symptoms in young cannabis users? A prospective epidemiological study. J Psychiatr Res 2006; 40:394.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Version for 2007. file://www.who.int/classifications/apps/icd/icd10online/ (Accessed on September 2, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21783/abstract/11\">",
"      Hasin DS, Keyes KM, Alderson D, et al. Cannabis withdrawal in the United States: results from NESARC. J Clin Psychiatry 2008; 69:1354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21783/abstract/12\">",
"      Mennes CE, Ben Abdallah A, Cottler LB. The reliability of self-reported cannabis abuse, dependence and withdrawal symptoms: multisite study of differences between general population and treatment groups. Addict Behav 2009; 34:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21783/abstract/13\">",
"      Budney AJ, Hughes JR, Moore BA, Vandrey R. Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry 2004; 161:1967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21783/abstract/14\">",
"      von Sydow K, Lieb R, Pfister H, et al. The natural course of cannabis use, abuse and dependence over four years: a longitudinal community study of adolescents and young adults. Drug Alcohol Depend 2001; 64:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21783/abstract/15\">",
"      Wagner FA, Anthony JC. From first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacology 2002; 26:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21783/abstract/16\">",
"      Degenhardt L, Chiu WT, Sampson N, et al. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med 2008; 5:e141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21783/abstract/17\">",
"      Gavin DR, Ross HE, Skinner HA. Diagnostic validity of the drug abuse screening test in the assessment of DSM-III drug disorders. Br J Addict 1989; 84:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21783/abstract/18\">",
"      Swift W, Copeland J, Hall W. Choosing a diagnostic cut-off for cannabis dependence. Addiction 1998; 93:1681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21783/abstract/19\">",
"      Kleber HD, Weiss RD, Anton RF Jr, et al. Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry 2007; 164:5.",
"     </a>",
"    </li>",
"    <li>",
"     DuPont, RL, Selavka, CM. Testing to identify recent drug use. In: The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th ed, Galanter, M, Kleber HD (Eds), American Psychiatric Publishing, Washington, DC 2008. p.655.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21783/abstract/21\">",
"      ElSohly MA, deWit H, Wachtel SR, et al. Delta9-tetrahydrocannabivarin as a marker for the ingestion of marijuana versus Marinol: results of a clinical study. J Anal Toxicol 2001; 25:565.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7811 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-222.190.118.195-3C09538E6E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_17_21783=[""].join("\n");
var outline_f21_17_21783=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION AND DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Intoxication",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Mood, perception, thought content",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Cognition, psychomotor performance",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Physiologic signs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Abuse",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Dependence",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Withdrawal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Cannabis intoxication",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Cannabis abuse",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Cannabis dependence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Screening",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Drug testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Acute cannabis intoxication",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Intoxication from other substances",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Primary mental disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Cannabis abuse and dependence",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Polysubstance dependence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PSYCH/7811\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PSYCH/7811|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/29/19931\" title=\"table 1\">",
"      DSM-IV-TR diagnostic criteria for cannabis intoxication",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/5/24667\" title=\"table 2\">",
"      DSM-IV-TR diagnostic criteria for cannabis abuse",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?31/34/32299\" title=\"table 3\">",
"      DSM-IV-TR diagnostic criteria for cannabis dependence",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/3/1079?source=related_link\">",
"      Cannabis use disorders: Epidemiology, comorbidity, and pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/28/4554?source=related_link\">",
"      Cannabis use disorders: Treatment, prognosis, and long-term medical effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?17/54/18274?source=related_link\">",
"      Patient information: Marijuana use and addiction (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/58/5033?source=related_link\">",
"      Substance use disorders: Principles for recognition and assessment in general medical care",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_17_21784="Management of comorbid problems associated with Parkinson disease";
var content_f21_17_21784=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management of comorbid problems associated with Parkinson disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/17/21784/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/17/21784/contributors\">",
"     Daniel Tarsy, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/17/21784/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/17/21784/contributors\">",
"     Howard I Hurtig, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/17/21784/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/17/21784/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/17/21784/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Parkinson disease (PD) is a chronic, progressive neurodegenerative disease characterized by any combination of four cardinal signs: rest tremor, rigidity, akinesia, and gait disturbance. The clinical features most suggestive of idiopathic PD rather than an atypical or secondary parkinsonian syndrome include asymmetric or unilateral onset, the presence of resting tremor, and a clear-cut response to treatment with L-dopa.",
"   </p>",
"   <p>",
"    In addition to these typical features, patients with PD may experience problems related to the disease itself or to the medications used to treat it. These comorbid problems include psychosis, hallucinations, daytime sleepiness, depression, fatigue and dementia.",
"   </p>",
"   <p>",
"    Management of these comorbid problems will be reviewed here. Dementia in PD and the clinical aspects of nonmotor symptoms in PD are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/36/15946?source=see_link\">",
"     \"Parkinson disease dementia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/13/14554?source=see_link&amp;anchor=H9#H9\">",
"     \"Clinical manifestations of Parkinson disease\", section on 'Nonmotor symptoms'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PSYCHOSIS AND HALLUCINATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psychosis is a frequent complication of Parkinson disease (PD), and it is characterized mainly by visual hallucinations and delusions, which are often paranoid in flavor [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/1\">",
"     1",
"    </a>",
"    ]. Hallucinations are the most common manifestation, and they affect up to 40 percent of patients with PD, particularly those at an advanced stage of illness. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/13/14554?source=see_link&amp;anchor=H11#H11\">",
"     \"Clinical manifestations of Parkinson disease\", section on 'Psychosis and hallucinations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The treatment of hallucinations includes general measures that are similar to the treatment of delirium. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/33/28185?source=see_link\">",
"     \"Prevention and treatment of delirium and confusional states\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Stopping all potentially offending antiparkinsonian drugs is usually not an option for most patients, although dose reduction can frequently be accomplished with amelioration of hallucinations and little loss of drug-related benefit.",
"   </p>",
"   <p>",
"    Antiparkinsonian drugs can be reduced or stopped in reverse order of their potency and effectiveness if hallucinations are causing disability; the suggested sequence begins with anticholinergic drugs, followed by",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/46/13031?source=see_link\">",
"     amantadine",
"    </a>",
"    , then catechol-O-methyl transferase (COMT) inhibitors, and, lastly, dopamine agonists. Levodopa is essential for almost all patients with PD, although levodopa dose reduction can be considered if all else fails.",
"   </p>",
"   <p>",
"    The atypical neuroleptics",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/21/35161?source=see_link\">",
"     clozapine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/56/20361?source=see_link\">",
"     quetiapine",
"    </a>",
"    may be helpful in low doses [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/2-7\">",
"     2-7",
"    </a>",
"    ]. Although several open label studies have shown that quetiapine is effective for treatment of psychosis in patients with PD, and two single-blind randomized trials comparing quetiapine and clozapine showed they were equally effective, only one of five small randomized controlled trials found benefit for quetiapine compared with placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/8\">",
"     8",
"    </a>",
"    ]. However, despite the inconsistent study data, the practical value of quetiapine in clinical practice is well established, and it is by far the most widely used antipsychotic for dopaminergic-induced psychosis.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/21/35161?source=see_link\">",
"     Clozapine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/56/20361?source=see_link\">",
"     quetiapine",
"    </a>",
"    do not appear to worsen parkinsonism as do other atypical neuroleptics, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/33/11802?source=see_link\">",
"     risperidone",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/36/37449?source=see_link\">",
"     olanzapine",
"    </a>",
"    , and the typical neuroleptics, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/50/32553?source=see_link\">",
"     haloperidol",
"    </a>",
"    . Clozapine can cause granulocytopenia in 1 to 2 percent of patients, and weekly to biweekly blood counts are required by law in order for patients to use it. The risk of clozapine-induced leukopenia or agranulocytosis decreases exponentially over time, and the likelihood of developing fatal granulocytopenia beyond six months of clozapine treatment is almost nil [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/21/35161?source=see_link\">",
"     Clozapine",
"    </a>",
"    is underutilized because of the nuisance of hematologic monitoring, but it is probably the most effective of the atypical neuroleptics in this setting. In this regard, a practice parameter from the American Academy of Neurology (AAN) issued in 2006 concluded that clozapine is probably effective and that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/56/20361?source=see_link\">",
"     quetiapine",
"    </a>",
"    is possibly effective for the treatment of psychosis in patients with PD [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/10\">",
"     10",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/36/37449?source=see_link\">",
"     Olanzapine",
"    </a>",
"    was deemed ineffective.",
"   </p>",
"   <p>",
"    Since",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/56/20361?source=see_link\">",
"     quetiapine",
"    </a>",
"    is easier to use than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/21/35161?source=see_link\">",
"     clozapine",
"    </a>",
"    (no monitoring required) and often effective, it should be the treatment of first choice.",
"   </p>",
"   <p>",
"    All atypical neuroleptics appear to be associated with a small increased risk of mortality when used to treat behavioral disorders in elderly patients with dementia. However, this risk must be balanced with the high morbidity and mortality of untreated psychosis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/10\">",
"     10",
"    </a>",
"    ]. The issue of mortality risk with neuroleptic medications is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/10/15530?source=see_link\">",
"     \"Second-generation antipsychotic medications: Pharmacology, administration, and comparative side effects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/45/44760?source=see_link\">",
"     \"Pharmacotherapy for schizophrenia: Side effect management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although the data are inconsistent, a potential benefit of cholinesterase inhibitors for improvement in neuropsychiatric symptoms in patients with Parkinson disease dementia and dementia with Lewy bodies has been suggested by some studies. However, these drugs do not appear to improve neuropsychiatric symptoms to a clinically significant extent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27402?source=see_link&amp;anchor=H18#H18\">",
"     \"Treatment of behavioral symptoms related to dementia\", section on 'Cholinesterase inhibitors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DEMENTIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;While Parkinson disease can coexist with other common causes of dementia, such as Alzheimer disease and vascular dementia, dementia is increasingly recognized as a common feature of Parkinson disease itself. Dementia associated with Parkinson disease is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/36/15946?source=see_link\">",
"     \"Parkinson disease dementia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     DAYTIME SLEEPINESS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Excessive daytime sleepiness (EDS) is common in patients with Parkinson disease (PD) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. The sudden onset of sleep, a phenomenon known as sleep attacks, has also been described. EDS and sudden somnolence can be a hazard for PD patients when driving [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/13/14554?source=see_link&amp;anchor=H16#H16\">",
"     \"Clinical manifestations of Parkinson disease\", section on 'Sleep disorders'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Management of EDS involves efforts to improve nocturnal sleep hygiene and to treat causes of poor nocturnal sleep. Pharmacologic treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/8/1159?source=see_link\">",
"     modafinil",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/60/39881?source=see_link\">",
"     methylphenidate",
"    </a>",
"    , or judicious use of coffee during the day may offer some benefit.",
"   </p>",
"   <p>",
"    However, data regarding the effectiveness of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/8/1159?source=see_link\">",
"     modafinil",
"    </a>",
"    are sparse and conflicting [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. In the largest of these small trials, 40 subjects with PD and EDS were randomly assigned to treatment with modafinil (200 to 400",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    or placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/16\">",
"     16",
"    </a>",
"    ]. There was no benefit for modafinil treatment in the primary outcome measure, the Epworth sleepiness score, or any of the secondary outcome measures. Modafinil is not approved by the US Food and Drug Administration (FDA) for the treatment of sleepiness in PD.",
"   </p>",
"   <p>",
"    In the author's clinical experience,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/8/1159?source=see_link\">",
"     modafinil",
"    </a>",
"    has",
"    <strong>",
"     not",
"    </strong>",
"    been effective for treating drowsiness in patients with PD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     FATIGUE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fatigue is a common problem in patients with Parkinson disease (PD), and it appears to be an independent symptom of PD that overlaps with, but is not causally related to, depression and daytime sleepiness. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/13/14554?source=see_link&amp;anchor=H18#H18\">",
"     \"Clinical manifestations of Parkinson disease\", section on 'Fatigue'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Treatment of fatigue in PD begins with an attempt to identify the cause. Excessive daytime sleepiness and depression are both the most common and the most treatable identifiable causes. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Daytime sleepiness'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H6\">",
"     'Depression'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Differentiating between sleepiness and fatigue is also important. True fatigue unassociated with sleepiness or depression is more difficult to treat. Suboptimally treated bradykinesia sometimes presents as subjective fatigue and should be identified and treated by readjusting antiparkinson medications. However, in some cases fatigue appears in patients with mild bradykinesia and is poorly understood.",
"   </p>",
"   <p>",
"    Medications used for empiric treatment of fatigue, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/46/13031?source=see_link\">",
"     amantadine",
"    </a>",
"    and stimulants, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/60/39881?source=see_link\">",
"     methylphenidate",
"    </a>",
"    and pemoline, may be considered, but response to these is often disappointing. In one trial, 36 patients with PD were randomly assigned to treatment with either methylphenidate (10 mg three times daily) or placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/17\">",
"     17",
"    </a>",
"    ]. At six weeks, there was a significant reduction in two measures of self-reported fatigue for patients assigned to methylphenidate. Based upon the results of this trial, a practice parameter from the American Academy of Neurology concluded that methylphenidate is \"possibly useful\" for treating fatigue in patients with PD [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/18\">",
"     18",
"    </a>",
"    ]. However, it is unclear whether the benefit of methylphenidate for fatigue in this setting is clinically meaningful.",
"   </p>",
"   <p>",
"    Of note,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/8/1159?source=see_link\">",
"     modafinil",
"    </a>",
"    was not effective for improving either excessive daytime sleepiness (the primary outcome measure) or fatigue (a secondary outcome measure) in the randomized controlled trial cited above [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Daytime sleepiness'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In the author's clinical experience,",
"    <strong>",
"     no",
"    </strong>",
"    medications have been effective for fatigue in patients with PD, including",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/60/39881?source=see_link\">",
"     methylphenidate",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/8/1159?source=see_link\">",
"     modafinil",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     DEPRESSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Depression is one of the most common psychiatric disturbances seen in PD. Depressive symptoms in PD are associated with a negative impact on motor disability and decreased quality of life. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/13/14554?source=see_link&amp;anchor=H12#H12\">",
"     \"Clinical manifestations of Parkinson disease\", section on 'Mood disorders'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no clear consensus regarding the use of antidepressants for the treatment of depression in patients with PD. A 2006 practice parameter from the American Academy of Neurology (AAN) reviewed small six randomized controlled trials that evaluated pharmacologic treatment of depression in patients with PD [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/10\">",
"     10",
"    </a>",
"    ]. In one of these trials,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/30/27112?source=see_link\">",
"     amitriptyline",
"    </a>",
"    but not",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    treatment was associated with significant improvement [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/19\">",
"     19",
"    </a>",
"    ]. The AAN found insufficient evidence to support or refute the effectiveness of other antidepressant medications in this setting.",
"   </p>",
"   <p>",
"    Since the 2006 AAN report, a number of small randomized placebo-controlled trials have reported the following observations regarding the treatment of depression in patients with PD:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/14/39144?source=see_link\">",
"       Desipramine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"       citalopram",
"      </a>",
"      were equally effective [",
"      <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/20\">",
"       20",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/21/30040?source=see_link\">",
"       Nortriptyline",
"      </a>",
"      was efficacious while",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"       paroxetine",
"      </a>",
"      controlled release was not [",
"      <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/21\">",
"       21",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/62/999?source=see_link\">",
"       Atomoxetine",
"      </a>",
"      was not beneficial [",
"      <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/22\">",
"       22",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"       Paroxetine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/45/22233?source=see_link\">",
"       venlafaxine",
"      </a>",
"      improved depression and did not worsen motor function [",
"      <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/23\">",
"       23",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Evidence from other randomized controlled trials suggested that the dopaminergic agonists",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/11/18615?source=see_link\">",
"     ropinirole",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/19/32055?source=see_link\">",
"     pramipexole",
"    </a>",
"    may improve depressive symptoms in patients with PD [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/24,25\">",
"     24,25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the absence of a clear first choice for treating depression associated with PD, drug selection should be based on potential advantages versus potential side effects [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/26\">",
"     26",
"    </a>",
"    ]. It is reasonable to start with a selective serotonin reuptake inhibitor (SSRI) in most patients, as the likelihood of adverse events is lower with SSRIs than with tricyclics such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/30/27112?source=see_link\">",
"     amitriptyline",
"    </a>",
"    (and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/21/30040?source=see_link\">",
"     nortriptyline",
"    </a>",
"    to a lesser extent). The anticholinergic side effects of tricyclic medications, which can include cognitive impairment and orthostatic hypotension with an increased risk of falls, may be particularly troublesome in the setting of PD [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/10\">",
"     10",
"    </a>",
"    ]. However, for patients who do not improve with SSRI treatment, a tricyclic antidepressant is a reasonable option when tremor is a dominant symptom and the potential benefit is thought to outweigh the risk of anticholinergic side effects.",
"   </p>",
"   <p>",
"    Patients with PD who have apathy as a feature of depression can be treated with antidepressant medications, as there is no specific treatment for apathy or abulia in the absence of depression. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/13/14554?source=see_link&amp;anchor=H12#H12\">",
"     \"Clinical manifestations of Parkinson disease\", section on 'Mood disorders'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Overviews of depression in adults, including clinical manifestations and treatment, are found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/13/11481?source=see_link\">",
"     \"Clinical manifestations and diagnosis of depression\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40074?source=see_link\">",
"     \"Initial treatment of depression in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Concerns with SSRI use",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two potential concerns regarding the use of selective serotonin reuptake inhibitors (SSRIs) for treatment of depression in patients with Parkinson disease (PD). These are the possibility of aggravating motor symptoms and the possibility of an adverse interaction with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/54/25448?source=see_link\">",
"     selegiline",
"    </a>",
"    , a MAO B inhibitor sometimes used to treat PD. Although the use of SSRIs in PD with or without selegiline appears to be safe, caution is advised when introducing these drugs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Aggravating motor symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extrapyramidal symptoms such as dystonia, akathisia, tremor, and parkinsonism are associated with SSRIs [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/27\">",
"     27",
"    </a>",
"    ]. These symptoms may be due to increased serotonin-mediated inhibition of dopamine release in the substantia nigra [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/28\">",
"     28",
"    </a>",
"    ]. Several case reports indicate that SSRIs may also exacerbate the motor symptoms of PD [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/29-31\">",
"     29-31",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     Fluoxetine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"     paroxetine",
"    </a>",
"    have been the SSRIs most commonly associated with increased parkinsonism, while",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"     sertraline",
"    </a>",
"    has been associated with relatively few cases [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/32,33\">",
"     32,33",
"    </a>",
"    ], possibly related to its greater effect on dopamine reuptake inhibition compared with the other SSRIs [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A survey of specialists who treat PD found that 43 percent were concerned that SSRIs may worsen motor signs, while 37 percent reported having at least one patient in which this had occurred [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, several studies of patients with PD who were treated with SSRIs indicate that the risk of exacerbation of PD is actually very low.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A retrospective case series found that only 5 of 58 patients with PD and depression showed worsened motor function, and alternative explanations or contributing factors could be identified in each case [",
"      <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Three prospective, open-label studies of several different SSRIs in patients with PD with [",
"      <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/37,38\">",
"       37,38",
"      </a>",
"      ] or without [",
"      <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/39\">",
"       39",
"      </a>",
"      ] depression have shown no worsening of quantitative motor scores following treatment lasting one to six months.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, it appears that SSRIs only rarely aggravate motor symptoms in PD, and that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"     sertraline",
"    </a>",
"    may be the least likely of SSRIs to do so. It remains possible that patients with increased susceptibility to aggravation of motor symptoms due to advanced age [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/40\">",
"     40",
"    </a>",
"    ] or higher SSRI plasma levels because of drug-drug interactions [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/34\">",
"     34",
"    </a>",
"    ] may be at greater risk for this complication.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Serotonin syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serotonin syndrome is a potentially severe condition associated with increased serotonergic activity in the central nervous system and severely disturbed mental, motor, and autonomic function. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/63/16376?source=see_link\">",
"     \"Serotonin syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The MAO B inhibitors",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/54/25448?source=see_link\">",
"     selegiline",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/13/24791?source=see_link\">",
"     rasagiline",
"    </a>",
"    should be used only at recommended doses and with caution when combined with other antidepressants, including tricyclics and SSRIs, because of the risk of causing the serotonin syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/41\">",
"     41",
"    </a>",
"    ]. Despite this theoretical risk, movement disorder specialists often use an MAO B inhibitor and an antidepressant for patients with PD without causing serotonin syndrome. The risk of the serotonin syndrome is uncertain, but two chart reviews have shown no serious side effects in a total of 48 patients receiving selegiline and an SSRI [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. Another study surveyed 47 specialists who manage PD and reported that among 4568 patients treated with a combination of selegiline and an antidepressant, symptoms consistent with the serotonin syndrome were observed in only 11 (0.24 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/41\">",
"     41",
"    </a>",
"    ]. Published and US FDA-reported cases of adverse effects of selegiline-antidepressant combinations are also very few, and most do not fulfill criteria for the serotonin syndrome.",
"   </p>",
"   <p>",
"    At higher than recommended doses (10 mg daily for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/54/25448?source=see_link\">",
"     selegiline",
"    </a>",
"    ; 1 mg daily for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/13/24791?source=see_link\">",
"     rasagiline",
"    </a>",
"    ;) the MAO B inhibitors may also inhibit MAO A and, when given with an antidepressant, carry the risk of the tyramine \"cheese\" reaction, characterized by a severe hypertensive crisis. However, this reaction is rare when the MAO B inhibitors are given at recommended doses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10643347\">",
"    <span class=\"h1\">",
"     CONSTIPATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Constipation is one of the nonmotor problems related to autonomic dysfunction and slowed colonic transit time in PD. The general approach to the management of constipation is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/57/30616?source=see_link\">",
"     \"Management of chronic constipation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Limited data from small randomized trials suggest that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/28/38339?source=see_link\">",
"     lubiprostone",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/44\">",
"     44",
"    </a>",
"    ] and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/17/4374?source=see_link\">",
"     polyethylene glycol",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21784/abstract/45\">",
"     45",
"    </a>",
"    ] are more effective than placebo for improving constipation in patients with PD. However, nausea was a common side effect of lubiprostone in larger trials involving non-PD subjects with chronic constipation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/57/30616?source=see_link&amp;anchor=H30891009#H30891009\">",
"     \"Management of chronic constipation in adults\", section on 'Lubiprostone'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?13/40/13954?source=see_link\">",
"       \"Patient information: Parkinson disease (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H103839407\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Psychosis is a frequent complication of Parkinson disease (PD), and it is characterized mainly by visual hallucinations and delusions, which are often paranoid in flavor. Antiparkinsonian drugs can be reduced or stopped in reverse order of their potency and effectiveness if hallucinations are causing disability; the suggested sequence begins with anticholinergic drugs, followed by",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/46/13031?source=see_link\">",
"       amantadine",
"      </a>",
"      , then catechol-O-methyl transferase (COMT) inhibitors, and lastly, dopamine agonists. Despite inconsistent data from randomized controlled trials supporting its effectiveness, the practical value of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/56/20361?source=see_link\">",
"       quetiapine",
"      </a>",
"      in clinical practice is well established, and it is by far the most widely used antipsychotic for dopaminergic-induced psychosis. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Psychosis and hallucinations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Dementia is a common feature of PD. Dementia associated with PD is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/36/15946?source=see_link\">",
"       \"Parkinson disease dementia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Management of excessive daytime sleepiness in PD involves efforts to improve nocturnal sleep hygiene and to treat causes of poor nocturnal sleep. Pharmacologic treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/8/1159?source=see_link\">",
"       modafinil",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/60/39881?source=see_link\">",
"       methylphenidate",
"      </a>",
"      , or judicious use of coffee during the day may offer some benefit. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Daytime sleepiness'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment of fatigue in PD begins with an attempt to identify the cause. Excessive daytime sleepiness and depression are both the most common and the most treatable identifiable causes. Medications used for empiric treatment of fatigue, such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/46/13031?source=see_link\">",
"       amantadine",
"      </a>",
"      and stimulants, such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/60/39881?source=see_link\">",
"       methylphenidate",
"      </a>",
"      and pemoline, may be considered, but response to these is often disappointing. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Fatigue'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is no clear consensus regarding the use of antidepressants for the treatment of depression in patients with PD. In the absence of a clear first choice, drug selection should be based on potential advantages versus potential side effects. It seems reasonable to start with serotonin specific reuptake inhibitor (SSRI) in most patients, as the likelihood of adverse events is lower with SSRIs than with tricyclics antidepressants. Patients with PD who have apathy as a feature of depression can be treated with antidepressant medications, as there is no specific treatment for apathy or abulia in the absence of depression. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Depression'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are two potential concerns regarding the use of selective serotonin reuptake inhibitors (SSRIs) for treatment of depression in patients with PD. These are the possibility of aggravating motor symptoms and the possibility of an adverse interaction with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/54/25448?source=see_link\">",
"       selegiline",
"      </a>",
"      , a MAO B inhibitor sometimes used to treat PD. Although the use of SSRIs in PD with or without selegiline appears to be safe, caution is advised when introducing these drugs. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Concerns with SSRI use'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/1\">",
"      Forsaa EB, Larsen JP, Wentzel-Larsen T, et al. A 12-year population-based study of psychosis in Parkinson disease. Arch Neurol 2010; 67:996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/2\">",
"      Rabey JM, Treves TA, Neufeld MY, et al. Low-dose clozapine in the treatment of levodopa-induced mental disturbances in Parkinson's disease. Neurology 1995; 45:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/3\">",
"      Fernandez HH, Friedman JH, Jacques C, Rosenfeld M. Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease. Mov Disord 1999; 14:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/4\">",
"      Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease. The Parkinson Study Group. N Engl J Med 1999; 340:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/5\">",
"      Morgante L, Epifanio A, Spina E, et al. Quetiapine versus clozapine: a preliminary report of comparative effects on dopaminergic psychosis in patients with Parkinson's disease. Neurol Sci 2002; 23 Suppl 2:S89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/6\">",
"      Juncos JL, Roberts VJ, Evatt ML, et al. Quetiapine improves psychotic symptoms and cognition in Parkinson's disease. Mov Disord 2004; 19:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/7\">",
"      Pollak P, Tison F, Rascol O, et al. Clozapine in drug induced psychosis in Parkinson's disease: a randomised, placebo controlled study with open follow up. J Neurol Neurosurg Psychiatry 2004; 75:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/8\">",
"      Shotbolt P, Samuel M, David A. Quetiapine in the treatment of psychosis in Parkinson's disease. Ther Adv Neurol Disord 2010; 3:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/9\">",
"      Schulte P. Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring. Ann Pharmacother 2006; 40:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/10\">",
"      Miyasaki JM, Shannon K, Voon V, et al. Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2006; 66:996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/11\">",
"      Hobson DE, Lang AE, Martin WR, et al. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA 2002; 287:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/12\">",
"      Gjerstad MD, Alves G, Wentzel-Larsen T, et al. Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease? Neurology 2006; 67:853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/13\">",
"      Frucht S, Rogers JD, Greene PE, et al. Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 1999; 52:1908.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/14\">",
"      H&ouml;gl B, Saletu M, Brandauer E, et al. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial. Sleep 2002; 25:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/15\">",
"      Adler CH, Caviness JN, Hentz JG, et al. Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease. Mov Disord 2003; 18:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/16\">",
"      Ondo WG, Fayle R, Atassi F, Jankovic J. Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial. J Neurol Neurosurg Psychiatry 2005; 76:1636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/17\">",
"      Mendon&ccedil;a DA, Menezes K, Jog MS. Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial. Mov Disord 2007; 22:2070.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/18\">",
"      Zesiewicz TA, Sullivan KL, Arnulf I, et al. Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2010; 74:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/19\">",
"      Serrano-Due&ntilde;as M. [A comparison between low doses of amitriptyline and low doses of fluoxetin used in the control of depression in patients suffering from Parkinson's disease]. Rev Neurol 2002; 35:1010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/20\">",
"      Devos D, Dujardin K, Poirot I, et al. Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study. Mov Disord 2008; 23:850.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/21\">",
"      Menza M, Dobkin RD, Marin H, et al. A controlled trial of antidepressants in patients with Parkinson disease and depression. Neurology 2009; 72:886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/22\">",
"      Weintraub D, Mavandadi S, Mamikonyan E, et al. Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease. Neurology 2010; 75:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/23\">",
"      Richard IH, McDermott MP, Kurlan R, et al. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology 2012; 78:1229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/24\">",
"      Pahwa R, Stacy MA, Factor SA, et al. Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease. Neurology 2007; 68:1108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/25\">",
"      Barone P, Poewe W, Albrecht S, et al. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2010; 9:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/26\">",
"      Okun MS, Watts RL. Depression associated with Parkinson's disease: clinical features and treatment. Neurology 2002; 58:S63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/27\">",
"      Bharucha KJ, Sethi KD. Complex movement disorders induced by fluoxetine. Mov Disord 1996; 11:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/28\">",
"      Kapur S, Remington G. Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry 1996; 153:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/29\">",
"      Steur EN. Increase of Parkinson disability after fluoxetine medication. Neurology 1993; 43:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/30\">",
"      Jim&eacute;nez-Jim&eacute;nez FJ, Tejeiro J, Mart&iacute;nez-Junquera G, et al. Parkinsonism exacerbated by paroxetine. Neurology 1994; 44:2406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/31\">",
"      Mannion, L, O'Sullivan, S, Carney, PA, et al. Parkinson's disease exacerbated by paroxetine. Ir J Psych Med 1997; 14:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/32\">",
"      Jimenez-Jimenez, FJ, Molina, JA. Extrapyramidal symptoms associated with selective serotonin reuptake inhibitors. CNS Drugs 2000; 14:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/33\">",
"      Gerber PE, Lynd LD. Selective serotonin-reuptake inhibitor-induced movement disorders. Ann Pharmacother 1998; 32:692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/34\">",
"      Leo RJ. Movement disorders associated with the serotonin selective reuptake inhibitors. J Clin Psychiatry 1996; 57:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/35\">",
"      Richard IH, Kurlan R. A survey of antidepressant drug use in Parkinson's disease. Parkinson Study Group. Neurology 1997; 49:1168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/36\">",
"      Richard IH, Maughn A, Kurlan R. Do serotonin reuptake inhibitor antidepressants worsen Parkinson's disease? A retrospective case series. Mov Disord 1999; 14:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/37\">",
"      Hauser RA, Zesiewicz TA. Sertraline for the treatment of depression in Parkinson's disease. Mov Disord 1997; 12:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/38\">",
"      Dell'Agnello G, Ceravolo R, Nuti A, et al. SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study. Clin Neuropharmacol 2001; 24:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/39\">",
"      Montastruc JL, Fabre N, Blin O, et al. Does fluoxetine aggravate Parkinson's disease? A pilot prospective study. Mov Disord 1995; 10:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/40\">",
"      Gormley, N, Watters, L, Lawlor, BA. Extrapyramidal side-effects in elderly patients exposed to selective serotonin reuptake inhibitors. Human Psychpharmacology 1997; 12:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/41\">",
"      Richard IH, Kurlan R, Tanner C, et al. Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease. Parkinson Study Group. Neurology 1997; 48:1070.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/42\">",
"      Waters CH. Fluoxetine and selegiline--lack of significant interaction. Can J Neurol Sci 1994; 21:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/43\">",
"      Toyama SC, Iacono RP. Is it safe to combine a selective serotonin reuptake inhibitor with selegiline? Ann Pharmacother 1994; 28:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/44\">",
"      Ondo WG, Kenney C, Sullivan K, et al. Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease. Neurology 2012; 78:1650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21784/abstract/45\">",
"      Zangaglia R, Martignoni E, Glorioso M, et al. Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study. Mov Disord 2007; 22:1239.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4900 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.55.141.10-E9920BD3B2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_17_21784=[""].join("\n");
var outline_f21_17_21784=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H103839407\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PSYCHOSIS AND HALLUCINATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DEMENTIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      DAYTIME SLEEPINESS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      FATIGUE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      DEPRESSION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Concerns with SSRI use",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Aggravating motor symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Serotonin syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10643347\">",
"      CONSTIPATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H103839407\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/13/11481?source=related_link\">",
"      Clinical manifestations and diagnosis of depression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/13/14554?source=related_link\">",
"      Clinical manifestations of Parkinson disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40074?source=related_link\">",
"      Initial treatment of depression in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/57/30616?source=related_link\">",
"      Management of chronic constipation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/36/15946?source=related_link\">",
"      Parkinson disease dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?13/40/13954?source=related_link\">",
"      Patient information: Parkinson disease (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/45/44760?source=related_link\">",
"      Pharmacotherapy for schizophrenia: Side effect management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/33/28185?source=related_link\">",
"      Prevention and treatment of delirium and confusional states",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/10/15530?source=related_link\">",
"      Second-generation antipsychotic medications: Pharmacology, administration, and comparative side effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/63/16376?source=related_link\">",
"      Serotonin syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27402?source=related_link\">",
"      Treatment of behavioral symptoms related to dementia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_17_21785="Radiation-related risks of imaging studies";
var content_f21_17_21785=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Radiation-related risks of imaging studies",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/17/21785/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/17/21785/contributors\">",
"     Christoph I Lee, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/17/21785/contributors\">",
"     Joann G Elmore, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/17/21785/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/17/21785/contributors\">",
"     Suzanne W Fletcher, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/17/21785/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/17/21785/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/17/21785/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 1, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H2016112\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ionizing radiation from medical imaging now accounts for nearly half of the radiation exposure experienced by the population in the United States (US) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Medical imaging may contribute less to total radiation exposure in other countries, however; 2005 data from the United Kingdom, for example, suggest that an average annual dose of imaging accounted for approximately one-sixth of annual exposure to ionizing radiation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The average radiation dose per US resident per year has been continuously increasing over the past 30 years [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/4\">",
"     4",
"    </a>",
"    ]. Among participants in managed care plans in the United States, for whom there would be no financial incentive to promote excess testing, increased use of CT scanning resulted in a doubling of per capita radiation exposure between 1996 and 2010 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/5\">",
"     5",
"    </a>",
"    ]. Although the immediate and long-term benefits of medical imaging procedures are widely discussed, their risks are often overlooked. The radiobiological detriment from a single procedure is likely very small. However, the cumulative effect of small individual doses in a patient population undergoing frequent and often repeated imaging presents a new public health concern for risks such as radiation-induced malignancies.",
"   </p>",
"   <p>",
"    The majority of radiation from medical imaging arises from CT procedures. As an example, a single abdominal CT scan involves radiation equivalent to more than 200 chest x-rays, and the associated future risks from such a scan remain uncertain. Use of CT scans has grown exponentially over the last two decades. Almost three-quarters of all CT scans in the US were ordered in acute care settings; in one large inner city hospital, the overall rate of CT scans ordered per patient doubled between 2001 and 2007, with the rate of chest CT scans increasing sixfold [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/6\">",
"     6",
"    </a>",
"    ]. By one estimate, use of CT may account for 1.5 to 2 percent of all future cancers in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will present an overview of the measurement of radiation associated with medical imaging, the effects of radiation exposure, the radiation associated with specific diagnostic imaging studies, and issues in clinical decision-making, including informed consent. Other related topics, including discussions of radiation injury, diagnostic imaging in pregnancy, radiation exposure in cardiovascular imaging, and total body imaging, are presented separately. &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/0/4106?source=see_link\">",
"       \"Biology and clinical features of radiation injury in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/29/28120?source=see_link\">",
"       \"Diagnostic imaging procedures during pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/2/14376?source=see_link\">",
"       \"Radiation dose and risk of malignancy from cardiovascular imaging\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/35/16952?source=see_link\">",
"       \"Full body CT scan for screening\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2016120\">",
"    <span class=\"h1\">",
"     IONIZING RADIATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ionizing radiation involves the detachment of electrons from subatomic particles or electromagnetic waves (eg, photons) at the atomic or molecular level, thus forming ions. Ionizing radiation is found in the natural environment in the form of radon or cosmic rays. Ionizing radiation is used for interventional and diagnostic radiology procedures, and in higher doses, for therapeutic and palliative procedures in the context of radiation oncology. With large catastrophic exposures, such as from an accident at a nuclear industrial facility, skin damage and acute radiation sickness may result. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/0/4106?source=see_link\">",
"     \"Biology and clinical features of radiation injury in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    At the lower doses used in diagnostic and interventional procedures, ionizing radiation may cause DNA damage that increases the risk for future cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/7\">",
"     7",
"    </a>",
"    ]. It should be noted that ionizing radiation causes structural damage at the cellular or molecular level, while non-ionizing radiation (which is not associated with medical imaging) causes damage through the transfer of heat (eg, microwave heating). Relative sources of exposure to ionizing radiation in the United States are shown in a figure (",
"    <a class=\"graphic graphic_figure graphicRef61739 \" href=\"UTD.htm?41/14/42222\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2016127\">",
"    <span class=\"h2\">",
"     Biologic effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;The proposed mechanism for cellular damage by ionizing radiation involves the production of free radicals. These free radicals interfere with chemical bonds between molecules that regulate key cellular processes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/8\">",
"     8",
"    </a>",
"    ]. Direct interaction between ionizing radiation and cellular macromolecules leads to DNA mutation or cell death, while indirect interaction causes free radical damage to essential cell enzymes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Tissues are more or less susceptible to radiation injury, based on their rate of cellular proliferation and their degree of cellular differentiation. Thus, blood-forming (lymphoproliferative) organs with rapid cell turnover are the most sensitive, while nervous tissue with little or no cell turnover is the least sensitive. Relative radiosensitivities of different organs and tissues are listed in a table (",
"    <a class=\"graphic graphic_table graphicRef68401 \" href=\"UTD.htm?13/60/14283\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The probability of occurrence of the chronic effects of ionizing radiation is a function of the total radiation dose, although the severity of effects cannot solely be attributed to radiation and is influenced by other factors (eg, environmental, genetic). While induction of future cancer is the effect of greatest concern, other potential outcomes include hereditary effects, shortening of life span, and cataract formation in the eyes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/10\">",
"     10",
"    </a>",
"    ]. Radiation-induced cancers may develop decades after exposure, and include myeloma, leukemia, lung cancer, thyroid cancer, breast cancer, bone cancer, and skin cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2016134\">",
"    <span class=\"h2\">",
"     Dose-response model",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several theoretical dose-response models, correlating radiation exposure with risk of developing cancer, have been developed. The linear no-threshold (LNT) model is the most conservative and most widely used [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/7,12-14\">",
"     7,12-14",
"    </a>",
"    ]. LNT assumes that any exposure to ionizing radiation, however small, can induce future cancer.",
"   </p>",
"   <p>",
"    The model is based on extrapolation of data from survivors of the Hiroshima atomic bomb. These data are used to project the cancer risk from estimates of very small radiation doses (eg, equivalent to a single chest x-ray). While some studies suggest that a meaningful threshold is not reached by very low dose radiologic studies, or that very low doses may even have a beneficial adaptive effect, fostering DNA repair and immune stimulation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/15\">",
"     15",
"    </a>",
"    ], most of the scientific community uses the LNT model. In particular, the US National Council on Radiological Protection and Measurements (NRCP) and the US National Academy of Sciences Biological Effects of Ionizing Radiation (BEIR) committees suggest that LNT is the best model for estimating the possible risks of ionizing radiation, although recognizing that it may err on the side of caution [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/7,12,13\">",
"     7,12,13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2016148\">",
"    <span class=\"h1\">",
"     MEASURING RADIATION DOSE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2016155\">",
"    <span class=\"h2\">",
"     Terminology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several terms are used to describe different aspects of radiation and radiation dose.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Radiation exposure",
"      </strong>",
"      refers to the concentration of ionizing radiation in a specific volume of air, measured in roentgens (R).",
"     </li>",
"     <li>",
"      <strong>",
"       Absorbed dose",
"      </strong>",
"      signifies how much radiation is absorbed by a specific tissue, measured in grays (Gy) or rads.",
"     </li>",
"     <li>",
"      <strong>",
"       Effective dose",
"      </strong>",
"      takes into account the particular tissue or organ that absorbs the radiation and reflects the equivalent whole-body dose that would result in the equivalent risk from a non-uniform source of irradiation such as a CT scan. It is the weighted average of doses to the irradiated organs and is measured in sieverts (Sv) or rems (100 rem = 1 Sv). &nbsp;",
"      <br/>",
"      <br/>",
"      Effective dose provides a quantification of the potential radiobiological detriment caused by a radiation exposure including carcinogenesis, decreased life expectancy, and hereditary effects, and thus is an indicator of the potential detriment to the patient caused by ionizing radiation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2016162\">",
"    <span class=\"h2\">",
"     Effective dose",
"    </span>",
"    &nbsp;&mdash;&nbsp;Estimation of the effective dose is the method most commonly used in clinical practice and the medical literature to estimate a patient&rsquo;s risk of detriment from a radiologic procedure. This detriment includes all cancers and hereditary effects induced by an exposure. Calculating the effective dose allows for comparison across different imaging modalities and spatial dose distributions. Additionally, the effective dose can be a useful parameter for determining the appropriateness of a radiologic examination in light of the possible adverse effects of ionizing radiation.",
"   </p>",
"   <p>",
"    The effective dose related to any radiologic procedure can be considered in the context of the annual effective dose to individuals from natural background radiation sources, including radon, cosmic rays, terrestrial, and internal sources. This background effective dose, approximately 3 mSv, is not felt to pose a significant risk of future cancer to individuals. The International Commission on Radiological Protection (IRCP) estimates a 4 to 5 percent increased relative risk of fatal cancer after an average person receives a whole-body radiation dose of 1 Sv (1 Sv = 1000 mSv ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A retrospective study of claims data for 2005 to 2008 from an insurance database in the United States for approximately 950,000 enrollees aged 18 to 64 years found that nearly 70 percent of enrollees underwent at least one imaging study [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/16\">",
"     16",
"    </a>",
"    ]. The median effective dose from imaging per year was 0.1 mSv; moderate, high, and very high effective doses (&gt;3 to 20 mSv, &gt;20 to 50 mSv, and &gt;50 mSv, respectively) were incurred by 194, 19, and 2 enrollees per 1000 per year, respectively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2016169\">",
"    <span class=\"h1\">",
"     ESTIMATING RISK FROM RADIATION EXPOSURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are currently no epidemiologic studies that document cancer arising directly from radiologic medical studies or procedures. A deterministic effect between imaging studies, such as diagnostic CT scans, and cancer will undoubtedly be difficult to show.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H147222742\">",
"    <span class=\"h2\">",
"     Epidemiologic basis for risk estimates",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risk estimates of radiation-induced cancer from medical imaging are mainly based on extrapolation of existing data from Japanese survivors of atomic bombings that took place in 1945 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. Radiation doses to more than 100,000 individuals have been estimated based on the individuals&rsquo; distance from atomic bomb epicenters; exposed individuals have been followed for cancer incidence and mortality for more than 60 years. Analysis of this patient registry demonstrates a linear relationship between the risk of developing any solid cancer and increasing radiation dose. Patient radiosensitivity was heavily dependent on age at the time of exposure, with children at greater risk of developing future radiation-induced cancer than adults.",
"   </p>",
"   <p>",
"    Some experts believe that direct comparisons of radiation dose from CT scans and atomic bomb survivors can be made, without the need for extrapolation of existing data, since roughly one-third of the atomic bomb survivors studied were exposed to low radiation doses, in the range of single or multiple CT procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/19\">",
"     19",
"    </a>",
"    ]. This subpopulation of survivors had a small, but statistically significant, increased risk of developing future cancer after exposures in the range analogous to radiation associated with a single abdominal CT scan. However, for very low-dose radiologic procedures, such as conventional x-ray and mammography, the linear no-threshold model is still required to estimate possible cancer risks, and the actual risk associated with low dose medical imaging remains controversial.",
"   </p>",
"   <p>",
"    While there are no data showing a causal relationship between actual medical examinations such as CT scans and cancer, there is epidemiologic evidence of future cancer development from exposure to x-rays and gamma rays. In the 1930s through the 1950s, repeat fluoroscopic exams were standard of care in tuberculosis patients, used to follow therapeutic pneumothoraces. The radiation doses for these fluoroscopic studies were slightly higher than current CT doses, and these patients were found to have an increased risk of developing breast cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/20\">",
"     20",
"    </a>",
"    ]. In another study involving more than 400,000 nuclear industry workers in 15 nations, an excess relative risk for cancer deaths was identified, equivalent in magnitude to that found in Japanese atomic bomb survivors [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2016183\">",
"    <span class=\"h2\">",
"     Future cancer risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;Estimating the risk of developing cancer from an individual radiologic study is controversial, given the stochastic nature of harm from ionizing radiation and the limited epidemiologic data. However, there is mounting consensus in the medical and scientific communities that the risk is real, however small to the individual.",
"   </p>",
"   <p>",
"    To estimate the lifetime risk of developing cancer attributable to any single imaging study for an individual patient, the American Society of Radiologic Technologists has an online",
"    <a class=\"external\" href=\"file://www.xrayrisk.com/\">",
"     radiation risk calculator",
"    </a>",
"    . Cumulative radiation dose and cancer risk from several studies over time can also be calculated.",
"   </p>",
"   <p>",
"    The 2006 Biological Effects of Ionizing Radiation (BEIR) VII lifetime attributable cancer risk model predicts that 1 in 1000 persons exposed to 10 mSv (which is in the range of a single diagnostic CT scan of the neck, chest, abdomen, or pelvis) will develop cancer due to that single exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/22\">",
"     22",
"    </a>",
"    ]. One study assessed the risks of developing a fatal cancer from CT scanning in the pediatric population and estimated the lifetime attributable cancer mortality risk attributable to a single radiation exposure in a one year-old child to be 1 in 550 following an abdominal CT and 1 in 1500 following a brain CT. These findings equate to a 0.35 percent increase in cancer deaths over the present background rate [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The International Commission on Radiological Protection (ICRP) has confirmed that doses for diagnostic exams such as CT scans approach or exceed levels associated with an increase in lifetime cancer risk [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One study estimated that roughly 29,000 future cancers could be attributed to CT scans performed in the US in 2007 alone [",
"      <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another study reports that 1 in 500 women and 1 in 660 men will develop cancer from their abdominal CT scan if the procedure is performed at the age of 20 [",
"      <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In the case of elective screening, one study estimated that a 45-year-old adult undergoing one single full-body CT procedure would accrue an additional lifetime attributable cancer mortality risk of 0.08 percent from a single scan; the lifetime attributable cancer mortality risk is 1.9 percent lifetime for 30 years of annual scans [",
"      <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Estimated effective doses for the most common radiologic procedures are provided below. (See",
"    <a class=\"local\" href=\"#H147223785\">",
"     'Radiation dose for common radiologic studies'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6024263\">",
"    <span class=\"h1\">",
"     IMAGING MODALITIES WITH IONIZING RADIATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most of the ionizing radiation from medical procedures originates either from x-rays (including computed tomography [CT] and fluoroscopy) or radioactive tracers. Fluoroscopic procedures include interventional radiology (eg, aortography, pulmonary angiography, neuroangiography) and more traditional procedures such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    enemas. Nuclear medicine procedures involve introducing a radioactive tracer into the body, which then emits gamma rays as it undergoes nuclear decay.",
"   </p>",
"   <p>",
"    CT, fluoroscopy, and nuclear medicine studies represent the vast majority of imaging-related radiation exposure for the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/13\">",
"     13",
"    </a>",
"    ]. CT scans result in radiation doses that are 100 to 250 times larger than those from conventional plain X-ray films and represent the fastest growing component of the US population's collective dose. Patients with certain diagnoses, such as inflammatory bowel disease, may be at particular risk for repeated imaging with CT scanning [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/28\">",
"     28",
"    </a>",
"    ]. The radiation dose attributable to fluoroscopic procedures, including interventional cardiology procedures, is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/2/14376?source=see_link\">",
"     \"Radiation dose and risk of malignancy from cardiovascular imaging\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H147223785\">",
"    <span class=\"h2\">",
"     Radiation dose for common radiologic studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;The average effective doses for the most common radiologic and nuclear medicine procedures in the US for the adult population have been calculated [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/29\">",
"     29",
"    </a>",
"    ]. The following tables are adapted from this summary report and other published summary reports [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/26,27,30,31\">",
"     26,27,30,31",
"    </a>",
"    ]. It should be noted that these are average effective doses for adults and that actual dose for any one patient may differ from the average effective dose reported by up to 10-fold (",
"    <a class=\"graphic graphic_table graphicRef81179 \" href=\"UTD.htm?16/33/16924\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef82239 \" href=\"UTD.htm?1/62/2029\">",
"     table 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef69998 \" href=\"UTD.htm?10/12/10445\">",
"     table 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef73485 \" href=\"UTD.htm?19/16/19724\">",
"     table 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef55620 \" href=\"UTD.htm?34/14/35052\">",
"     table 6",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6024332\">",
"    <span class=\"h3\">",
"     CT examinations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of CT scans has increased more than three fold in the United States since 1993 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/25\">",
"     25",
"    </a>",
"    ] and accounts for the majority of radiation from medical imaging. It is difficult to accurately estimate individual organ effective doses from a CT scan due to the unique physical characteristics of each patient, including their weight, age, and gender. Larger patients may require increased dose to penetrate additional body mass to generate adequate images, while younger patients will have more years of life left in which they may develop radiation-induced cancer. Moreover, since radiosensitivity differs by tissue type, the dose to a female&rsquo;s breasts or ovaries will differ from a male&rsquo;s dose to the testes even with the same magnitude of exposure.",
"   </p>",
"   <p>",
"    A number of technical factors also influence radiation dose associated with CT, including the x-ray beam energy, tube current, tube voltage, exposure time, patient thickness, and scan pitch (overlap of adjacent CT slices). Multiphasic CT scanning, in which the same organ is scanned in different phases of contrast enhancement to improve lesion detection, can increase the radiation dose almost four fold [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/32\">",
"     32",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    To help develop a general estimate of effective dose for common CT scans, researchers developed standard patient models using Monte Carlo simulations that allow estimated organ doses to be combined with appropriate weighting factors. These standard patient models result in estimated effective doses for each type of CT scan for the average adult patient [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/33\">",
"     33",
"    </a>",
"    ]. Software programs are available for gauging CT radiation dose after inputting certain technical parameters. Two estimations commonly used to quantify radiation dose, the volume CT dose index and the dose length product, are available on all modern CT scanners. These parameters cannot be directly converted into an estimate of effective dose but can gauge the difference in dose a patient will receive when altering specific technical scan parameters (eg, scan pitch) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/34\">",
"     34",
"    </a>",
"    ]. While frequently referred to in the context of modifying protocols to decrease dose to the patient, these two figures do not describe the actual radiation dose to the patient.",
"   </p>",
"   <p>",
"    One analysis used risk models from the Biological Effects of Ionizing Radiation report combined with age and sex-specific CT scan frequencies in the United States in 2007 and used Monte Carlo simulations to project incidence of CT radiation-related cancers [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/25\">",
"     25",
"    </a>",
"    ]. Their data suggest the following number of future cancers that could be attributable to CT scanning in 2007:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Abdominal and pelvic CT: 14,000 (95% CI 6900-25,000)",
"     </li>",
"     <li>",
"      Chest CT: 4100 (1900-8100)",
"     </li>",
"     <li>",
"      Head CT: 4000 (1100-8700)",
"     </li>",
"     <li>",
"      Chest CT angiography: 2700 (1300-5000)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The Institute of Medicine has identified CT scanning as one of the two major environmental causes of breast cancer (the other being postmenopausal hormone therapy) and recommends avoidance of medically unnecessary CT scans as one of the most important steps women can take to reduce their risk of breast cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/35\">",
"     35",
"    </a>",
"    ]. It has been estimated that 30 percent or more of advanced imaging studies ordered in the United States may be unnecessary [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H244329\">",
"    <span class=\"h1\">",
"     EFFORTS TO REDUCE THE RISK OF RADIATION FROM IMAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Three guiding principles of radiation protection are justification, optimization, and limitation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Justification",
"      </strong>",
"      refers to an appropriate indication for a radiologic procedure.",
"     </li>",
"     <li>",
"      <strong>",
"       Optimization",
"      </strong>",
"      , or As Low As Reasonably Achievable (the ALARA) principle, recommends that protocols be designed to obtain diagnostic images at the lowest possible dose to the patient, and is referred to widely [",
"      <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/24\">",
"       24",
"      </a>",
"      ]. &nbsp;",
"     </li>",
"     <li>",
"      <strong>",
"       Limitation",
"      </strong>",
"      refers to setting maximum aggregate doses over a given period of time. Traditionally, this has been focused on occupationally exposed individuals.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Several initiatives have been undertaken to implement these guiding principles.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The American College of Radiology (ACR) has developed appropriateness criteria for specific radiologic exams to limit the number of inappropriate studies [",
"      <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/37,38\">",
"       37,38",
"      </a>",
"      ]. Appropriateness guidelines have also been developed by the Royal College of Radiologists [",
"      <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/39\">",
"       39",
"      </a>",
"      ] and the European Commission [",
"      <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/40\">",
"       40",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      It has been estimated that up to 30 percent of all current CT scans are performed unnecessarily or for an inappropriate indication [",
"      <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/41\">",
"       41",
"      </a>",
"      ]. The ACR guidelines are being incorporated into computerized physician order entry (CPOE) systems as a component of the campaign for electronic medical records [",
"      <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/42\">",
"       42",
"      </a>",
"      ]. Early studies demonstrate a substantial decrease in the utilization of low-yield CT studies with incorporation of CPOE and decision support systems [",
"      <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/42-44\">",
"       42-44",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Many researchers have focused on optimizing CT protocols to ensure that the ALARA principle is followed, with a particular focus on pediatric patients [",
"      <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/45\">",
"       45",
"      </a>",
"      ] and on new screening techniques that involve asymptomatic adult patients [",
"      <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      There is renewed interest in documenting individual radiation doses and setting maximum aggregate exposures systematically in the United States, with legislative initiatives called for [",
"      <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/46\">",
"       46",
"      </a>",
"      ]. California has passed a law that requires radiation dose information to be documented in the patient&rsquo;s medical record [",
"      <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/47\">",
"       47",
"      </a>",
"      ]. Education campaigns about the radiation risks from medical imaging geared towards patients and physicians are in development by large organizations, including the US Food and Drug Administration [",
"      <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/48\">",
"       48",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In the United Kingdom, the Committee on Medical Aspects of Radiation in the Environment (COMPARE) issued a report on personally initiated X-ray CT scanning for asymptomatic individuals, recommending regulation of CT services and that screening take place as part of a coordinated care program [",
"      <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/49\">",
"       49",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      &ldquo;Image Wisely,&rdquo; a 2011 campaign to promote safe imaging, and &ldquo;Choosing Wisely,&rdquo; a 2012 campaign to promote wise use of imaging resources, were launched by the American College of Radiology, the Radiological Society of North America, the American Association of Physicists in Medicine, and the American Society of Radiologic Technologists [",
"      <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/50,51\">",
"       50,51",
"      </a>",
"      ]. US medical organizations, working with Choosing Wisely, have identified a list of 45 tests (including 24 diagnostic imaging studies) that were felt to be frequently overused. These are listed on the",
"      <a class=\"external\" href=\"file://www.choosingwisely.org/\">",
"       Choosing Wisely",
"      </a>",
"      website [",
"      <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/52\">",
"       52",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The Radiological Society of North America and the American College of Radiology have jointly developed a website, RadiologyInfo.org, that is meant to provide patients with information on radiation exposure in x-ray and CT examinations [",
"      <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/53\">",
"       53",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2810649\">",
"    <span class=\"h2\">",
"     Shielding",
"    </span>",
"    &nbsp;&mdash;&nbsp;A small number of studies have examined the benefits of shielding to reduce radiation to the female breast, male gonads, and thyroid. Shielding of these radiosensitive organs may substantially decrease associated radiation-related risks, especially in children and young adults. For CT scans, in-plane bismuth shields selectively lower dose of the underlying superficial tissue while allowing enough x-rays to pass through to constitute a diagnostic image [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/54,55\">",
"     54,55",
"    </a>",
"    ]. Commercially available breast shields reduce female breast dose by 40 to 61 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/54-57\">",
"     54-57",
"    </a>",
"    ], testicle capsules can decrease dose to male gonads by 87 to 96 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/58,59\">",
"     58,59",
"    </a>",
"    ], and thyroid shields have been found to reduce radiation dose to the thyroid by 31 to 57 percent during CT scans [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/54,57\">",
"     54,57",
"    </a>",
"    ]. However, studies are conflicting as to whether the beam hardening artifacts may degrade CT images enough to adversely affect their interpretation and more data is needed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H244336\">",
"    <span class=\"h1\">",
"     CLINICAL DECISION-MAKING AND INFORMING PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Over the past several decades, a gradual lowering of the threshold for obtaining diagnostic radiologic procedures in the United States has been observed and attributed to a number of reasons, including medical-legal concerns, patient demand, financial incentives, knowledge gap of the ordering clinician, and inaccessibility or lack of knowledge about previously performed examinations [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/60,61\">",
"     60,61",
"    </a>",
"    ]. Studies show that patients and physicians are unaware of the potential risks associated with medical imaging [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/62\">",
"     62",
"    </a>",
"    ]. In most instances, the benefits of information gained from a diagnostic radiologic procedure clearly outweigh the risks. However, for patients undergoing studies for inappropriate indications, frequent repeat studies for the same indication, or elective",
"    <strong>",
"     screening",
"    </strong>",
"    examinations, the future potential risks may outweigh the benefits.",
"   </p>",
"   <p>",
"    While estimating the radiation dose for any specific patient and the theoretical risks of future cancer associated with",
"    <span class=\"nowrap\">",
"     his/her",
"    </span>",
"    radiologic procedure is difficult, communicating with patients about these risks may be even more difficult. Estimated effective dose for a patient undergoing a particular radiologic procedure can be calculated, using the dose length product (DLP), which is recorded as part of each CT scan, combined with details of the imaged area and published conversion factors [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/63\">",
"     63",
"    </a>",
"    ]. For the purposes of patient-physician communication, however, relative magnitudes as outlined in the tables are probably sufficient (",
"    <a class=\"graphic graphic_table graphicRef55620 \" href=\"UTD.htm?34/14/35052\">",
"     table 6",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef82239 \" href=\"UTD.htm?1/62/2029\">",
"     table 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef81179 \" href=\"UTD.htm?16/33/16924\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef73485 \" href=\"UTD.htm?19/16/19724\">",
"     table 5",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H147223313\">",
"    <span class=\"h2\">",
"     Informed consent",
"    </span>",
"    &nbsp;&mdash;&nbsp;Discussion about the possible risks of ionizing radiation should be part of the consent process prior to any radiologic procedure utilizing CT, fluoroscopy, or radioisotopes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/64\">",
"     64",
"    </a>",
"    ]. However, a report in 2004 found that over 90 percent of patients undergoing CT scanning were not informed of radiation risks prior to the study [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/62\">",
"     62",
"    </a>",
"    ]. As of 2005, at least two-thirds of all US academic medical centers had institutional guidelines for informed consent regarding routine CT scans [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/65\">",
"     65",
"    </a>",
"    ]. However, in the majority of cases, the radiology technologists rather than the physicians were most likely to inform patients about the risks associated with CT scans. While only 15 percent of centers explicitly informed patients about radiation risks in 2005, this number will hopefully increase due to widely-publicized incidences of CT radiation overexposure for CT brain perfusion studies to rule out stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/66\">",
"     66",
"    </a>",
"    ]. Moreover, as public concern increases regarding radiation associated with medical imaging, physicians will likely be called upon to discuss the possible radiation-induced cancer risks associated with routine diagnostic imaging studies with their patients. &nbsp;",
"   </p>",
"   <p>",
"    We present one approach to informing patients about possible risks from ionizing radiation.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It should be made clear to the patient that their actual risk of developing cancer from any one or multiple radiologic procedures cannot be calculated exactly and that any resulting adverse effect is theoretical at diagnostic radiation doses.",
"     </li>",
"     <li>",
"      It should also be specified that representative effective doses for each procedure, as detailed in Tables 1 to 5, may be off by an order of magnitude (factor of ten) for any given patient and varies widely by institutional protocols, equipment specifications, age, sex, and weight [",
"      <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The patient should be given a general idea about the magnitude of the proposed radiation dose in terms that",
"      <span class=\"nowrap\">",
"       s/he",
"      </span>",
"      can understand. It may be helpful to compare the estimated effective dose to a single chest x-ray (0.02 mSv), a transcontinental airplane flight (0.02 mSv), or annual individual radiation dose from the natural background (3.0 mSv). For instance, the dose from a single abdominal CT scan is comparable to the collective dose of 400 chest x-rays or natural background radiation for three years.",
"     </li>",
"     <li>",
"      The possibility of future development of cancer must be weighed against the possible benefits, given the clinical scenario and suspected diagnosis. Alternatives to the procedure involving ionizing radiation, if any, must be reviewed during the discussion.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The question of who should obtain consent is not readily resolved [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/67\">",
"     67",
"    </a>",
"    ]. The clinician requesting the test has the best information about the patient&rsquo;s history, need for the examination, and prior radiation history, while the radiologist has the most knowledge about specific radiation risks. However, discussing consent and alternative management strategies is likely most appropriate prior to scheduling the procedure, especially when special procedure preparations (eg, bowel preparations) are required.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H147223323\">",
"    <span class=\"h2\">",
"     Screening studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;New screening diagnostic procedures have been developed, including coronary CT screening, whole body CT screening, and chest CTs for lung cancer screening [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/68-70\">",
"     68-70",
"    </a>",
"    ]. For these patients who are either asymptomatic or vaguely symptomatic, the increased risks, such as radiation-induced cancer, may outweigh the benefits of their radiologic procedures, and a full discussion of risks, benefits, and alternatives is of particular relevance [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/71\">",
"     71",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H244750\">",
"    <span class=\"h1\">",
"     SPECIAL POPULATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are specific patient populations for whom ionizing radiation should be avoided if at all possible. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H244757\">",
"    <span class=\"h2\">",
"     Pediatrics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiosensitivity is increased in pediatric patients, in particular involving tissues such as the thyroid and gonads. In addition to organ sensitivity, children&rsquo;s smaller size accounts for a greater radiation dose compared to that imparted to adults [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/72\">",
"     72",
"    </a>",
"    ]. One study estimated that radiation dose from a single CT scan in a one year-old is an order of magnitude higher than for adults [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/23\">",
"     23",
"    </a>",
"    ]. In a cohort study of individuals who had CT scans when they were younger than 22 years of age, compared to those who received a cumulative radiation dose &lt;5 mGy, the risk of subsequent leukemia was tripled for those who received a cumulative radiation dose &ge;30 mGy and the risk of a subsequent brain tumor nearly tripled for those who received a cumulative radiation dose &ge;50 mGy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Radiation risk in children is further compounded with their longer lifespan following exposure so that there is a longer time over which radiation-induced cancers can occur. Due to this increased sensitivity to radiation, lifetime radiation risk from just one CT scan in a pediatric patient is an important factor in the individual risk-benefit assessment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H244764\">",
"    <span class=\"h2\">",
"     Pregnant women",
"    </span>",
"    &nbsp;&mdash;&nbsp;A second patient population for whom ionizing radiation should be avoided is the pregnant patient population. Multiple epidemiologic studies have linked in utero radiation exposure to pediatric cancer mortality in offspring [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/74,75\">",
"     74,75",
"    </a>",
"    ]. Specific recommendations for pregnant patients and ionizing radiation are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/29/28120?source=see_link\">",
"     \"Diagnostic imaging procedures during pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H727187342\">",
"    <span class=\"h1\">",
"     AIRPORT PASSENGER SCREENING",
"    </span>",
"    &nbsp;&mdash;&nbsp;There has been increasing concern regarding radiation exposure from whole-body transmission or backscatter x-ray scanners at airport security checkpoints that have been deployed in some airports across the United States. Reports calculate the dose emitted from backscatter x-ray scanners as being equivalent to approximately three to nine minutes of radiation received from the environment through normal daily living [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/76,77\">",
"     76,77",
"    </a>",
"    ]. Put another way, among 100 million annual passengers, only six cancers may be attributed to airport x-ray screening over the lifetime of these individuals. Current evidence thus suggests that there is negligible individual risk from airport passenger screening [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/78\">",
"     78",
"    </a>",
"    ]. Millimeter-wave scanning is a similar technology without the use of ionizing radiation which may become a comparable technology and preferable alternative to x-ray airport passenger screeners [",
"    <a class=\"abstract\" href=\"UTD.htm?21/17/21785/abstract/78,79\">",
"     78,79",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H147223510\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ionizing radiation from medical imaging now accounts for nearly half of the radiation exposure experienced by the population in the United States. The cumulative effect of small individual doses in a patient population undergoing frequent and often repeat imaging presents a new public health concern for risks such as radiation-induced malignancies. (See",
"      <a class=\"local\" href=\"#H2016112\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      At doses used in diagnostic and interventional procedures, ionizing radiation releases free radicals that may cause DNA damage. Tissues are variably susceptible to radiation injury, based on their rate of cellular proliferation and their degree of cellular differentiation (",
"      <a class=\"graphic graphic_table graphicRef68401 \" href=\"UTD.htm?13/60/14283\">",
"       table 1",
"      </a>",
"      ). Radiation-induced cancers may develop decades after exposure and include myeloma, leukemia, lung cancer, thyroid cancer, breast cancer, bone cancer, and skin cancer. (See",
"      <a class=\"local\" href=\"#H2016120\">",
"       'Ionizing radiation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The linear no-threshold (LNT) model assumes that any exposure to ionizing radiation, however small, can induce future cancer. (See",
"      <a class=\"local\" href=\"#H2016134\">",
"       'Dose-response model'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      &ldquo;Effective dose&rdquo; takes into account the particular tissue or organ that absorbs the radiation and reflects the equivalent whole-body dose that would result in the equivalent risk from a non-uniform source of irradiation such as a CT scan. Effective dose is measured in sieverts (Sv) or millisieverts (mSv) and allows comparison of exposure across different imaging modalities. Background effective dose is approximately 3 mSv; it is estimated that a whole body radiation dose of 1 Sv is associated with a 4 to 5 percent increased relative risk of fatal cancer. (See",
"      <a class=\"local\" href=\"#H2016162\">",
"       'Effective dose'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2016169\">",
"       'Estimating risk from radiation exposure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are currently no epidemiologic studies documenting cancer arising directly from radiologic medical studies or procedures; risk estimates are based on extrapolations from individuals exposed to radiation following the 1945 atomic bombing in Japan. Estimating the risk of developing cancer from an individual radiologic study is controversial, given the stochastic nature of harm from ionizing radiation and the limited epidemiologic data. However, it is likely that doses for diagnostic exams such as CT scans approach or exceed levels associated with an increase in lifetime cancer risk. (See",
"      <a class=\"local\" href=\"#H2016183\">",
"       'Future cancer risk'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The average effective doses for the most common radiologic and nuclear medicine procedures in the US for the adult population have been calculated (",
"      <a class=\"graphic graphic_table graphicRef55620 \" href=\"UTD.htm?34/14/35052\">",
"       table 6",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef82239 \" href=\"UTD.htm?1/62/2029\">",
"       table 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef81179 \" href=\"UTD.htm?16/33/16924\">",
"       table 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef73485 \" href=\"UTD.htm?19/16/19724\">",
"       table 5",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H147223785\">",
"       'Radiation dose for common radiologic studies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Three guiding principles of radiation protection are justification, optimization, and limitation. Discussion about the possible risks of ionizing radiation should be part of the consent process prior to any radiologic procedure utilizing CT, fluoroscopy, or radioisotopes. Radiation risk in pregnant women is also heightened, with epidemiologic studies linking in utero radiation exposure to pediatric cancer mortality in offspring. (See",
"      <a class=\"local\" href=\"#H244336\">",
"       'Clinical decision-making and informing patients'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H244750\">",
"       'Special populations'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     National Council on Radiation Protection and Measurements. Ionizing radiation exposure of the population of the United States. Report, Bethesda, MD 2009.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/2\">",
"      Brenner DJ, Hall EJ. Computed tomography--an increasing source of radiation exposure. N Engl J Med 2007; 357:2277.",
"     </a>",
"    </li>",
"    <li>",
"     Ionising radiation exposure of the UK population: 2005 review. Health Protection Agency. file://www.hpa.nhs.uk/web/HPAweb&amp;HPAwebStandard/HPAweb_C/1247816567393.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/4\">",
"      Mettler FA Jr, Bhargavan M, Faulkner K, et al. Radiologic and nuclear medicine studies in the United States and worldwide: frequency, radiation dose, and comparison with other radiation sources--1950-2007. Radiology 2009; 253:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/5\">",
"      Smith-Bindman R, Miglioretti DL, Johnson E, et al. Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010. JAMA 2012; 307:2400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/6\">",
"      Lee J, Kirschner J, Pawa S, et al. Computed tomography use in the adult emergency department of an academic urban hospital from 2001 to 2007. Ann Emerg Med 2010; 56:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/7\">",
"      The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP 2007; 37:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/8\">",
"      Bolus NE. Basic review of radiation biology and terminology. J Nucl Med Technol 2001; 29:67.",
"     </a>",
"    </li>",
"    <li>",
"     Dowd SB, Tilson ER. Practical Radiation Protection and Applied Radiobiology, 2nd ed, Saunders, Philadelphia 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/10\">",
"      Radiation and your patient: a guide for medical practitioners. Ann ICRP 2001; 31:5.",
"     </a>",
"    </li>",
"    <li>",
"     Ladou J. Occupational Medicine, Appleton &amp; Lange, Norwalk, CT 1990.",
"    </li>",
"    <li>",
"     NCRP. Evaluation of the linear nonthreshold dose-response model for ionizing radiation. Report No 136, National Council on Radiation Protection and Measurements, Bethesda, MD 2001.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/13\">",
"      Hall EJ, Brenner DJ. Cancer risks from diagnostic radiology. Br J Radiol 2008; 81:362.",
"     </a>",
"    </li>",
"    <li>",
"     International Marketing Ventures. 2006 CT Market Summary Report. Rockville, MD; 2006. Available at: file://www.imvinfo.com (Accessed on July 24, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/15\">",
"      Feinendegen LE. Evidence for beneficial low level radiation effects and radiation hormesis. Br J Radiol 2005; 78:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/16\">",
"      Fazel R, Krumholz HM, Wang Y, et al. Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med 2009; 361:849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/17\">",
"      Pierce DA, Preston DL. Radiation-related cancer risks at low doses among atomic bomb survivors. Radiat Res 2000; 154:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/18\">",
"      Preston DL, Ron E, Tokuoka S, et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res 2007; 168:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/19\">",
"      Brenner DJ, Doll R, Goodhead DT, et al. Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc Natl Acad Sci U S A 2003; 100:13761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/20\">",
"      Miller AB, Howe GR, Sherman GJ, et al. Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis. N Engl J Med 1989; 321:1285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/21\">",
"      Cardis E, Vrijheid M, Blettner M, et al. The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: estimates of radiation-related cancer risks. Radiat Res 2007; 167:396.",
"     </a>",
"    </li>",
"    <li>",
"     The National Academies. Health risks from exposure to low levels of ionizing radiation: BEIR VII phase 2. Available at: file://www.nap.edu (Accessed on July 30, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/23\">",
"      Brenner D, Elliston C, Hall E, Berdon W. Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol 2001; 176:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/24\">",
"      Task Group on Control of Radiation Dose in Computed Tomography. Managing patient dose in computed tomography. A report of the International Commission on Radiological Protection. Ann ICRP 2000; 30:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/25\">",
"      Berrington de Gonz&aacute;lez A, Mahesh M, Kim KP, et al. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med 2009; 169:2071.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/26\">",
"      Smith-Bindman R, Lipson J, Marcus R, et al. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 2009; 169:2078.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/27\">",
"      Brenner DJ, Elliston CD. Estimated radiation risks potentially associated with full-body CT screening. Radiology 2004; 232:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/28\">",
"      Kroeker KI, Lam S, Birchall I, Fedorak RN. Patients with IBD are exposed to high levels of ionizing radiation through CT scan diagnostic imaging: a five-year study. J Clin Gastroenterol 2011; 45:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/29\">",
"      Mettler FA Jr, Huda W, Yoshizumi TT, Mahesh M. Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology 2008; 248:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/30\">",
"      Shrimpton PC, Hillier MC, Lewis MA, Dunn M. National survey of doses from CT in the UK: 2003. Br J Radiol 2006; 79:968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/31\">",
"      Diederich S, Lenzen H. Radiation exposure associated with imaging of the chest: comparison of different radiographic and computed tomography techniques. Cancer 2000; 89:2457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/32\">",
"      Lin EC. Radiation risk from medical imaging. Mayo Clin Proc 2010; 85:1142.",
"     </a>",
"    </li>",
"    <li>",
"     Jones DG, Shrimpton PC. Survey of CT practice in the UK. Part 3: Normalised organ doses calculated using Monte Carlo techniques. NRPB R-250. Chilton, England: National Radiological Protection Board, 1992.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/34\">",
"      Frush DP. Review of radiation issues for computed tomography. Semin Ultrasound CT MR 2004; 25:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/35\">",
"      Smith-Bindman R. Environmental causes of breast cancer and radiation from medical imaging: findings from the Institute of Medicine report. Arch Intern Med 2012; 172:1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/36\">",
"      McCollough CH, Primak AN, Braun N, et al. Strategies for reducing radiation dose in CT. Radiol Clin North Am 2009; 47:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/37\">",
"      Amis ES Jr, Butler PF, Applegate KE, et al. American College of Radiology white paper on radiation dose in medicine. J Am Coll Radiol 2007; 4:272.",
"     </a>",
"    </li>",
"    <li>",
"     ACR appropriateness criteria www.acr.org/SecondaryMainMenuCategories/quality_safety/app_criteria.aspx.",
"    </li>",
"    <li>",
"     The Royal college of Radiologists. Making the best use of clinical radiology services (MBUR6). file://www.rcr.ac.uk/content.aspx?PageID=995.",
"    </li>",
"    <li>",
"     The European Commission. Referral guidelines for imaging. file://ec.europa.eu/energy/nuclear/radioprotection/publication/doc/118_en.pdf.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/41\">",
"      Hall EJ. Lessons we have learned from our children: cancer risks from diagnostic radiology. Pediatr Radiol 2002; 32:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/42\">",
"      Vartanians VM, Sistrom CL, Weilburg JB, et al. Increasing the appropriateness of outpatient imaging: effects of a barrier to ordering low-yield examinations. Radiology 2010; 255:842.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/43\">",
"      Rosenthal DI, Weilburg JB, Schultz T, et al. Radiology order entry with decision support: initial clinical experience. J Am Coll Radiol 2006; 3:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/44\">",
"      Sistrom CL, Dang PA, Weilburg JB, et al. Effect of computerized order entry with integrated decision support on the growth of outpatient procedure volumes: seven-year time series analysis. Radiology 2009; 251:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/45\">",
"      Callahan MJ. CT dose reduction in practice. Pediatr Radiol 2011; 41 Suppl 2:488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/46\">",
"      Brenner DJ, Hricak H. Radiation exposure from medical imaging: time to regulate? JAMA 2010; 304:208.",
"     </a>",
"    </li>",
"    <li>",
"     Radiation Reporting: California Senate Bill 1237 (2010). Available at: file://www.leginfo.ca.gov/pub/09-10/bill/sen/sb_1201-1250/sb_1237_bill_20100902_enrolled.pdf (Accessed on February 02, 2012).",
"    </li>",
"    <li>",
"     US Food and Drug Administration. White paper: initiative to reduce unnecessary radiation exposure from medical imaging. file://www.fda.gov/Radiation-EmittingProducts/RadiationSafety/RadiationDoseReduction/ucm199994.htm (Accessed on February 17, 2011).",
"    </li>",
"    <li>",
"     Committee on Medical Aspects of Radiation in the Environment (COMPARE). 2007. file://www.comare.org.uk/documents/COMARE12thReport.pdf.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/50\">",
"      Brink JA, Amis ES Jr. Image Wisely: a campaign to increase awareness about adult radiation protection. Radiology 2010; 257:601.",
"     </a>",
"    </li>",
"    <li>",
"     American College of Radiology. ACR in Choosing Wisely Campaign to Promote Wise Use of Resources Among Physicians and Patients. Available at: file://www.acr.org/HomePageCategories/News/ACRNewsCenter/ACR-Joins-Choosing-Wisely.aspx (Accessed on February 02, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/52\">",
"      Rao VM, Levin DC. The overuse of diagnostic imaging and the Choosing Wisely initiative. Ann Intern Med 2012; 157:574.",
"     </a>",
"    </li>",
"    <li>",
"     RadiologyInfo.org file://www.radiologyinfo.org/en/safety/index.cfm?pg=sfty_xray (Accessed on May 13, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/54\">",
"      Hohl C, Wildberger JE, S&uuml;ss C, et al. Radiation dose reduction to breast and thyroid during MDCT: effectiveness of an in-plane bismuth shield. Acta Radiol 2006; 47:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/55\">",
"      Yilmaz MH, Albayram S, Ya��ar D, et al. Female breast radiation exposure during thorax multidetector computed tomography and the effectiveness of bismuth breast shield to reduce breast radiation dose. J Comput Assist Tomogr 2007; 31:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/56\">",
"      Parker MS, Kelleher NM, Hoots JA, et al. Absorbed radiation dose of the female breast during diagnostic multidetector chest CT and dose reduction with a tungsten-antimony composite breast shield: preliminary results. Clin Radiol 2008; 63:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/57\">",
"      Geleijns J, Salvad&oacute; Artells M, Veldkamp WJ, et al. Quantitative assessment of selective in-plane shielding of tissues in computed tomography through evaluation of absorbed dose and image quality. Eur Radiol 2006; 16:2334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/58\">",
"      Hohl C, Mahnken AH, Klotz E, et al. Radiation dose reduction to the male gonads during MDCT: the effectiveness of a lead shield. AJR Am J Roentgenol 2005; 184:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/59\">",
"      Grobe H, Sommer M, Koch A, et al. Dose reduction in computed tomography: the effect of eye and testicle shielding on radiation dose measured in patients with beryllium oxide-based optically stimulated luminescence dosimetry. Eur Radiol 2009; 19:1156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/60\">",
"      Dunnick NR, Applegate KE, Arenson RL. The inappropriate use of imaging studies: a report of the 2004 Intersociety Conference. J Am Coll Radiol 2005; 2:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/61\">",
"      Swensen SJ. Patient-centered Imaging. Am J Med 2012; 125:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/62\">",
"      Lee CI, Haims AH, Monico EP, et al. Diagnostic CT scans: assessment of patient, physician, and radiologist awareness of radiation dose and possible risks. Radiology 2004; 231:393.",
"     </a>",
"    </li>",
"    <li>",
"     American Association of Physicists in Medicine. The Measurement, Reporting, and Management of Radiation Dose in CT: Report of AAPM Task Group 23 of the Diagnostic Imaging Council CT Committee. College Park, MD: American Association of Physicists in Medicine; 2008. AAPM report 96.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/64\">",
"      Earnest F, Swensen SJ, Zink FE. Respecting patient autonomy: screening at CT and informed consent. Radiology 2003; 226:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/65\">",
"      Lee CI, Flaster HV, Haims AH, et al. Diagnostic CT scans: institutional informed consent guidelines and practices at academic medical centers. AJR Am J Roentgenol 2006; 187:282.",
"     </a>",
"    </li>",
"    <li>",
"     Safety investigation of CT brain perfusion scans: Update 11/9/2010. file://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm185898.htm (Accessed on November 23, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/67\">",
"      Baerlocher MO, Detsky AS. Discussing radiation risks associated with CT scans with patients. JAMA 2010; 304:2170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/68\">",
"      Illes J, Fan E, Koenig BA, et al. Self-referred whole-body CT imaging: current implications for health care consumers. Radiology 2003; 228:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/69\">",
"      Brenner DJ. Radiation risks potentially associated with low-dose CT screening of adult smokers for lung cancer. Radiology 2004; 231:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/70\">",
"      Winchester DE, Wymer DC, Shifrin RY, et al. Responsible use of computed tomography in the evaluation of coronary artery disease and chest pain. Mayo Clin Proc 2010; 85:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/71\">",
"      Bach PB, Mirkin JN, Oliver TK, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012; 307:2418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/72\">",
"      Linet MS, Kim KP, Rajaraman P. Children's exposure to diagnostic medical radiation and cancer risk: epidemiologic and dosimetric considerations. Pediatr Radiol 2009; 39 Suppl 1:S4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/73\">",
"      Pearce MS, Salotti JA, Little MP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet 2012; 380:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/74\">",
"      Wakeford R, Little MP. Risk coefficients for childhood cancer after intrauterine irradiation: a review. Int J Radiat Biol 2003; 79:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/75\">",
"      Preston DL, Cullings H, Suyama A, et al. Solid cancer incidence in atomic bomb survivors exposed in utero or as young children. J Natl Cancer Inst 2008; 100:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/76\">",
"      Mehta P, Smith-Bindman R. Airport full-body screening: what is the risk? Arch Intern Med 2011; 171:1112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/77\">",
"      Hupe O, Ankerhold U. X-ray security scanners for personnel and vehicle control: dose quantities and dose values. Eur J Radiol 2007; 63:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/78\">",
"      Brenner DJ. Are x-ray backscatter scanners safe for airport passenger screening? For most individuals, probably yes, but a billion scans per year raises long-term public health concerns. Radiology 2011; 259:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/17/21785/abstract/79\">",
"      Schauer DA. Does security screening with backscatter x-rays do more good than harm? Radiology 2011; 259:12.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14613 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-200.131.240.2-817E36F31F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_17_21785=[""].join("\n");
var outline_f21_17_21785=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H147223510\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2016112\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2016120\">",
"      IONIZING RADIATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2016127\">",
"      Biologic effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2016134\">",
"      Dose-response model",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2016148\">",
"      MEASURING RADIATION DOSE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2016155\">",
"      Terminology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2016162\">",
"      Effective dose",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2016169\">",
"      ESTIMATING RISK FROM RADIATION EXPOSURE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H147222742\">",
"      Epidemiologic basis for risk estimates",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2016183\">",
"      Future cancer risk",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6024263\">",
"      IMAGING MODALITIES WITH IONIZING RADIATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H147223785\">",
"      Radiation dose for common radiologic studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6024332\">",
"      - CT examinations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H244329\">",
"      EFFORTS TO REDUCE THE RISK OF RADIATION FROM IMAGING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2810649\">",
"      Shielding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H244336\">",
"      CLINICAL DECISION-MAKING AND INFORMING PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H147223313\">",
"      Informed consent",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H147223323\">",
"      Screening studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H244750\">",
"      SPECIAL POPULATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H244757\">",
"      Pediatrics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H244764\">",
"      Pregnant women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H727187342\">",
"      AIRPORT PASSENGER SCREENING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H147223510\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/14613\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/14613|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?41/14/42222\" title=\"figure 1\">",
"      Estimated average ionizing radiation by source",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/14613|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/60/14283\" title=\"table 1\">",
"      Sensitivity of human organs or tissues to ionizing radiation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/33/16924\" title=\"table 2\">",
"      Adult screening effective doses",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/62/2029\" title=\"table 3\">",
"      Adult thoracic effective doses",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?10/12/10445\" title=\"table 4\">",
"      Adult abdominal and pelvic effective doses",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/16/19724\" title=\"table 5\">",
"      Adult skeletal and dental effective doses",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?34/14/35052\" title=\"table 6\">",
"      Relative radiation doses for spine imaging studies",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/0/4106?source=related_link\">",
"      Biology and clinical features of radiation injury in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/29/28120?source=related_link\">",
"      Diagnostic imaging procedures during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/35/16952?source=related_link\">",
"      Full body CT scan for screening",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/2/14376?source=related_link\">",
"      Radiation dose and risk of malignancy from cardiovascular imaging",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_17_21786="Posterior cerebral artery territory";
var content_f21_17_21786=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F60416&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F60416&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 591px\">",
"   <div class=\"ttl\">",
"    Posterior cerebral artery distribution and signs and symptoms of occlusion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 571px; height: 695px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Kistler, JP, et al, Cerebrovascular Diseases, Harrison's Principles of Internal Medicine, 13th ed. McGraw-Hill, New York 1994. Copyright 1994 McGraw-Hill Companies, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_17_21786=[""].join("\n");
var outline_f21_17_21786=null;
var title_f21_17_21787="Typical radiographic response in bone to select tumors";
var content_f21_17_21787=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F54124&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F54124&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Typical radiographic response in bone to select tumors*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Predominantly osteoblastic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prostate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carcinoid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Small cell lung cancer",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hodgkin lymphoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Medulloblastoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Predominantly osteolytic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Renal cell cancer",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Melanoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Multiple myeloma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Non-small cell lung cancer",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thyroid cancer",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Non-Hodgkin lymphoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Mixed osteoblastic and osteolytic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Breast cancer",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gastrointestinal cancers",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Squamous cancers at most primary sites",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * These represent the most common patterns of metastatic involvement; individual variations may occur.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_17_21787=[""].join("\n");
var outline_f21_17_21787=null;
var title_f21_17_21788="Pleurodesis agents II";
var content_f21_17_21788=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F64436&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F64436&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Complete success rates and adverse effects in patients treated with antineoplastic agents for malignant pleural effusions",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Pleurodesis agent (dose)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Success rate cases (percent)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Adverse effects cases (percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fluorouracil (2 to 3 g)",
"       </td>",
"       <td>",
"        23/35 (66)",
"       </td>",
"       <td>",
"        Most had a moderate decrease in leukocytes 7-10 days after pleurodesis, returning to normal within 4 weeks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Bleomycin (15 to 240 units)",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        108/199 (54)",
"       </td>",
"       <td>",
"        Pain: 56/199 (28)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fever: 48/199 (24)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nausea: 21/199 (11)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Interferon-B (5 to 35 million units)",
"       </td>",
"       <td>",
"        8/29 (41)",
"       </td>",
"       <td>",
"        Pruritus: 2/29 (7)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Mitomycin-C (8 mg)",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        11/27 (41)",
"       </td>",
"       <td>",
"        Pain: 2/27 (7)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fever: 3/27 (11)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Leukopenia: 1/27 (4)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"5\">",
"        Cisplatin (100 mg/m2 ) + cytarabine (600 mg/m2 or 1200 mg)",
"       </td>",
"       <td colspan=\"1\" rowspan=\"5\">",
"        12/44 (27)",
"       </td>",
"       <td>",
"        Pain: 33/50 (55)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nausea and vomiting: 38/50 (76)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bone marrow suppression: 26/50 (52)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cardiopulmonary symptoms: 27/50 (54)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Renal toxicity: 17/50 (34)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"4\">",
"        Doxorubicin (10 to 40 mg)",
"       </td>",
"       <td colspan=\"1\" rowspan=\"4\">",
"        13/55 (24)",
"       </td>",
"       <td>",
"        Pain: 16/55 (29)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fever: 9/55 (15)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nausea or vomiting: 16/55 (29)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anorexia: 13/55 (24)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Etoposide, 100 mg/m2 (weekly x 3)",
"       </td>",
"       <td>",
"        0/9 (0)",
"       </td>",
"       <td>",
"        Progressive alopecia, emesis, malaise, and mild bone marrow",
"suppression were seen with 150 mg/m2. Severe myelosuppression was seen",
"with 225 mg/m2.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Walker-Renard, PB, Vaughan, LM, Sahn, SA Ann Intern Med 1994; 120:56).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_17_21788=[""].join("\n");
var outline_f21_17_21788=null;
var title_f21_17_21789="Hysteroscopy distend media";
var content_f21_17_21789=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F71692&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F71692&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Distending media for hysteroscopy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Category",
"      </td>",
"      <td class=\"subtitle1\">",
"       Medium",
"      </td>",
"      <td class=\"subtitle1\">",
"       Hysteroscopic procedure",
"      </td>",
"      <td class=\"subtitle1\">",
"       Biochemical properties",
"      </td>",
"      <td class=\"subtitle1\">",
"       Complications or Adverse effects",
"      </td>",
"      <td class=\"subtitle1\">",
"       Safety measures*&bull;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Gaseous",
"      </td>",
"      <td>",
"       Carbon dioxide",
"      </td>",
"      <td>",
"       Diagnostic",
"      </td>",
"      <td>",
"       Colorless gas",
"      </td>",
"      <td>",
"       <p>",
"        Gas embolism",
"       </p>",
"       <p>",
"        Shoulder pain",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Use hysteroscopic insufflator",
"       </p>",
"       <p>",
"        Safety thresholds:",
"       </p>",
"       <p>",
"        Flow &lt;100 mL/min",
"       </p>",
"       <p>",
"        Intrauterine pressure &lt;100 mmHg",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       Electrolyte fluid",
"      </td>",
"      <td>",
"       <p>",
"        Saline",
"       </p>",
"       <p>",
"        0.9 percent",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Diagnostic",
"       </p>",
"       <p>",
"        Operative: without electrocautery",
"        <strong>",
"         OR",
"        </strong>",
"        with bipolar electrocautery",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Water and sodium chloride",
"       </p>",
"       <p>",
"        Istotonic",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Thermal burn if used with monopolar electrocautery",
"       </p>",
"       <p>",
"        Volume overload",
"       </p>",
"      </td>",
"      <td rowspan=\"2\">",
"       <p>",
"        Fluid deficit thresholds:",
"       </p>",
"       <p>",
"        750 mL: Plan completion of procedure",
"       </p>",
"       <p>",
"        2500 mL: Stop procedure (or earlier in patients who are elderly or have comorbidities)",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Lactated Ringer's solution",
"      </td>",
"      <td>",
"       <p>",
"        Diagnostic",
"       </p>",
"       <p>",
"        Operative: without electrocautery",
"        <strong>",
"         OR",
"        </strong>",
"        with bipolar electrocautery",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Water and sodium chloride, lacatate, potassium, calcium",
"       </p>",
"       <p>",
"        Isotonic",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Thermal burn if used with monopolar electrocautery",
"       </p>",
"       <p>",
"        Volume overload",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"3\">",
"       Electrolyte-poor fluids",
"      </td>",
"      <td>",
"       <p>",
"        Mannitol",
"       </p>",
"       <p>",
"        5 percent",
"       </p>",
"      </td>",
"      <td>",
"       Operative: monopolar electrocautery",
"      </td>",
"      <td>",
"       <p>",
"        Six-carbon sugar",
"       </p>",
"       <p>",
"        Cleared by kidneys; acts as its own diuretic",
"       </p>",
"       <p>",
"        Elimination half-life: &ge;100 min&Delta;",
"       </p>",
"       <p>",
"        Isoosmolar",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Volume overload",
"       </p>",
"       <p>",
"        Hyponatremia",
"       </p>",
"      </td>",
"      <td rowspan=\"3\">",
"       <p>",
"        Fluid deficit thresholds:",
"       </p>",
"       <p>",
"        750 mL: Plan completion of procedure",
"        <strong>",
"         OR",
"        </strong>",
"       </p>",
"       <p>",
"        Stop procedure in patients who are elderly or have comorbidities",
"       </p>",
"       <p>",
"        1000 mL: Stop procedure",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <p>",
"        Sorbitol",
"       </p>",
"       <p>",
"        3 percent",
"       </p>",
"      </td>",
"      <td>",
"       Operative: monopolar electrocautery",
"      </td>",
"      <td>",
"       <p>",
"        Six-carbon sugar",
"       </p>",
"       <p>",
"        Metabolized in the liver to fructose and glucose",
"       </p>",
"       <p>",
"        Elimination half-life: &ge;33 min&Delta;",
"       </p>",
"       <p>",
"        Hypoosmolar",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Volume overload",
"       </p>",
"       <p>",
"        Hyponatremia",
"       </p>",
"       <p>",
"        Hypoosmolality",
"       </p>",
"       <p>",
"        Hyperglycemia",
"       </p>",
"       <p>",
"        Peritonitis&loz;",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <p>",
"        Glycine",
"       </p>",
"       <p>",
"        1.5 percent",
"       </p>",
"      </td>",
"      <td>",
"       Operative: monopolar electrocautery",
"      </td>",
"      <td>",
"       <p>",
"        Amino acid",
"       </p>",
"       <p>",
"        Metabolized into serine and ammonia",
"       </p>",
"       <p>",
"        Elimination half-life: &ge;40 min&Delta;",
"       </p>",
"       <p>",
"        Hypoosmolar",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Volume overload",
"       </p>",
"       <p>",
"        Hyponatremia",
"       </p>",
"       <p>",
"        Hypoosmolality",
"       </p>",
"       <p>",
"        Hyperammonemia",
"       </p>",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * ACOG technology assessment in obstetrics and gynecology, number 4, August 2005: hysteroscopy. Obstet Gynecol 2005; 106:439.",
"     <br>",
"      &bull; Loffer, FD, Bradley, LD, Brill, AI, et al. Hysteroscopic fluid monitoring guidelines. The ad hoc committee on hysteroscopic training guidelines of the American Association of Gynecologic Laparoscopists. J Am Assoc Gynecol Laparosc 2000; 7:167.",
"      <br>",
"       &Delta; Hahn, RG. Br J Anaesth 2006; 96:8.",
"       <br>",
"        &loz; Phillips, AJ. Obstet Gynecol 2003; 102:1148.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_17_21789=[""].join("\n");
var outline_f21_17_21789=null;
var title_f21_17_21790="Eval Referral options Ab defic";
var content_f21_17_21790=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F64471&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F64471&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 582px\">",
"   <div class=\"ttl\">",
"    Evaluation and referral options",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 562px; height: 288px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * This option is acceptable when the patient has upper respiratory infections only, eg, otitis media or recurrent and chronic sinusitis. When patients have been treated very frequently with antibiotics, a complete evaluation is indicated even if infections appear to be minor. Antibiotics alter and mask the natural course of the immunodeficiency.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Sorensen, RU, Moore, C. Peds Clin N A 2000; 42:1225.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_17_21790=[""].join("\n");
var outline_f21_17_21790=null;
var title_f21_17_21791="Achondroplasia";
var content_f21_17_21791=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F80450&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F80450&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Achondroplasia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 202px; height: 421px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGlAMoDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDxhWYjbnikDsPlYnHpmmd808bSucgUASFsE8nBxQh+82DTd3ABHNOHByOM+poAXPOTSbie+PenbcjB6VUvbkQBghzkflQAzUL77OMIFeUjv0H1rnbhjcgfaWLv/ep8zEyFvvbveqc6yhBkEDrQA6S1RUyjZX681XaJsjZn371L88g+bgVdsI5EPBBU9QaAKcaERMCQdvtSwhGJGXiP5itmaFFO1woYjoKjFmpDbSMUAUEt3STIlweuavQ3NwAQ7bx6mpPscnCqM54GKsnTZgn3WDe4oArR3sqEKwJXNXjeAEeYhCnuKiNhIoXdE4HqRxV+LTpZkARSeO9ADotrkMpGParAIIxj8abNo7W/lvE4WQ8lDSxTwNaEEsLxXwU7bfWgCRiCAc1HjJw3App6EkgjFIzHAPGTQA9iN+ByOxqOQeh/KhCME0ScDI5PtQA2MMW44/Gn8sAOg65zTWbPpzTRnp2NACSAHkE1XIbJ/eKP+AH/AAqxISQx6D0qD/tln3wf/iqALLDac9cUikZAYcGgjcev50nPfpQBJGu5umQOpqVSNuAOKhU4XHtT427E8CgBLqcRREnBz6Vzt3dA7iOTV7UpVeUryEA5I4zWM/zLk4C9qAGq3mEsABTJSryAYOO/NTiIiPgYxyfeprKwa6ZSN2M8YHWgCGC3G3O0Kp6k1o2Nis7BVDZYdTxiu70fwgXhDXCAxDBPGa6KLwmk7xtbWohiPAbufegDgLHQVnYQwRGS4zkkCut0b4dzXKiW4lMSnogTk16foPh2y0i08q2jLSt8zu3JJrftLIW8YHPHNAHntj8OLeNA7zMzgdAnFaCeBrVY28xAewyvWvQLZWBBC/Keme1TmAg5AJU9BQB5XN4Mjtn/AHbKsJ6ljuP5ViX2lRw3YjtUMvy5ZkXAFe1zaeJ9rMgx6VUl0lTG0fkBVYYyooA8Sk05AspaI+YBgn0Fed65aSQX7SLkEHrX1DP4ct/KkjWPCbdue5/GvKvE3hV47uRLgBUK/Iw6ZFAHnVvN58QJ+UgYwKeSe46VnSo9lqMkZPyhiCDWlyVUq3uKAANk+/p6UmcknHtQASc5xSZzk9BQAbcNkjikkwG4J254pEU5JBzmlVh0IGaAGyDgnFU22ZPH6rV2VuMYxVcjnqfz/wDrUAWAcNzinHBFIoGKDwNoXg0APUqRz1xxTLhligZvXjNAGeCKq6mcJGqjA6mgDNnLXLPkYAGfoKbbxruBdd2BgCpwMxvnAVRk570tnGZJk2jjOaAJEtDIg3cM54Feg+CfDWVUyRM6lhkDn8Ky9I02N5YnfLAHPI5Jr2zwVpoitFJDAsc9O1AF+18OrJFEHTYoGSB29q2E0+MR7SnSte0j+Tjpjqe9T+SG5/KgDHtrPBHHOfSrptBjnniry25AyM1PFb7jkEn8KAM2K3LZwDj3qYQsqg446c1ppbYbgEipPs4zk9OooAyo4STgng96la2CjjJFa32dFVSFGRzmoHHBHT0oAw7mFgCoA69aw9a06O8tykiZZehrqZVyvqM1nSRZDAjPPFAHyv8AEHS2stbZmx8xOcDHOawoGynJyR2r074t2yveyrH80hIYnHKivN0j8uBWPcH8aABQMcn6UgHr09KQHjHQCnEqB3zQA0lgx20ueTxg0uO4ODQwGFOeDQAyQfLkEn+lQlxnr+hqw5AQ+9V8r3RfzoAnZiB1zjpTmcbBgZqTaoxhcfjUZAIOABigBM7mOOOKp6gcbVH3jxVv5hjHPGKr3gJaInGAcUAZMrFYZBn0BGa3/CcInnIKknH5VgXyFLp0J4POK6TwHKn2potxVmxjPfmgD0HRbQI8RKZwRjjNew6Gy/Z0JB/wrzvR4onZicqo4BFei6OvlQqMkqcYJ6n3oA6VflC89BVqH5jnAJ9Kpw4IG2r0S4HHQ9aALUEIPUgd6uxwxhfeqUcvlnjBNONw+T+lAF5VQgj1602UKVFUo5GAJLcUjM56NwKALTEEAZ69Paqtwi/NjmnxozgAHv2p88Wzg5IxQBmOm5T0qqyAIxY4A9K0JlGCVByO3rVK7H7sgLzjt3oA8k8eaMLjUJZI2y8gywPQDH868e1q2Fs6xHO4Z719KXVtFdGfKgSYwO1fPvjyJINZ28l8HcvvmgDmMEc4zTkJyTjNSb128Jke5pq8YHQdKAGvg4xQHULxyen0oZSrAZ49aMYUgECgCNuT1qI9fvGrDoApGcmq5L54WTHspoAvKwHXnnrTCd5Axz2xSAHcM9ByRTud3ynHoaACIFW+btUNyu+JuSMcjAqVjkA5wfekGCp5ye9AGHqCMbmKXPDYBqfQJJLe/DJnhsGnXifIQeq8ireg25ku0YYIbn0oA9W8PzFwqs23cQSTXq+gyRtCh3knsTwK8U8PXHkwEux+U8/SvUPCV89/CNi7gnGaAPQLd1GOfxrUjT5AQc+9cz50wKqkX1oOp3UJAk4Udh3oA6jjr0HSkIAX5SKwrTV/OIUjIzzkVqRzK6/WgCZGxwTUqKS31PemKo4OKrPJIrc8L/OgC+blIgQeuaryah5zFVyWPAqg5lMgUqxYjIHtS3JvoM+VYTMcc4WgCzIT1GfTmqMk21wjcVQsvEST372c8MkdwvBV1I5rSdFLbmXn0NAGdeW4QtIoHKnca+aPiLNHL4quUiDbIlCHPc9T/OvqHUmSG0mlkO1EQsST0GK+QdVuzeand3RwTJIzDb0xnigCsDhdtKAc84HGaj+bAyePUVL1AJ5I7GgAwNqjOT1pxG8/KMGmbj261Ih469qAI5CVBGOarEyZOCfz/wDr1YkZpGxgCoSDnr/KgCypOQQBmnZyD04qMgrnmkB9TigCRvlK5Pamk4PQfhSlsrg9BTWPIOeR0oAju03Rs2ANvP1qxoLb7qGOMfKxzmklBKkdjVLTp30+fJ5VHyM+lAHppsj9mIQ49TXpPw7h+y6ayhi7Fug+lcHpcqXliJEO5CAARXaeD7tLG1lWQ/xYGB7UAaWra/qb67DpGiWsdzcP/rHLcR/Wte7trG0aO21vxDY2uoNgmNpgpAP17VStpRafbLnTYdl08JIcjGXwcfrXyRq+p6lJ4imuNQWS4u3d9+9iCZCTy3rj0oA+0rnTpLBYzFL9ot3AZZFwc/QjqKnt7oxuqyDDk45rhfgNcanN4Ce01ZZ1hiuC0M0ykYTAOFz2znFaviHV47Lz7uVsxoflA7nsKAPRkaIWgk3jPpWecXU6xbgoY8GuN0PUdR1G2ScIqRtyB/jXQWczySFJFKyLz1/WgCxrGpDQdF1XUfKM0tlGzKnXcQOPwr5j1X45+Lpr/wA9NXaGcS+WttGgCIuOSQRyK+pb6G31O1e3vlJSVDHIBxuU15tq3wU8L3V9HcWkckJTqok+99c80AdJ4R1iTxR4U0XWb+KNdSmj+fyxx1Iz+OM4rpkiL/fxkVX0PSoNJsYIIgqJCgRFXoo7VfZTGSfXkUAc140tb6/0C9sdMC/a50MaFugz1r5Nu4JbO7ntp12zQuY3HowODX134q1tPDeiXGqTKreXyAx+8eyj3NfI1/cNe39xdS4DzSNIwHQZOcfrQBCGIXGB+NL35P4UAsxOBx2JqMH5sZoAlA+fjAB60vIbBpuSCBmnggLyuTQAxhuOeh/nUBJyetTFSG5zgioSOTz+lAFjqDnBoZcjIHTtSDByMVIVODigCEnK8DpQVIXJ5p54J56j86XdgcdPQUAIduACea3PCel6dqupSw6o2yLyWKnPcf8A1qwmHcdOtPWZ4nWWF2WQHIZTjFAHoOh2cWhz2tta6hFeafK+6KRGHDf3SOxrttJ3y3EihVHzbsGvIDqMd4JLpYlhv1hySgwrMvIbHrXfeAPE7a1BDeOojnBCSqOhI70AeyWdpDPZqkqkH1FYtx4I8PxX7X8tpDLMx3EvGCc9jzW1YXKNCCOCR0qWRhO6hj8o6k0AR5e6EdrGpjt142j0rh/HNn/aut2Gi6cQsVtIs9/IR8sadhn1NeoWluLNGdhgnmsyPSobe6ubhVVxdNukRvWgC1oEmkvZH7E0c0cbeX+7YEAjsazY/EGl6vrVzp2n+Ybu0YrJtQ7UPoSas6D4W03R2uW0qNrdLmVppU3Eguep56VsRWNvbs8sMMccsgAeQKNzfU0AEUIuYDvAEi8Eio/IeNiSoIFXowscY2khvanuwaPpj15oAqKELZIGcdaJF3FVI4PSnk8cUgysikcsKAPC/wBpDVzFf6foEMjFI0+0zDtuPCj8Bn868SLZNdz8bZnf4n615jbtpjUZ7DYK4Nj83A6/rQA8Nxx0pBwMnGTSBsgAimtwMA5FAEgO7nvUu4c7jjFQRnntzUxUduR6UAMY5G7PSoSvJqeTBAIGOKqEgEjBoAuswJO4gnHWm5BA6inMq545HpTRgZHbtQA3ByfQUqHCsOM+tJn0GKQNg5ABPvQApJKAZ/Gl4AGDkemKRtoHXrQo+Tr3oAcrFc9j+lWfC+oT6DqcMzRstlI2OemM9apknoORWjOkV74XkiaUi4gcsqk9FPp+OaAPoXRtWie2jCMzsy5BC102nSbuQeOvNeLfCLxK93pi2d4oSSEBAx6uOxr1W0uWDgxk4HUH0oA626uHMUaNJxjHFLCyYG48Z61kXFyTEsgAIFcDr/jWdp7mzsI8mHh35+U0AeszalaWiKZ5FXPQmq6a7YSFv3o2D1OK+cfEOo6jqkEcV1ezuFbK7Tjn8KitbM30SWshnlLHgK5JzQB9O2mq2kxxE6lhxip2kHPOfSvmu4h1LwbphvbPU7hroyhVtZfnXb3J7gV7f4Jv7zV/DlrfX0QjmlTO1SeO1AG95m0c1iax400HQNRSy1y9W1uJofOTchIK5I6jvkGr1xeW9jYz3d4/l20KmR2PYDrXyb458RSeKvEt1qUq7Yz+7gT+5GOg+vf8aALfxL1y08S+MtQ1OwWRLaXaF8wYLYUDJHbpXJtkgnHQ07O4ZXOaOsfP6UABJIBHSmsPlB5+tN3hTxx9a6PwR4Zm8Wat9ghuorQbC3mSDI+gHegDnQwB4BNWFYEfX9K9huvgcBbullrDy3wTcFeMbCcdODkdq8iltZbW6mtrmNoriFijowwQwODQBFIQyjAxUe0+gqRmwRjBxUZc5PFAEw4BIJAHam5BAJ7+vakLHkHjFNyDg80AHJPOMUEHPtTWJBzmm5PTPFAD2A4yDSjgUxjwKXqOeDQA8HC/KAaQ5we3tTeMUiEEHOcUAXtL1CbTLuK6tjh0Oceo9K908IeKbfW7JWiIS4xtePuDXz9I3QU6x1O70y9SXT22zd+eooA+utKHnQbWxgdq8+8Z+HLnSL+W/wBEj8xLrmQNzg+9Z3w4+ISXtwlrfN5czEfKRivXZolvIOAHU9R2IoA8Dt9SniulF74djlkzg5mKrnP0rTvtb1aGNU0iDRtMJU5kXLsM9+e9etpo0SLtjVTHn7rrnmnf2Fbhi6WdupyCT5eaAPIdG0m6lBSKee8FywN3eXCkNKRzsUHooNe6aGotdIjjICKkYGPSqlhoscTqWyQOBkYAqbV7l4rcQWSBsdT0oA8O+N/jcX9wfD2mOfssRDXUgOA7jov0Hp615BnnvXe/FfwteaXqcmrKpa0u5Cz/APTOQ/0Nef7xnrQBKGYKOgpR8xC52gnFRfM2CFYjp0pC/P0oA+q/BHw18MW/hmxF3p9rf3TxiSWeYbssR+gryPxVocs/xBli8Bh5Y4OXMDBUiI6qD0r0Ow8Qxf8ACCaTZabLM+r39uIlQNhVOMEk+lV/DehT+BdWsoA483UhmaSUZVCOTj3P+e1AHUeD/tf2aJr21vFnC4d5JASW454/H/PTxv47wwRePne3jETTW6O4Axk8jPv068fTufpWG4MZxLCDz95RXn/xn8Kafrvhu71eEFL+xhMgdf40HJU/49vpxQB8zE4HP3ajyn+1+dOfHGOh6Cm59hQBYYkZzg49B0q3YaNe30XmwqohJxuc4z9KdpNg13dqW4t0ILnu3tXpGl6WbiJWUYUcBF7CgDldO+H95exo7XUUYb2Jx+NXJ/hndR27Ml9G0noUwPxNelaXFNpcW2SNmRsc9a0orq2ubaXyVDkAhk9KAPnq+8MavY3a29zZtvc4j2nIf6Go5NC1KG+FrPayQzHB/eDAx619I3OgW2paho0xQkWw804Pt39a5bV7ATfEG+lcb0ijRQCc7RjsKAPLIfBuozQGVcMucfKvel1fwdf2dn9pSP8AdqPnHf6179a2UX2WIQj5WbpVfXvDdpPulmD7duGAbAIoA+XBh3WNAWkY7Qo5JNdToHhWXz1n1BQVf7sZ649fau/1TS9FsJlNlbRxyA8kDvUtjbvI2SBz0PoKAMK/8ExXpjl08SW045V1boa6Twd4n1rwnImneJ4nns14jvFGQB/tV0mnrHbgKVz7iulg8m6g8uSFCOhBXIIoA3NJ1KxvbVZbeVJI27g5q+bmAMVBGK5200S0gYvbQ+UG6hOB+VXliSPGAPrQBYvLksGWBTt7k1ksH5IO71HrV2VZHyEPT9aqPAw6E+4FAGHq0EN9BLbX8AlhkBVkb0IrC0XwF4etpHf7LkZ3DIyK665VT8r/AC8dTT7P5cnAVenPegCra+G9F+RVtYB6DYPTH8qNc8A6HqNm/naXbszAneq7WHvkV1VksbhQQpPXNT60jRabO0ByAhoA83+HWgWkdilnOf3lrIzWr7ssoz611PifQotQs1XUZ5RsbfGwbBBHfip/Dumb7O2u7UobrbyHHBq3PYXk8u7UDyWyRjj6fSgDlPAOranHJd6bq++dIXPkXRj2+YnYHtx7enPTne8eWwu/A2txxskRe0kJdjgLxn/Pf05rQezgjYPgCQD5cDr7V538cfEB0rwgdPiDJdagdhO7BEQ+9j0B6Z684Hc0AfNzKF+Ug8cc1Ftx2NSEDIAI4HAFG5aAO18GCKW0ljP3g53c16Lp8W5QyOoOMcCvG9E1E6deiQgmJhtcDrj1rtL/AMXw2NgrQDcT0x3oA7e2gvbkeUJtqg8E9TUd7Bf2CiRURygwWQHJFZ3gZfEniKya8DxWcBfbH8mS/HX6V1f/AAiPiIZZtXiaQjGNnFAGj4FuvtlmzSsfMU7Sh4KCnWtpFJr1xORuLrgk9+axNP0rxJpty8rRRTFgVYqduRWfb67dWurxQzK8bt8jI45HPWgDp9UJ0eza4bJgR8kDqBXM+IdcOo26raXBQkcDtiuuluBe2UgmjDxsNrKe4rx3xXGPDvihbSJy1tPEJot3UAkgj9KANKGyJEc0jF2zk5rprYJb2wBi5x1BrL0lkuoUYDORgjPetK7kVJ4lDBTnrjNAGtpqvIxIj46cjpXX6fGpQe/tWHpMiAAbfv45rrLKMRIMjP1oAljVAhx+NMARehBJ7GpXTdGCvHOacqpu3Ac9DQBGYtwO7AOMcVAbTZxu57Yq+WQjkc1HJk4A6f3qAMK8tc543A+tQm2MSBlywHUHtWxOgwMEA+lMeJJIMdQf50AVLKd4pMRkN9a0bu5E1lLE7bQwx+dZDsUmIVVyP1q1pkBubrfIflH8OeKAGaJrA0J7ax1mPdDISsFxEp+oDD1+ldtbS2l9CDa3KuG5w1efeP7KW70oSWfM1kwnUA9cdR+VaXhjVbPVdPhuLcKSR83Yg+lAHWXunWqRb5AVYD+E9TXzv+0J4Y1G+nGuWLmexsohE9sR86DkmQeo559Mele+NKWxgnA6c1mXNp5gbkNnqD3oA+IU+bnpRuPoK9W+M3w9XQpm1vSIgmnSNieBRxC56Ef7J/T8zXk27PROKALQGeD/ADrV8L2seo63ZWM6gwSyANk1lAYJ79jV7w/cx2OtWVzLnyo5VLbeuM0AfYGnWNtpWh7bWJV2phFA71Y060f7PulbLHmslr557Wz8lg8cihlJ7jFatjevHC6SjBGOc9c0AShZWi4i3EHAFY+ueHbPV45RcxhZSuFdOGX6GulS6gjtixZRx1JqCGPcGkI+ZueaAPBLvUl8K69Po13qG8R43u3VFIBBx34NedfEy/nOvabmTzVVMJIB95CTitP43zCX4oavJHj5TGhwehCAVwOrXUl5f2G9mYooTJOelAHqHhnVmhhVQvPXJNdjpEiXt0GKk5P1ryyF5ilrBDtBfkkntXrHgi2IhVQ4zjr70Ad/oyoVwUUkfwkdK6OLaygbePYVmabb+XECQHPrW3bK7xhVU59DxQA1lAYAZxjpUJGH7Yqy4KqMnjFV2HYUAOiH7xi/pxT2UgngFfaiFAQSGGR1Bp3MhbbxigCjOgaPC4BH61WjbchVXAYdRVq6yHyvDHuK5rUb1rbVLZVKkP8AK47mgBbyTZfLvJRQ3JHep01C2guSI3VsAEDP3iara6AwjcMpI5xXhvjzxTqFr4/upLWZo4rYCFI1+6BtGePXPOaAPouG4yzCQcPyQe1cR4Vt5tN1u/sthSOJzJGAedjdPw6/5ya5n4b+JpbjRZfOvjdXqvxFI/zlc9Rnr+Feh6vC8epWmoQqu+eMKrY7+lAHVW8jSQ/IwJA5yalZAqLuzuz2rKtHZmBdQrH04xWlC2V+Zt3agCnrenwatY3FheIr2txGUkUnqCP8/wD6q+QNU8PX9jqd3aNEpNvM8RI77WI7tntX2VqF1Bp9jcXt3J5UEEZkeTptAGc57V8b6tr1xe6re3Rjx58zy/djH3mJ6Hnv3oAzQcdqcMcDuKA2fuj3pAQCccHrQB2Gm/EHWrDQl0xJEKxkeVKwy8Y9M963fCfxBvL7WwPEGoGK0EeBtQKu4dzXmO7A5GTSZPRuAaAPrnQdQ0m9iWdLpJ4zyG35UYrD+JvxGj8MWXlWJjmvpVPkx/3R03H2/nXzjpms6hpauun3ksCt94I2Aar6je3Wp3T3F9M887cF3OSfSgCveTy3d5Nc3Ll5pnMkjk8sx6mixtvOuMkHKjPFQsu0fMcVo+HkDXUx3YCp0oA2bS3NzfQbM5jr2zwfZKlqsRfe5GSa828H6YZrxWz1PXtXr2iQeU6InJHpQB1mljy48EYUVrKS+OwHpWdargDvWgJAFAC5oAldRt+UdqgC5cY4qUMu0tk5HGKYjggkfhQAxiFc45x1oeRXAZflPpQE3PnuetOWIKuMHNAFS6ztztJY9MVzep2yyXsMkq/OmcGummLbceh4rKuUEjneuG65oAzZoFmhbOCV5Ar5f8ZzNP4u1hmUIwuWGAPQ4/pX1JJtRiDyOlfP3xp0X+zfFi3sWfJv4w/TgOOCP5H8aAOKgdkdWRmV1OQynBFe2/Dr4kWVzpB0bxVc+SYhugu3BI+hP+f5V4cDkDNOzzg0AfXWm6xpF9EiW2r2MzdBtmXPT0z/AJwa1pdQ0vT4FkvL+1gjxnc8qjIAycfhzXxkCcjGRjjjtTi7qvzSOxznLHJznP8APmgD1v40fExNciOgeHHb+z0INzcMNpkYfwgf5x9a8bK+qinFgAah8wdzz9aALgxgYbnv701gQcDBFH3eT3pvO4ZGM96ADaFY8ngcUAAnGDjrS8jp0pwGBwPx9KAGAKT8vFNcYAIzn9KexAGNtNJbZ82MUAQtlsg9RW54ftXkgZkzl321inYBzXovgbTUNpD5ij5jvI9c0Adv4L0aSCAsxx0IFd7Yx+SyuRx1IrB06UoiQgYXqCDk10drIo55ORQBrw3W7aMYY1ejYkDnFY8O5yMD8K1YdygBgeB3oAnccZBI7fWnRLhssOKcpJ46DvmlyUXHFADtyn7wIP0p2MplBz0qIkvCRkZqvDvRTlzgnPNAE0wBGCOP1rJuk2PhRlSeDW0QGODhiO9QTwqygMACe3pQBzF+XQbtu729a89+NOnrqPgdb7kS2MyvgDqrfKf6V6tfWRAAjbI71h6vpwv9LvbFgNlxC8XI45GKAPkyNQOadgb88Yp0sRt5pIZB80TsjD3BxTMcA/pQA9cLg5yT0zTXLGTbgkKKGK7MEcClB5+U/n3oAYwznP4e1Q7scZWp2BKkg0zH0oAmVc+xBpH3MCOtK332BbODge9MbuOABQAgOzHenGQ+tNCk5I696Qd/WgBwO7JznNNYEngdaHB4wQBnpTpCSoIODQAyONpZFiUMzOQMAV7F4XQJEi7SUiAUlvQDFeY+FrQ3WqqzciFd554z2r1XQt3k+X/DmgDrLTIO5ScYGAe9bmmo8r5bkdx2rAgZhIqKSy9+5FdPpJ8pNuDjHTpQBvWkWMOvSrsallDEd6qWz/IVTpVyHP1HvQBIAMYJ/KkYoQ2cEU5F5zs+bPWhkHC7QaAI4XRMp3pGIKkBcgUrwgDftAwKntSoRZMBgeoNAFZJCOAtEmWJYc4qaY7nyg2qeRiqs2MlcnkUAR3ByMZxVVUAb3qy0e5ec4BqNQoXpkZ5oA+UvifZpYePdZgij8uPzfMAHbcAf61zEYOMg5PevUP2grNbfxla3MabftVopY+pUkfyxXmC5LY7YoADyvpQT8uT1z2pzKBxjnrSMoXOBkdc0ANVl+YZyelQmLJ+8anIyAcY3dxTcH+9QA/Pbof1phJB5xx2pDw2cc55NPPbjigBGIBBB5Pamc7smpNwOR+tRgNnFAC9GyRxTiAcZ4+lBOB81Jk7SeMdqAOm8CRjzrqTPBwvPevTNEiwzE/d9a878CorQyY5ZpMfpXqGiQMJCx4AoA2dLj8+7BUY9+ldVG6xxAAZcHFc5Z742ByFGa1reUvgqcqOtAGpFPJv6EdjWnAzvtwxB9qyoGBXIPHpV6CbaQFAJ9fSgDS3lTgnFOWRgemeKomR2cl/pVhZPU0AWTgpjNQjMKhWbdznGMUx2wC2RnpVcyEkZOTQBbZwchcAVA3D5Oc4ojnSOSNnQOoPIPekuJonvCYxtjPKqeooAjd8cL95vWmSrtKkEe4qRo1L5PBI6elIYjI3XigDwn9o4Z1rQ25ybZwfTG7ivHlBDEjnPTNetftFuo8TaXbqwYxWZZh3GWP+FeTjgZHLDvigBp6H160qDcN3I+tOXn5jwfSnfw4bgUAMb7mFbAxUHTuankIXAz1pvlsec0AKSVQAqMUn3Pp1oc4GAc4pDyAcEE9KADOW7YFHvTduM7s5p7D06fyoAFGVweKTHyZJGO1AfB6cUMBtBNAHWeAV4kAxgSg/pXrWikKxXqp5znrXkHgKXZdzxn7pwwxXrmksGQOq7jjqD0oA6WxQSKTjp1rRhWMcD9PWsPSLnc7jneDg/SuitkVkDDG4mgCeBAi88+1XbSIN83NR2y/MCeRjitCMbh8o/CgCNxlunakIwo61ZZSUzjik2jHGRx0NAFUnI2gk/hSAdOOlTAbWznANSfL14oApOwDY205druDgdMg0+UBiScZPYVAildwJyT79KALIlBJBqSNgOAOtUUPlBtx5PQmrMYbcoLAmgD5s+PMyyfEe5RXDGKCNDg52nGcfrXnanA59a2vGV22qeLtZvGfPm3L457A4H6CsdM7T2IoAEXIOT9KApB6kj3o57jr2pVBPHORQAyQcduah3AcbGqw3IBPFQllz900AOcBT8p5oi3MMN0FOcYPt2pg5PT8KACQEvu559aRWwenFKWyeaaeTkCgBwPQ9fakYnJyMU0sVOQeaCSV5HXnmgDU8N3Ag1RS7YDDbXr+h3pWDbHyxbGMV4hA4iYOcFgcgV6p4UvFmgSUjBYdc9DQB3mmKyzZYhQT0rp7PggBic9RXHWs+yUBm+ma6nTJGn2HdjPRhQB0KSAIoC8dya0I2XAbtWXbymMAPhuetXy6xQ+Y+NooAtAHGQR9DTHDE8gYFcprPii5sojNbWnnxA9c4NaWha4mq2yvseN/4kPagDUfGzGKgV2ClQNpzxT3yQe49apyBmfGSaAJFcoSZvvHoKiaUG4GMAY5Jpk5LwqFyCpqoqlsc5cHH0oA12eNuCudtYvjDV10XwrqmoOSpjhKx4PO9uFx+JrSU7VGcEmvGf2gdfLS2nh+F02xgXFxg5+Y/dX8Bz+IoA8bd8sSxyx5J9aUDdkknPSjYM9adggKOME9aAI+Qe4I4p65L4LZ4pqnnBHfvT8en40AEi56E59Ki+Qev608jg5b2yah84DjaaAHMxL5ANOVc4yMUrKdue+MUKAFOCSc0ANkAx6DOAKb3GBkd6djd149M0u3aQT1oAhbAbimk8evtSu2WJHWkx8vPBoAQNngHFd74CuEktGjZzvV8DHauC+7yMZNbfg+/NnqYXaSjck5wAaAPbkVSEZiGPc44NdDojP5fXCdvaud0SRJ7cS5+U87e1btoWEoEYwMfgKAOkgb5RknI5q87JdRNHklCPpWXZznaVfGcd607bYy9s9KAOZbT9XszJbwRrcWzZKtuGQPQitHRNOawVnfIkPVR0FbzqSp8vt0qEh1BYgE98UAK8hjQnHJ7VUkkwN24qfWlkYnkg++ahmy6kgf/AF6AHK3HIOTSIh808gZpEYFQGBzT8BZAGOKAKfirWrfw34futSunTMSYiU/xyEfKo/GvlHU7y41PUZ727cyXE7mSR/c/0rtPjH4sGv6+LGzdjp1iSgPZ5O7f0FcL5YEYYMOvSgBjcj/CnDgdeac0e3B5AxmlCjGSMjvQBHjml2nGAelPOcE5/wD1ULkLntQA1uVOfyNVCSD92rTLwxBOarkjJ+f+dAEoYgNyfYelJklf7o9aaysM9CaU4OO/9KAHdBjjPck1CxPc596kIw2OT9KjlUcjnNADDgdKRmx0PPtSEcVpaBol3rdz5VsAEXl3PQc/qaAMvcBw3Oa6zRPCd/e6LLPFE4llOY8nHA6V2eifD6yQlmja4kBAyx6Y7iu80bRJIB5E5kiAxtPb/PFAHm3gjULyyu307WI5Le5jwu1uh9D7ivWdPkK7eNwPUCptS8JWWsWoS4+S+j5huF7fX1FZWnQ3ljKbS+AEqHCn1HTNAHRgq75U5+lWhIYhjIIB6iqsbKmOmSKkUK3Xj2oA1be64I3cUST7ugxx61nt5QyoJUk+lMRfmPzkCgCzPKFX5/0oj+Ygk8VCiKTzJuPpUhlZfurwO57UAOlcJGXJx6VieIReX3h/U49Oci8a2cRleu7HQe9Ovbl76fyI3+QH5iv9Ks2cf2YBY4nC5yzOeSaAPkiIMMq4ZXBwQ3UEVOjeo/Gu7+MvhtdI8RLqVpFss9RJbaOAko+8Px6/nXBKxA9B0oAlLHnv2FKGYqAeR7UzK4JJpP4eKAJGHBBbrzxTS3AwRSRkquMcj0pSPmU9+9AETbudrHmoto/yKtyAZzjv1qqxTcfkJ564oAnBIdgBkUrYJ2ikI+8Md/WmjseRxQAoIz0O6oZGyTkng1IORzUbqByfwxQBJYWb397FbR8FzkkDOB3Ne2eDNDjtdPjht0K4Odxxkn1Ncd8MtD8+4+1bDvOB83OBXtul6Y0cYHyjFAEdjbXe4LbsgYdjWy11dWyhLu0yh6svNQtZNjejsjjuBUtvcahGmx/LuE9xg0AWrae1l+4xUjqD1qe8sLe+hG9Q5X7rjrWaskVyzMqGKRfvKRg1Y0y5+zzmCU7kb7rentQBVa3+zsY3O5RwM9qsJFFKqgAqR2FO1zbDNHJn5WODUcUsWzIfb7jtQAps4i3MsmfTirC20ACj94c8cmoUlgL5BL8ckVcWWFIi5cgDnJHSgClqVxHZJlI1z0AxyTWcsDXa+Zqtz9nhPSJDgt9TWZcX0mralm1fKqcByOAKr654m0bw7xcYvr4DIQtnB/pQB0X2iys4VXT7aaXIJyi4HHqTWVJrk0rbZoUiGOx3GuU0zVNc8TTtLI72lk5+WOBccfWu00nRbaJFBDZPBLHJJ9aAMTxjoy+KPDM1iXBlA82FicYcDj8+lfOZwo2sMMpw3sRX19Dp0cYG0D5a+YviDp7aV401a1MWyPzjJGMY+VuR/OgDncDd1NLghu2Md6dgMOMj0poGDz19aAANuIHA9c9alGARiowwBUkZNSD5T0FADXJIIzVfHs35VZG0nB4BqLIHG1qAFYDfx+NNYYK5IxSkASkA9M01zk4zQAp5bPGKltoWmnijTGSc8jNQIPmA7Vs+GYhPq8aDG7HAPegD2L4Z6duVizFcDBr1W208KF+YnjrXlfgiV7G9eGUbN3OSa9fsZg0QOQ2B1oAbLEqJwvasa6QbswyFGz1FbVxKCCpU5PTFYd5tiJaXcB60AZmozy2rpIyrnoXBxkUXj7VSUtgv0IrC8V6tAlg6Ik8xJ/gQ8Vwer+PpIbRYIFxsHBY85+lAHq/iO+X+wYp2PzKwB+tc23imGBZQ5P7sDkd68/1n4kQ6t4bgt5EaG+8wblH3SAOtYby3F3pNzNGSzHnI7igD6C0C+a/skngjGxxxnvUuqXEzabdxEeUdpAI61j/DDXYtT8O2oRgJIQEYEegqD4qeIE8P6V9rzu3HYAPWgDmLzVhpdmNNsJv9JfmaVz9z6VzWi6dBquvBDL9oIbLMTkE1ytg2oeMvEpkQiOGRskZ6CvfPCPhC20yFGiQb8csBQB1Hh3S4YbZESIKAABgYrbSyQ5Yx0WKpEgLMOPerMt6pBWM84oAoCLYSK+bvjh5f/Cw7rGA3kRBseu2vpXBZsua+W/jAyv8AEjWj1IdFz9EFAHHknGAfwqTlsk9T3pmDjHQ+tPjPBLA4FADepoQEZ3NmlB4x7+lAGADk0ANZTnhgfWkO7Pb9KdnAJHGepNVixyfloAe3Ehz1J7Ukm7eeKc3Vux7j0puBgnnNAD0YBCe9afhe6jt9ZtzNjYTtJJxisnG3v+VC/KSwPNAH0hZW8coimHzZH3wOK6jTp3iYAsSnfFeP/C7xVuZdPvJCB0Ut+levW3KKy7WB/KgDokkhmRedp9aralCfKJ4bjioILuNFAaPGO9TXNyJkJGD24oA5ySGWeFo9g5z2rxb4meDJLSaK+sE3uciWJepHYgV7wzMoIwfwrJvNPiuG86U5ZTkUAfJ8ymRMKcMp4HvXYeFdVT7P5NyFyVKnNdR43+HUk0k+paKAHJLNDjAb3HvXl6SSW8jKw2yIcMrDkH0oA67SNaufDGqP9lffp7ksy54XPetfxz4usfFWkrZW0Rl2YcyHorVyVho9/qdiNQML/YhJsLdAff6VvnQrZIC1odrMPmUdqANj4IWKJdTyOgyDj8K+ibOCIRgq2eOmOleL/Duy+wwK8YyWbDc4OK9g0mceWABz70AXkgXeewpxtRkHjGasLyuQOar3d9BZW0k13KkMEY3M7HAAoAmZI0jLykCNBuOewHWvjfxVfR6l4q1a9Ry6T3Mjxk91zx+mK9G+J3xUl1eK60rw+DFp8nySXRJDyjuAOwP615GyguB3HpQA9CApyeaTk8jgUw9SMYX1qRQMcmgA2/MGGSKGJ3AZp2TznAAqMg78e3UUASFcj5vwqAjnt+RqU7gOcketRFeTy1ACykbjjOc9aaRgHOMHinOAs7emTzSOfYYIoAZx0B4ox83OMGlOD0BC96RgegPFAD4JmhlDRkgg8Edq9S8H/E9dPtUt9UtXkVePMjPb6GvKS3XdwBxmnBgqgA9qAPpOz8c6JqcWYLoAjqjDDflWnba/YsmyOTcT2zXy/EzKCVYhuvFbmi+Kr2yKhsSop7/e+maAPo1b1XB8teevWqc0k12yxopx32mvOtF8ax3CgmZgwA3IV5B/qK77QNUSaIPCM56n0oA3pIE+zCPaFAUDHXFfL/xEsVtPGl5DGMLKwdSBwc19REG5UiM5H8VeZfEfRre81qytkt1LoVZpcfMBzx9KANbwdp8X/CDxWkgG7aVJrm30cwzOrE8HjHcV3Omae9jp8cIYsmBtJ6H2qjf20TSfOXhdicGgDF0kvaKArYYHPNdJaeJJoNqG38wf3lNYUGkXROWb7R7qOa53xJ40h0aaWw0wR3F6nyvMeUjPcD1NAHrFz4yj02ya5viLa2A++55P0HevEPiT48uvFc0cEHmW+mx/8s2PzSNnq2P5VyWqapeapKJtQuJJ5c/xHgemB2qm5IXOORQAHnimjk89aTewGTyaagzjJ+lADwQSc8YpwI3Z7CkOOwFBAOR2oAN4PJHFIXyRgU87QvOMYoOMjjHpQA0Eq2QevaoyWz/FUmBu74/nSYT+6/5mgBkozK+AAcn8qY2Gbgnp1p7EmWXjgsf50gJ/SgBrZ24HTvTA5BJJ6dBUiYIO7gVHuAI+XPNACnleuR70YX60rnk5XimhuQoHX9KAJdwVRx+GaMYTIzUbEHp92ngnYD0xQBb0g7tTtVO4gvggdx6V7l4R0opcLJEX8mQZaJieK8U8LIk/iGzWZfk3Zya96m1yz8N6aklwcttzGM8k0AdjLc2ukW3m3MixjsueSfSuc0e0k1HV5tQvY1ZXPyqR/D2rB0H7b4s1H7fqAKwKcxoOgr060t0jjX5cD6UANNmiRBFHyj+Fu1Zd5aptIIkX/gO4V0LlWTJPFUp2U9OlAHmfxI1VvDvhZ2t8m4vn+zq33dgwSzD1OOPxrwJOM8da9U+Pt7v1jS9P3sVhgaZ17ZY4H6CvKz1zmgCVHTB9aTc2cNUQOMlhmlzuOTQBK5OecEUgOOcYApC24AY474oBwPm5oAep2qT1oUkgHOD6YpmdnzADHpR5nzfWgCQvxjvQGPfOcZqMuDx79aN/zErnI9aAHM/moc/LSb09DTAQXwT75pcp70AD5E8q5J+cjP402TIOBj3ok+W7lyQfnOAPrRIBwfUc0AMViNxPI9KXAxkdPWkyBglRTmYEnKjFAAcADaSfrTCB3apUIEZz36VCSvPP6UAOGxcYJyadGoJIJyPWog+eNox2oBZc4I5oAt2Mz2t5HNE5RkYEEV3nhlLrxvr4Oof8etv1UcA+1echgeO+a94+FEcFrpjXAjwH446/j/n/AAoA9J0qytrOBI4ECooA4rXJ+6B0xWVpwyrS5JDHgGtVGTbzyaAK87Or8LwRVaeVIwZJSqqqkkngAD1NXHaNiVQ8r1Aryn42eKP7N0c6Pat/pl2P3hB5jj7/AIn+VAHkfjrXn8Q+Jr2+IxEW8uJTzhF4H59fxrBHC4pHkB5pMZUnpmgB4+5x2pyKD1I+lR9UwKAxxz27UATRlM8N+lBKKQSck9OKgGc57elDE9O/rQBK7KW4NNdhx396iXBODzQeOBQBKD+NC5xyajLc4FG/PsaAHnKnn8aXPoy/lUTux55PbFPDcdqAGzkNczMBtDOzAenJ4pwkJ2KelFFADXO5iOgFR7jnFFFABk8ikLEtiiigBGYgjFOB4NFFAAj4IJGQOcV7B4Qt3WSw8qeSON/vIOQf85oooA9bW5eIQQqBjpk/SryyFpgcDgZoooAgF3taYiMZBx1r5g+IV5JeeMtVmmJLebtGTnAHQCiigDm1Y81IrEg5oooAAaaxIHFFFAAvzkZ4pGYj3oooAB0oz83AoooAFbJJ70oGWUDuKKKAELE49KNx9vyoooA//9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Three-month-old infant with achondroplasia. Note the large head, short extremities, and protruding abdomen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Sadler T, PhD. Langman's Medical Embryology, Ninth Edition Image Bank. Baltimore: Lippincott Williams &amp; Wilkins, 2003. Copyright &copy;2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_17_21791=[""].join("\n");
var outline_f21_17_21791=null;
